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ABSTRACT
Membrane proteins are complexes formed of long chains of amino acids capable of
carrying out various functions in cellular life. Correct folding of the protein struc-
ture is relevant for its function, the folding patterns arising from the amino acid
sequence. Membrane proteins are also primary targets for many diseases, their func-
tion being inhibited by factors such as mutations in the gene encoding the protein
sequence. As a result, certain amino acids in the sequence may be point mutated,
often with unpleasant consequences to the protein function.
Due to the small scale of membrane proteins and their primary interaction part-
ners, lipids and ions, observing the molecular mechanisms and dynamics of protein
function can be impossible by traditional experimental measurements. Here, we are
able to bypass the visual limit by employing atomistic molecular dynamics simula-
tions in order to study the properties of these membrane proteins. Understanding
the dynamics of proteins at the atomistic level can be beneﬁcial for pharmaceutical
development as drugs targeting membrane proteins are cures for many diseases. Our
goal in this Thesis is to explore two different types of membrane proteins, to study
the dynamics and molecular mechanisms of their native states at an atomistic level,
and to employ various computational methods to establish potential links between
their function and related diseases.
The ﬁrst part of this Thesis focuses on P2, a major protein of the myelin sheath
of the peripheral nervous system, active in stacking myelin leaﬂets together. Cer-
tain mutations in the gene encoding P2 have been connected with an inherited de-
myelinating disease, while other mutations have been found to affect P2 activity in
other ways. We performed sets of simulations on the P2 wild type and a number of
its point mutated variants in order to gain insight on its structural dynamics at an
atomistic level, and found the point mutants to alter its properties. The results also
provide clues on how the changed activity is related to the demyelinating diseases.
We also discovered a mechanism for the opening of the P2 barrel structure, suggest-
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ing a similar mechanism for other fatty acid binding proteins as well. The research
was conducted alongside an experimental group allowing us to produce a wide and
thorough study on the protein function.
The second part of this Thesis focuses on rhodopsin, a G protein-coupled recep-
tor (GPCR) of the visual transduction cycle. Recent studies have found rhodopsin
to be a possible scramblase – to rapidly facilitate lipid translocation between the two
membrane leaﬂets, which is an essential element of cellular physiology. Scramblases
are found in nearly every cellular membrane, yet the mechanisms behind their func-
tion have remained unknown at a molecular level. Their dysfunction has also been
linked to a number of severe diseases. We extensively studied the molecular mecha-
nisms with which rhodopsin is able to create an energetically favorable environment
for scramblase-assisted lipid ﬂip–ﬂop and found its properties to be non-selective re-
garding the lipid headgroup. The mechanism functioned in a manner that could be
generalized to other GPCRs as well.
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TIIVISTELMÄ
Kalvoproteiinit ovat aminohappoketjuista muodostuvia monimutkaisia komplekse-
ja, joilla on tärkeä rooli solujen ylläpidossa. Jotta proteiini pystyisi toteuttamaan teh-
tävänsä kalvossa, sen muodostaman aminohappoketjun täytyy ensin laskostua oi-
keanlaiseen muotoon. Kalvoproteiinien toiminta heikkenee usein monien sairauk-
sien johdosta. Heikentävinä tekijöinä saattavat toimia muun muassa mutaatiot pro-
teiinin geenissä. Tämän seurauksena tietyt aminohapot proteiinissa saattavat muut-
tua toisiksi, vaikuttaen siten proteiinin rakenteeseen ja dynamiikkaan.
Kalvoproteiinit ovat kooltaan pieniä, joten niiden toimintamekanismien ja dyna-
miikan tutkiminen molekyylitasolla perinteisin menetelmin on vaikeaa. Perinteiset
pienen kokoluokan tutkimusongelmat voidaan kiertää käyttämällä atomitason mo-
lekyylidynamiikkasimulaatioita, joissa kalvoproteiinisysteemejä tutkitaan laskennal-
lisesti. Proteiinien rakenteellisen dynamiikan ymmärtäminen atomitasolla voi ol-
la hyödyllistä esimerkiksi lääkekehityksessä, jolloin lääkkeillä voitaisiin pyrkiä kor-
jaamaan vaurioituneita proteiineja. Tässä väitöskirjassa perehdymme kahteen hyvin
erityyppiseen kalvoproteiiniin ja tutkimme niiden natiivitilojen dynamiikkaa sekä
toimintamekanismeja atomitasolla. Tarkoituksenamme on löytää mahdollisia syy-
seuraus-suhteita niiden toiminnan katkeamisen ja siitä aiheutuvien sairausten välillä.
Väitöskirjan ensimmäinen osa koskee kalvoproteiinia P2, joka on yksi ääreisher-
moston myeliinitupen yleisimpiä proteiineja. Viimeaikaiset tutkimukset ovat yhdis-
täneet tietyt tämän proteiinin geenimutaatiot erääseen periytyvään myeliiniä hajot-
tavaan sairauteen. Muiden mutaatioiden on havaittu vaikuttavan proteiinin aktiivi-
suuteen toisilla tavoilla. Me tutkimme P2-proteiinia ja useita sen pistemutatoituja
variantteja atomitasolla saadaksemme lisää tietoa sen dynaamisista ominaisuuksista
ja nähdäksemme, miten pistemutaatiot vaikuttavat näihin ominaisuuksiin. Löysim-
me vihjeitä siitä, kuinka tämä muuttunut aktiivisuus saattaisi aiheuttaa myeliinika-
toa heikentämällä proteiinin kalvonsitomisominaisuuksia. Löysimme myös meka-
nismin, jolla tämän proteiinin tynnyrimäinen rakenne pääsee aukeamaan tavalla,
v
jonka voi yleistää muihinkin samantyyppisiin proteiineihin. Tämä osa tutkimuk-
sesta on tehty yhteistyössä kokeellisen ryhmän kanssa, joten pystyimme muodosta-
maan laajan ja kattavan kuvan kyseisen proteiinin toimintaperiaatteista.
Väitöskirjan toinen osa käsittelee rodopsiinia, silmässä sijaitsevaaG-proteiini-kyt-
kentäistä reseptoria (GPCR). Rodopsiinin on viimeaikoina havaittu omaavan tietty-
jä skramblaasiproteiinin ominaisuuksia – se kykenee nopeuttamaan lipidien siirty-
mistä solukalvon läpi, mikä on solun toiminnan kannalta elintärkeää. Skramblaasi-
proteiineja löytyy lähes jokaisesta solun kalvorakenteesta, mutta niiden toimintame-
kanismit ovat siitä huolimatta edelleen hämärän peitossa. Väärin toimivien skramb-
laasien on myös havaittu aiheuttavan useita vaarallisia sairauksia. Tutkimme atomi-
tasolla mekanismia, jolla tämä prosessi toimii. Havaitsimme lipidien siirtymisen ta-
pahtuvan spontaanisti rodopsiinin pinnalla tavalla, joka ei ole riippuvainen lipidin
pääryhmästä. Mekanismin toimintaperiaate on sellainen, jonka voisi yleistää käsit-
tämään muitakin GPCR-tyypin proteiineja niiden tyypillisestä rakenteesta johtuen.
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Well, this is it. The long journey towards becoming a Doctor of Science that began
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similarities to running a marathon – an excited start continued by steady progress
that at some point hit a wall, followed up with a sprint to the ﬁnish line.
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Tuomo Nieminen
There is nothing like looking, if you want to ﬁnd something. You certainly usually
ﬁnd something, if you look, but it is not always quite the something you were after.
J.R.R. Tolkien
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1 INTRODUCTION
Cells are the basic building blocks of every living organism. They are extremely
complex structures containing multiple different organelles such as the nucleus, mi-
tochondrion, endoplasmic reticulum and the Golgi device, each with their own spe-
ciﬁc function in cellular life. The cytoplasmic interior of a cell – as well as every
cellular organelle – is surrounded by a membrane. This membrane, at its core, is a
bilayer structure consisting mainly of lipids and proteins. It has numerous functions
ranging from protecting the organelle from its surroundings to regulating the con-
ditions within. Notable membrane structures relevant for this Thesis include the
plasma membrane, which surrounds the entirety of a cell, and the myelin sheath,
which is a special type of a membrane protecting the nerve ﬁbers in the nervous
system.
Each membrane type has its own speciﬁc composition of lipids and proteins.
Even the lipid composition between the inner and outer leaﬂets of a bilayer is usu-
ally different within the same membrane. This lipid asymmetry within a bilayer is
vital for many cellular functions, and sustaining it is the main function of many pro-
teins [2]. In some cases, inducing a speciﬁc type of lipid asymmetry can be a key to
create a signal from within a cell to extracellular enzymes. This can be achieved by
transferring speciﬁc types of lipids, typically found only in the cytosolic leaﬂet of a
bilayer, across the membrane interior into the extracellular leaﬂet. Appearance of
these lipids on the cell surface acts as a signal resulting in, for instance, a controlled
method for degrading a sick cell [3]. The translocation of lipids across themembrane
interior is facilitated by certain types of proteins called ﬂippases and scramblases [4].
Loss of function in these proteins – due to mutations or other issues – can have severe
consequences as the signaling pathway calling for outside aid is disrupted.
Proteins have many different roles in membranes. Some act as signaling path-
ways, others as fatty acid transporters, and many proteins may even have multiple
purposes. A group of signaling proteins of the G protein-coupled receptor (GPCR)
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Figure 1.1 A schematic drawing of the interior of a cell. Figure modiﬁed from Ref. [1].
family have recently been found to have scramblase properties – they are able to act
as lipid translocators in addition to their primary function [5]. In the myelin sheath,
there are a number of fatty acid binding proteins, capable of transporting lipids, such
as cholesterol, into the myelin [6]. These same proteins are also actively involved in
binding the alternating layers of myelin together, ensuring a compact and insulating
structure. Mutations targeting these proteins are involved in demyelinating diseases
where the integrity of the myelin sheath is compromised resulting in interferences
in the transmission of nerve signals [7].
Cell membranes and the function of membrane proteins have traditionally been
studied experimentally in laboratory conditions. The downside of these traditional
methods is the lack of information on events occurring on atomistic scale, such as
lipid-lipid or lipid-protein interactions. Recent evolution in computing has brought
molecular dynamics simulations up as an excellent alternative for the study of nano-
scale biological systems. The atom-level resolution of the simulated systems allows
for research onmolecularmechanisms ofmembrane proteins, whichwould typically
be invisible to human eye. Combining simulations with experimental results allows
us to draw an extensive picture on events happening on a cellular surface.
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1.1 Research objectives and scope of the Thesis
The research performed in this Thesis revolves around two proteins, both with very
speciﬁc and important functions in their respective locations. Due to their roles in
the cellular membrane, dysfunction of either protein can lead to severe health issues.
In order to properly establish a link between the failure of protein function to the
devastating effects arising as a result, one ﬁrst has to understand the dynamics and the
molecular mechanisms of the protein under native conditions at an atomistic level.
Changes in protein function can be observed by altering the conditions under which
they normally function. Our goal in this Thesis is to employ atomistic molecular
dynamics simulations on these proteins in order to study the function of their native
states and discover the potential root causes of their protein-related diseases through
various computational methods.
Our ﬁrst target is the protein P2 – a peripheral membrane protein found in the
myelin sheath of the peripheral nervous system. The nervous system is a vital part of
the human body that is in control of everyone’s actions. Whether it is conscious ac-
tions such as walking or talking, or subconscious actions such as breathing or heart-
beats, actions such as these are controlled by neural impulses that travel through the
human body. Damage to the nervous system, often caused by diseases or mutations
targeting proteins of the myelin sheath, can affect the speed at which nerves are able
to transmit these impulses and in severe cases block their passage completely. As a
result, this may cause weakened motor functions, loss of memory and other devas-
tating effects. In many cases, these diseases target membrane proteins in charge of
sustaining the integrity of the nervous system [8]. Investigating these proteins at an
atomistic level can provide deep insight on their function within the nervous system
and show how the loss of that function due to a disease will ultimately lead to the
aforementioned issues.
Myelin stacking in the central nervous system is known to be mainly performed
by the myelin basic protein [9]. In the peripheral nervous system, myelin basic pro-
tein is not as prevalent, suggesting that adjacent myelin sheaths are held together by
different proteins, such as P2. Therefore, diseases targeting P2 may change its prop-
erties, eventually resulting in demyelination. Recent advances have found implica-
tions of such effects in the Charcot-Marie-Tooth disease, facilitating demyelination
in the peripheral nervous system (PNS) [10]. As a peripheral membrane protein,
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the crystal structure of P2 has been relatively easy to resolve to an extremely high
detail [11], making it a prime candidate for computational studies. By conducting
molecular dynamics simulations at an atomistic detail, we are able to study the wild
type P2 along with its carefully selected point mutants and compare their functional
properties with each other in order to uncover how the dynamics of the protein
change upon mutation. By collaborating with an experimental wet lab group, our
goal was to create a wide and thorough picture on the dynamics of P2 and several of
its point mutated variants in order to further the research on diseases of the periph-
eral nervous system.
Our second protein target discussed in this Thesis is rhodopsin, a well-studied
G protein-coupled receptor found in the retina of the human eye. Our interest in
rhodopsin does not involve its relevance in the visual sense, but in the fact that opsin,
the apoprotein of rhodopsin, was recently revealed to greatly facilitate lipid translo-
cation between two membrane leaﬂets – a property common with all scramblase
proteins [12]. Lipid translocation is intrinsically a very slow process, therefore spe-
ciﬁc proteins are needed to increase the rate of lipid ﬂip–ﬂop to a high enough level
to sustain essential cellular events.
Scramblase proteins are found in nearly every cellular component. They are an
interesting group of proteins in a sense that their main function involves disrupting
the natural lipid composition of a cellular membrane. They are relevant for sus-
taining cellular life in many cases such as helping cellular growth by transferring
multiple types of lipids to the cellular surface, or apoptosis, where transfer of phos-
phatidylserine to the surface marks a sick cell to be degraded by phagocytes [13].
In other cases, the scrambling of the lipid composition of a membrane may, for in-
stance, often hinder the function of many proteins that depend on the surrounding
lipid environment [14]. One unanswered question regarding scramblase proteins is
how their function (or dysfunction) eventually leads to diseases that have been linked
to the protein group.
The existence of scramblase proteins has been known for a long time, but the
identities of speciﬁc lipid translocators have remained unknown. Only in the past
few years has progress been made in identifying potential scramblase candidates [15,
16], but the lack of available crystal structures on many transmembrane proteins
have made their study extremely difﬁcult. As a result, the molecular mechanisms be-
hind protein-facilitated lipid scrambling has remained unknown. The crystal struc-
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ture of rhodopsin has luckily been resolved to a highly accurate level, making it a
prime target for molecular dynamics simulations [17]. By employing molecular dy-
namics on rhodopsin at an atomistic level, our goal was to uncover these elusive
mechanisms to further our knowledge on these basic cellular functions. Understand-
ing the mechanisms behind GPCR-facilitated lipid ﬂip–ﬂop may have beneﬁts even
as far as research on a cure for cancer, as debilitation of lipid scrambling pathways
is prevalent in its initial stages, and as GPCRs are primary targets in drug research
[18].
1.2 Structure of the dissertation
This Thesis is divided into eight chapters, beginning from the introduction to the
research subjects in this ﬁrst chapter. In the second chapter we discuss the basic bio-
logical background relevant to understanding the concepts in this Thesis. Cells and
their building blocks – lipids and proteins – are introduced. One major subgroup of
the transmembrane proteins – the G protein-coupled receptors are further discussed.
Protein synthesis and mutations are also discussed at a basic level.
In the third chapter we focus on the background of Papers I-III of this Thesis. The
nervous system and its main function is introduced. Further background is given on
myelin sheath – the special membrane structure present in the nerve cells – and the
myelin protein P2 is introduced. Several common diseases of the nervous system are
also discussed.
In the fourth chapter we present background relevant to Paper IV of this Thesis.
The concept of transbilayer lipidmotion is introduced alongwith its difﬁculty due to
the amphipathic properties of lipids. Proteins facilitating this process – ﬂippases and
scramblases – are introduced with special focus on rhodopsin, a G protein-coupled
receptor. Diseases related to scramblase dysfunction are discussed with an example
given in the loss of the ability to perform programmed cell death.
The ﬁfth chapter introduces the computational mechanics behind molecular dy-
namics simulations. A basic introduction is given on different ways systems can
be built for simulation along with the equations on which molecular dynamics are
based on. The main analysis methods used in the Papers of this Thesis are presented.
The concept of free energy is also discussed due to its relevance in lipid ﬂip–ﬂop.
The sixth chapter gives an overview on the simulated systems of all four Papers.
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In the seventh chapter we discuss the results of all four Papers included in this Thesis.
Sections 7.1 to 7.3 include Papers I-III and research conducted on myelin protein P2.
Section 7.4 discusses Paper IV and research conducted on scramblase function. This
section includes large quantities of unpublished data, which is referenced to in the
review article that is the ﬁnal Paper of this Thesis. These unpublished results are
discussed in greater depth.
The ﬁnal chapter summarizes the research conducted for this Thesis and presents
ideas for future prospects.
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2 BIOLOGICAL BACKGROUND
This chapter comprises an introduction to lipids and proteins, the main building
blocks of every cell. Special focus is given to G protein-coupled receptors (GPCRs),
the largest subgroup of transmembrane proteins relevant for Paper IV of this Thesis.
A short introduction on protein synthesis, mutations and their roles in disease is also
presented as point mutated proteins are the main targets of research in Papers I-III of
this Thesis. The main reference on the basic knowledge given in this chapter is the
book by Alberts et al. [19].
2.1 Cellular life
Cells are the basic structural units of every living organism. They are highly com-
plex structures, containing all the biomolecules and organic machinery required for
sustaining life, surrounded by a plasma membrane, which separates the cell from its
surroundings. The plasma membrane is a lipid bilayer, built of two layers of amphi-
pathic phospholipids – fatty acids with a hydrophilic head group and a hydrophobic
tail group – and proteins embedded in the bilayer. Other primary constituents of
a cell membrane are cholesterol – a small lipid essential for a number of biological
processes – and carbohydrates, which generally attach to certain lipids and proteins
on the extracellular side of the membrane.
Even in the cell membrane, each constituent has an important function in sus-
taining cellular life. Membrane proteins can work as transporters, transferring ei-
ther lipids or ions across the hydrophobic interior of the membrane. They can also
have a role in keeping the membrane structure intact, or give signals to other or-
ganelles, transporting information from one cell to another. Cholesterol can bind
itself to various proteins, and even other lipids, giving it a major role in many cases as
a stabilizer. By attaching itself between lipid tails, it both strengthens the membrane
structure and helps keep the lipids and proteins in constant motion. As a result, the
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cell membrane is a ﬂuid, which is a prerequisite for many of its possible functions.
In addition to the plasma membrane of the cell, lipid bilayer structures can be
found in many other places as well. Many cellular components such as the endoplas-
mic reticulum, the Golgi device and the mitochondria have a membrane separating
them from their surroundings. An important membrane structure related to this
Thesis is the myelin sheath, a multilamellar membrane structure found in the ner-
vous system, consisting of alternating layers of lipids and proteins.
2.1.1 Lipids
Cells are protected from their environment by a membrane structure that encloses
the cellular components (see Fig. 2.1). These membranes are mainly composed of
lipids and proteins and their compositions are quite different in different cell types.
Lipids are small biomolecules with varying chemical structures united bymany com-
mon features such as amphiphilicity, insolubility in water and solubility in nonpolar
organic solvents [20, 21]. Due to their amphiphilic nature, lipids spontaneously
form membrane-like structures in water – their hydrophilic headgroups forming
bonds with water molecules while their hydrophobic tails prefer to interact with
each other. This results in either a spherical micelle consisting of a single layer of
lipids with the tailgroups pointing towards the center, or more commonly a bilayer
that surrounds a larger volume of ﬂuid, typically an organelle or even a whole cell.
The lipids found in cell membranes are often divided into three classes depending on
their general structure: phospholipids, glycolipids and sterols [22].
Phospholipids are the most abundant lipid group found in biological membranes.
They consist of a polar hydrophilic headgroup, a phosphate group, a glycerol back-
bone and two hydrocarbon tails formed out of fatty acids. The type of a phospho-
lipid is deﬁned by its headgroup and its hydrocarbon tails, and its structure can easily
be derived from its name. For instance, POPC, or 1-palmitoyl-2-oleoylphosphatidyl-
choline, is a common component of all cell membranes (visualized in Fig. 2.2).
The ﬁrst part of the name (PO) deﬁnes the tailgroup – the ﬁrst hydrocarbon
tail is a palmitic acid and the second an oleic acid. Palmitic acid is a saturated fatty
acid consisting of 16 carbon atoms connected by single bonds, often denoted by
a lipid number of 16:0, the latter number describing the number of double bonds
in the carbon chain. Oleic acid is a monounsaturated acid, meaning it has a single
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Figure 2.1 Schematic picture of a cellular membrane. Figure adapted from Ref. [23].
double bond in the carbon chain, consisting of 18 carbon atoms, and denoted by
a lipid number of 18:1. Oleic acid is also classiﬁed as an omega-9 fatty acid due to
the double bond located at the ninth bond from the end of the tail. The lengths of
the hydrocarbon tails of membrane lipids are generally between 14 and 24 carbon
atoms, meaning that a typical lipid bilayer has a thickness of 3 – 6 nanometres. The
tail lengths and the number of double bonds also affect membrane ﬂuidity.
The second part of the lipid name (PC) deﬁnes the headgroup – a charged choline
at the end of the lipid connected to a phosphate group. There is a large variety of
different headgroups ranging from a single hydrogen atom to extremely complex
molecular chains, all giving the phospholipid speciﬁc properties at the membrane
surface. The charge of the headgroup also has extreme importance in determin-
ing how the membrane surface behaves, creating repulsion between other similarly
charged molecules and attracting speciﬁc parts of membrane proteins. The size and
charge of the lipid headgroup also affect its ability to submerge into the hydropho-
bic membrane interior. This diversity allows lipids to partake in many vital cellular
activities such as cellular signaling or substrate transport [24].
Glycolipids are a speciﬁc group of lipids found only on the outer monolayer of
a membrane [25]. They are recognizable by long sugar chains attached to the lipid
backbone protruding from the membrane surface. They have several main func-
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Figure 2.2 Molecular structures of POPC (above) and cholesterol (below). Structures visualized with
Visual Molecular Dynamics (VMD) [26] and rendered using the Tachyon ray tracing library
[27].
tions depending on their localization, all related to the saccharide chains. One main
function is to serve as recognition sites for interactions between two cells, where the
saccharides bind to carbohydrate-binding proteins or to the carbohydrates found on
a neighboring cell. Glycolipids also have an important role in deﬁning the blood
group of a person. A speciﬁc glycolipid found on the surface of red blood cells is
able to bind only one type of three different antigens. The O blood group is deﬁned
by binding of the basic form of the antigen. By addition of one of two different
groups to the saccharide chain, the antigen is converted to a form found in people
with blood groups A or B. An exception is found in the AB blood group where the
antigen is able to bind either one of these two modiﬁed groups. As a consequence,
glycolipids have important roles in the immune system, where the antigens of the
red blood cells are able to identify whether an external cell with which they interact
belongs to the body or not, and activate the immune system against invaders such as
viruses or bacteria. Glycolipids serve as a prime example of lipids function in cellular
signaling.
Sterols are a group of small lipids with rigid structures consisting of three cyclo-
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hexane rings and a cyclopentane ring connected to a short functional group acting as
the lipid tail. The headgroup is a small polar hydroxyl group found on the ﬁrst ring.
Due to the rigidity of the core structure and their small size, sterols of both animal
and plant cells have general functions of supportingmembrane structures, regulating
membrane ﬂuidity and modulating the activities of many membrane proteins [28].
The most common sterol found in animal cells is cholesterol (see Fig. 2.2). It is a
well-studied molecule composing around 30 % of all biological membranes. Choles-
terol inserts itself into a lipid bilayer with the hydroxyl group at the membrane sur-
face along with the other lipid headgroups. The ring structure is in the membrane
interior, interacting with nearby lipid tailgroups reducing their mobility. As a result,
cholesterol concentration has a major effect on the relative ﬂuidity of local areas of
the bilayer, and whether these areas are in an ordered or disordered phase [29]. Ar-
eas with large cholesterol concentrations have more order and they become more
tightly packed and less permeable to small water-soluble molecules. Conversely, the
lack of cholesterol allows the lipid tails to move more freely, increasing the disorder.
Even though the bilayer structure in certain areas can become quite solid, the lipid
bilayer itself remains in a liquid state. Therefore, these two states are referred to as
liquid-ordered (Lo) and liquid-disordered (Ld) states. The existence of these states
has led to the hypothesis of lipid rafts – ordered membrane domains rich in choles-
terol that are involved in transporting proteins and other large molecules by ﬂoating
along the cell surface [30]. As the lipid rafts bind proteins and other enzymes, they
have important roles as platforms for cellular signaling.
In addition to its effect on membrane structure, cholesterol also has an important
role in stabilizing and activating many membrane proteins. For instance, many in-
tegral membrane proteins of the GPCR family have a cholesterol-binding interface
with bound cholesterol molecules found after crystallization [31, 32]. Upon bind-
ing, cholesterol increases the packing of the protein structure, increasing its thermal
stability and ability to form protein dimers.
Due to its small size, cholesterol is also able to ﬂip–ﬂop easily from one layer
of a membrane to the other. For instance, in order to reduce membrane curvature
in certain areas, cholesterol can readily transfer from the overcrowded side of the
membrane to the other and help relax membrane stress [33].
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2.1.2 Proteins
Proteins are masswise the most abundant group of molecules found in a cell. They
act both as building blocks of the cellular structure and as executors of the main
functions of the cell. Proteins have extremely complex structures, having developed
over the years of evolution to perform speciﬁc tasks within the cell. They consist
of a chain of amino acids, the length of which deﬁnes the size of the protein. There
are a total of 20 different types of natural amino acids, each with the same backbone
consisting of an amino group, a carbonyl group and a hydrogen atom, and a side-
chain group different for each amino acid. The side-chains can be large or small in
size, acidic or basic, polar or nonpolar, all depending on the amino acid in question.
The amino acid sequence, which deﬁnes a protein, is called the primary structure
of the protein. It has an important role in both intermolecular and intramolecu-
lar interactions. The intramolecular interactions deﬁne the ﬁnal three-dimensional
form of the protein – due to the electrostatic and van der Waals forces between each
amino acid, the protein will fold over time to a conformation where it has the lowest
possible free energy. The aforementioned forces along with the forming hydrogen
bonds and a hydrophobic clustering force then stabilize the ﬁnal form of the folded
protein. The ﬁnal three-dimensional structure of the protein is referred to as its ter-
tiary structure.
When observing partial segments of the protein, it can be seen that groups of
amino acids located near each other form speciﬁc types of structures. These struc-
tures are referred to as the secondary structure of a protein. They are well-known
spontaneously forming structures that are found in different proteins. The two most
common secondary structures are the alpha-helix and the beta-sheet. When the back-
bone of an amino acid chain rotates itself around the main axis in a certain fashion,
it forms a so-called alpha-helical structure. A certain amount of rotation allows the
side-chains of the amino acids in the same polypeptide chain to support each other,
creating a stable molecular structure common in the majority of proteins bound in-
side a lipid bilayer. Another example can be seen when a protein folds in such a way
that amino acid groups run parallel to each other. Often in such situations, an exten-
sive hydrogen bond network forms between two groups of laterally adjacent amino
acids, creating a sheet-like structure. This type of a structure is called a beta-sheet,
common in many barrel-like proteins that are capable of transporting a molecule.
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Membrane proteins can be divided into two main subgroups depending on how
they interact with the membrane: peripheral membrane proteins and integral mem-
brane proteins. Peripheral membrane proteins are a group of proteins that have only
temporary interactions with the surface of the membrane as they perform their bi-
ological functions. Upon making contact with the membrane surface, the tertiary
structure of a peripheral membrane protein may change as it interacts with the lipids
and other membrane-bound proteins. This usually involves conformational changes
around the binding region exposing the nonpolar regions of the protein with which
the binding is made possible. These conformational changes depend on the biolog-
ical function of the protein and may include, for instance, the opening of a ligand-
binding channel, unfolding of an anchor region, or dissociation of a transported
molecule. The ability to bind to a membrane typically requires the peripheral mem-
brane protein to be in a speciﬁc orientation near the binding site, and a certain lipid
composition or the presence of a binding protein at the target location. Many periph-
eral membrane proteins are typically associated with transporting of molecules from
one cell to another – they are able to bind a molecule at the surface of a membrane,
and transport it to another membrane where the molecule in question is dropped
off. These types of interactions also have a large signiﬁcance in cellular signaling
[34].
Integral membrane proteins are mainly bound to the interior of the membrane
with parts of the protein protruding from the membrane surface. Transmembrane
proteins are a major subgroup of integral membrane proteins. They cross the whole
membrane, often multiple times, thus making contact with both the intra- and the
extracellular sides of the membrane. The polypeptide chain that crosses the mem-
brane is generally in an alpha-helical conformation, but many transmembrane pro-
teins with a beta-barrel structure also exist. Multi-pass transmembrane proteins of-
ten act as channels for ions and other substances as they are able to create an ener-
getically favorable environment for these substances to traverse in their interior and
vicinity when compared to a pure lipid bilayer.
The function of many transmembrane proteins also involve a change in their con-
formation. Ion channel proteins among others use mechanic gating to control the
ﬂux of molecules between the membrane interior and exterior. Certain potassium
channels, for instance, are activated when intracellular calcium interacts with an in-
tracellular part of the channel protein, triggering a change in the conformation of
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the protein [35, 36]. The gate controlling entry from the extracellular side into the
channel, surrounded by many transmembrane alpha-helices, opens for a short while
and potassium ions are able to enter the protein interior. After a time, the protein
conformation changes again in a way that the extracellular side closes and the intra-
cellular side opens, releasing the ions into the cell interior. This mechanism is vital
for the function of many different cell types, especially prominent during conduc-
tion of signals in nerve cells.
Another major group of transmembrane proteins are the G protein-coupled re-
ceptors (GPCRs). They have a similar overall archistructure consisting of seven
transmembrane alpha-helices spanning the membrane, creating a cylindrical struc-
ture [37]. The main differences in their overall structures lie in their extracellular
parts which are able to interact with various protein-speciﬁc ligands. These interac-
tions in turn activate the protein. Instead of acting as transporters, their main func-
tion lies in signal transduction. Upon binding of an extracellular signal molecule,
the GPCR undergoes a conformational transformation enabling it to activate a G
protein – a trimeric GTP-binding protein – which couples the GPCR to enzymes or
other proteins, triggering protein-speciﬁc functions.
There are nearly a thousand different GPCR proteins, all with a speciﬁc duty in
cellular life [38]. Many GPCRs are involved with the function of the senses. Opsin,
for instance, is able to bind a retinal-ligand inside its transmembrane structure, thus
converting itself to rhodopsin. By changing the isomerization of the retinal by ab-
sorbing light, the protein changes its conformation initiating the visual transduction
process [39].
GPCRs are also prevalent in the nervous system. These receptors are able to bind
neurotransmitters – chemicals created at the synapses of the nervous system – which
activate the protein. The GPCR then is able to control nearby ion channels, thus
regulating the charge of the cell [40]. This kind of GPCR activation controls the
function of the sympathetic and parasympathetic parts of the nervous system. Some
GPCRs in the brain control the behavior and the mood of a person. Dopamine, for
instance, is a neurotransmitter created in the synapses of the central nervous system.
Dopamine receptors are GPCRs found in the brain able to bind dopamine as an
external ligand, which then triggers a typical GPCR signaling pathway resulting in
control over memory, motivation and other executive functions [41, 42].
Due to their large variety and importance in life, GPCRs are major drug targets.
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Currently approximately 34 % of all approved clinical drugs in the US are targeting
over a hundred different GPCRs [18] while ten years earlier the number was 27 %
[43]. GPCR drug discovery is the most intensively studied area in drug research
with signiﬁcant progress constantly made in order to identify new targets.
It is worth noting that proteins can function in more ways than their designated
group indicates. For instance, recent studies have shown that many proteins of the
GPCR family have secondary functions as lipid scramblases – they actively induce
lipid translocation across the bilayer, thus scrambling the lipid composition of the
two opposing leaﬂets [12, 44]. One such GPCR is rhodopsin, the protein mainly in-
volved in visual transduction. The transmembrane alpha-helices provide a favorable
environment for the hydrophilic lipid head groups giving them easier entry to the
membrane interior. There are also indications that the peripheral myelin protein
P2, a member of the fatty acid binding (FABP) family, acts as a lipid transporter as
is typical for fatty acid binding proteins, but also has an important role in holding
the myelin sheath – a membrane complex vital for the nervous system – together
[6]. These secondary functions of both rhodopsin and P2 are further explored in
the following chapters of this Thesis.
2.2 Point mutations – an issue in protein encoding
For proteins to function in their intended manner, they have to fold into a very
speciﬁc tertiary structure. The folding process is mainly spontaneous, led by the
sequence of amino acids that form the primary structure of the protein. The hy-
drophobic residues are buried within the protein core while the active parts partici-
pating in protein–substrate interplay are generally located on the protein surface. In
some cases, the amino acid sequence of a known protein can be disrupted, resulting
in a mutation in the protein. This can have major effects on both protein folding
and function.
Protein synthesis
Protein synthesis occurs in the ribosomes of a cell, but the process originates all the
way from the genetic sequence. Human DNA is a long double-helical molecule built
of four different types of nucleotides, containing all the genetic material required to
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create proteins. The genetic information is transported from the DNA chain to
ribosomes via messenger RNA (mRNA), which makes a copy of a certain part of
the DNA chain into its single-stranded structure. With the help of transfer RNA
(tRNA), which acts as a transporter for the required amino acids, and ribosomal
RNA (rRNA) located at the ribosomes, protein synthesis is able to take place.
During the RNA translation process, the ribosomes read the genetic chain en-
coded in the nucleotides of the mRNA chain three nucleotides at a time. These
nucleotide triplets are referred to as codons, which specify a certain amino acid, or
the beginning and the end of the translation process. Since there are 64 possible
nucleotide triplets, but only 20 different amino acids, a speciﬁc amino acid can be
obtained from multiple nucleotide combinations.
Protein synthesis is initiated at the N-terminus of the amino acid chain, always
containing methionine, from a speciﬁc start codon found in the mRNA. The ribo-
some then reads the following nucleotide triplet and the tRNA attaches the corre-
sponding amino acid to the previous one by a peptide bond. This continues until the
ribosome reads a nucleotide triplet containing a stop codon, upon which the ﬁnished
protein is released from the ribosome. The proteins are then folded and transported
to their ﬁnal destinations. Misfolded proteins are either captured by molecular chap-
erones which attempt to refold them, or degraded back to amino acids in order to
prevent them from causing harm.
Mutations
Mutations in protein structure occurmainly due to altered nucleotide base sequences
in the DNA. The DNA replication process involves unwinding the double helix un-
til new nucleotide pairs are generated for both divided halves. In rare cases, wrong
types of nucleotides or additional nucleotide pairs are inserted into the newly gen-
erated DNA, which modiﬁes the genetic code. Enzymes performing veriﬁcation of
these new chains are able to correct most of these errors, but some mismatched nu-
cleotide base pairs inevitably remain, resulting in a mutated DNA chain after the
next cell division. If the mutation is located in the part of the DNA encoding the
structure of a certain protein, the protein synthesis process produces a mutated pro-
tein if the codons read from the mRNA make sense. Errors may also occur in a
similar fashion when reading a correct mRNA sequence. The ribosomes operate in
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a rapid fashion, so the tRNA molecules may occasionally attach wrong amino acids
into the polypeptide chain. Additional proofreading mechanisms along the transla-
tion process, so most mutated proteins are rapidly identiﬁed and discarded.
Several different types of mutations of the polypeptide chain may occur as a re-
sult. Most common mutation types are substitutions – mutations of the nucleotide
sequence where one nucleotide base is replaced with another. A silent mutation oc-
curs when a change in one nucleotide base in a codon does not affect the generated
amino acid. This is possible because certain amino acids can be obtained from several
different nucleotide triplet combinations. Silent mutations are generally harmless as
they do not affect the protein structure, but they can slow down the protein synthe-
sis process.
Another common substitution is a missense mutation. This occurs when a nu-
cleotide base of a codon is replaced with another in such a way that the resulting
amino acid differs from the protein wild type. This is the main cause of point mu-
tations found in proteins and can have signiﬁcant effects in the protein function. As
the initial effect of the mutation is quite small – the protein essentially retains its size
and often folds properly – point mutated proteins are the most likely ones to pass
post-translational inspection and ﬁnd their way into the target cells.
The third type of substitution is called a nonsense mutation. It occurs when re-
placing a nucleotide base in a codon changes themeaning of the codon from inserting
a new amino acid to signal termination of translation. There are three different stop
codons identiﬁed by the ribosome that signal the end of the protein. Missense mu-
tations usually result in a truncated protein structure easily recognized by enzymes
and dissolved back into amino acids.
Another commonway the nucleotide base sequence can be altered is via frameshift
mutation. It happens when additional nucleotide base pairs are inserted (or some are
removed) into the replicated DNA. This in turn causes the nucleotides to be shifted
in either direction. As the nucleotides in the mRNA are read in triplets, each triplet
beginning from the insertion point is different from the wild type, resulting in ev-
ery codon changing its original meaning. If three additional nucleotide base pairs
are inserted, it merely corresponds to the addition of a single amino acid. Due to its
nature, frameshift mutations usually involve the change of multiple amino acids and
an early stop codon, resulting in an unusable protein.
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The effects of mutations
While protein mutations generally have negative effects on the function of the cell,
there are also many examples of beneﬁcial mutations with positive effects. One well-
known example is the ability to digest lactose contained inmilk [45]. Human infants
generate the enzyme lactase which breaks down the lactose sugar chains contained in
milk. In most mammals, the activity of the enzyme greatly subsides with time when
other food replaces milk as the main source of nutrition. However, many human
populations have a point mutation in the gene encoding the enzyme, keeping the
enzyme active throughout their lives. The lack of this mutation is known as lactose
intolerance.
One example of a well-known mutation with both beneﬁcial and negative effects
is sickle-cell anemia [46]. A single point mutation in the haemoglobin gene changes
the shape of the red blood cells from their typical ﬂuid round shape into a rigid
sickle shape. The sickle shaped cells are prone to clumping together at junctions of
the blood vessels, thus blocking blood ﬂow and resulting in many health problems
such as swelling and stroke. On the other hand, the unnatural shape of the red blood
cells makes them more resistant to several blood diseases such as malaria [47]. Geo-
graphically, high representation of the sickle-cell gene in the population is generally
found in areas where malaria has a high transmission intensity [48].
Most of the occurring mutations do not have such highly visible effects, but in-
stead are seen only at a cellular level, facilitating or hindering cellular functions. For
instance, a point mutation at a ligand-binding site of a protein may either accelerate
the binding process or prevent the binding altogether [49]. A GPCR with the ability
to facilitate lipid ﬂip–ﬂop across the lipid bilayer could become even more effective if
additional polar amino acids appear along the lipid translocation path [50]. A fatty-
acid binding protein found in themyelin sheath of the nervous system becomesmore
ﬂexible when a point mutation occurs near the lid region of its barrel-like structure,
which in turn increases its lipid stacking ability [51].
With recent advances in gene therapy, point mutated proteins can also be arti-
ﬁcially generated in laboratory conditions. Generating point mutated proteins can
be an interesting alleyway into further studying the structure and function of many
proteins and protein complexes. Many signaling proteins, among others, naturally
form dimer structures – two identical proteins attached to each other by an interface
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in the side of the protein [52]. One often asked question regarding protein func-
tion is whether these types of proteins are able to function alone or if they need to
dimerize in order to perform in their designated role. This is usually the case when
the functional site is located at the dimerization interface. A way to separate two
normally dimerized proteins is to generate point mutations at the dimerization in-
terface which in turn reduces the ability of the two proteins to attach to each other.
These point mutated proteins can then be reconstituted into vesicles as monomers
and their function studied. If the protein still works as intended in its monomeric
form, it can be deduced that dimerization or the dimerization interface is not essen-
tial for its function.
One such example can be found in opsin, a GPCR acting as a phospholipid scram-
blase transporting lipids from one membrane leaﬂet to the other. Several different
lipid translocation pathways have been suggested, one of them at the dimerization in-
terface of two opsin proteins. A recent study conducted by using the aforementioned
method showed that the point mutated dimerization interface (transmembrane he-
lix IV) is not the main location of the scrambling activity and monomeric opsin was
able to facilitate lipid ﬂip–ﬂop at a sufﬁcient level [53]. In a nutshell, performing
point mutations on speciﬁc amino acids at putative functional interfaces can gener-
ally be used as a method of researching whether the interface in question is relevant
for the studied function of the protein.
Artiﬁcially created proteins and targeting of mutated genes can also be used to
treat certain protein-altering diseases. For instance, proteins facilitating programmed
cell death are often disabled upon the onset of cancer. Gene therapy applied to pro-
teins involved in the apoptotic pathway, such as p53, are used to heal the lost ability
of the protein to aid in the controlled degradation of the sick cancer cell [54].
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3 MYELIN SHEATH AND THE P2 PROTEIN
In this part of the Thesis we focus on a central part of the nervous system. The
myelin sheath is the membrane layer that surrounds the axons transmitting neural
signals across the body. A major component of this speciﬁc type of membrane is
the peripheral membrane protein P2, which is a member of the fatty-acid binding
protein (FABP) group. The Papers I-III presented in this Thesis, conducted in col-
laboration with an experimental group, have provided new insight on the dynamics
of the P2 protein, its function in the myelin sheath and how certain point mutations
can be the root of many nervous diseases. In this chapter, we present an overview on
the structure and function of the nervous system and the myelin sheath surrounding
its axons, introduce the P2 protein, and discuss the many different diseases affecting
the nervous system.
3.1 The nervous system
The human body operates through signals sent from the brain. These signals are
transmitted to all parts of the body through nerve cells interconnected by long bun-
dles of branching ﬁbers called axons. Sensations obtained through sight, touch, hear-
ing, smell or taste are also transferred to the brain by the same route. The function
of all organs, or the ability to move our limbs is due to functional transmission of
nerve signals. Loss of this function may lead to paralysis, forgetfulness or loss of
other senses, highlighting the importance of the nervous system. The main sources
of reference in this chapter are the books on neuroanatomy by Patestas et al. [55]
and Amerman et al. [56].
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Figure 3.1 A schematic drawing of the structure of a neuron. The axon emerging from the cell body
is segmentally covered by the myelin sheath. The axon termini generally connect to the
dendrites of another neuron or muscle cells. Figure modiﬁed from Ref. [57].
Cellular structure
The basic elements of the nervous system are the nerve cells or neurons (see Fig.
3.1). They can be divided into two regions: the cellular body (soma) and branching
neuronal processes called dendrites and axons. The soma contains the basic elements
of any cell, but its size and form vary depending on its location inside the nervous
system. The nucleus is the source of the RNA produced in neurons required for the
protein translation process. The cytoplasm contains a large number of ribosomes
and the endoplasmic reticulum required for protein synthesis. The large number
of mitochondria ensure that the energy requirements for the neuron are met. The
Golgi complex is also present, its function being to modify and package the various
proteins and enzymes that are used by the cellular body.
Branching from the cellular body are the dendrites and axons. Dendrites are
short, branching extensions protruding from the cell surface. Their main function
is to receive the impulses coming from other neurons and transmit them forward to
their host cell body. One of the dendritic branches will be connected to an axon at
an area called the axon hillock. The axon, or nerve ﬁber, is a long projection of a
nerve cell responsible for conducting the electrical impulses known as nerve signals
from one neuron to another. The length of axons may vary from millimeters to over
40
a meter within the spinal cord. Axons typically branch both at right angles at their
length as axon collaterals, and at their termini forming numerous axon terminals
which permit a single axon to make contact with multiple neurons or other cells
such as muscle cells. These contact points are called synapses and are the locations
of ion or ligand exchange between neurons, electrical or chemical in nature.
Each nerve cell can contain multiple dendrites, but only one axon, highlighting
its importance in proper function of the nervous system. Most axons are surrounded
by a thick, multilamellar membrane structure called the myelin sheath. The myelin
sheath begins from the axon hillock and ends at the axon terminal, with small gaps
here and there called nodes of Ranvier. The main functions of the myelin sheath
are to both protect the axons from outside damage and to insulate them from their
surroundings in order for faster nerve signal propagation. A thicker myelin sheath
often results in better insulation and therefore a faster signal. Axon thickness is also
directly related to the conduction velocity of the signal. As a result, the thickness of
an axon varies depending on its location while remaining constant along its length
excepting the nodes of Ranvier.
In addition to the nerve cells, the nervous system is also a host to multiple other
cell types with their own functions. The glial cells are a group of several different
cell classes that mainly glue the nervous system together providing them support,
insulation and protection. In addition, they also support the neurons with other
functions such as regulating the chemical content of the ﬂuid outside the neurons,
providing nutrients to neurons, or aiding in sustaining the integrity of the myelin
sheath. [58]
Nerve signals
Information is transferred between nerve cells through electrical signals. The inside
of a nerve cell has a slight negative charge due to the proteins and ions located in the
cytoplasm. The charge is sustained by a number ofmembrane proteins located in the
outer membrane of the cell acting as ion channels allowing sodium and potassium
ions to enter and exit the cell interior at a controlled rate. The charge difference
between the cytoplasm and the extracellular area causes a potential difference across
the membrane of the neuron. The typical resting potential in a neuron is around
−70 millivolts.
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A nerve signal is generated when a sudden disturbance changes the resting poten-
tial across the neuron membrane. This happens when the ion channels on the neu-
ron surface open and allow a large amount of positively charged ions to pass into the
cytoplasm. As a result, the cell interior becomes less negatively charged. Once the
potential difference across the membrane reaches the threshold potential of around
−55 millivolts, a radical change in the voltage difference can be seen. For a short
period of time, the charge of the neuron interior becomes positive compared to the
extracellular area with a potential difference of about +40 millivolts. This abrupt
change is called the action potential. After the sudden change, which lasts for about
a millisecond, the potential quickly reverses back to even higher negative values than
the resting potential. After a short refractory period, during which a nerve cell can
not be excited to generate another action potential, the potential difference swiftly
returns to its resting state. As a result, action potentials are only very short pulses
often referred to as all-or-nothing electrical outputs of a neuron.
The potential differences happen only at small parts of themembrane of the nerve
cell at a time, but the generation of an action potential at one location changes mem-
brane permeability around that part of themembrane. This change allows the action
potential pulse to rapidly propagate along the membrane surface of an axon towards
another nerve cell. The propagation of the action potential is basically the nerve
signal as we know it. This active method preserves the strength of the nerve sig-
nal making it a very effective way of transmitting information. If the signal would
only be generated at one location, it would progressively weaken as a function of
distance. Upon reaching the target synapse, the action potential passes through to
the next nerve cell either through a rapid, but simple electrical transmission or by a
slower, but more intricate chemical transmission.
Regions of the nervous system
The human nervous system can be anatomically divided into two main regions: the
central nervous system (CNS) and the peripheral nervous system (PNS). The CNS
consists of the brain and the spinal cord, and the PNS are all the nerves connected to
the CNS. There are signiﬁcant differences between the two regions, including their
functions and composition.
The CNS is primarily responsible for processing and coordinating most of the
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functions of the human body. The brain consists mainly of nervous tissue, with
about 100 billion nerve cells, and can be thought of as the control center of all both
voluntary and involuntary human actions. The brain is directly connected with the
spinal cord, which enables the brain to communicate with other parts of the body.
The CNS has basically two kinds of nervous tissue: grey matter and white matter.
Grey matter consists of the unmyelinated parts of neurons including cell bodies,
dendrites, axon terminals and some unmyelinated axons. White matter is almost
completely made of axons, the color arising from the thick myelin layers. As such,
both white and grey matter have different roles in the central nervous system.
The PNS consists of all the parts of the nervous system that connect to the CNS.
It is made up primarily of nerves – enclosed bundles of axons coupled with blood
vessels and protective tissue. Nerves can be categorized according to their origin or
destination. Cranial and spinal nerves act as links between the CNS and the rest
of the body and are in charge of performing sensory and motor functions of the
body. The sensory division carries signals beginning from the internal or external
environments of the body to the CNS. Such signals may come externally from sight,
touch or hearing, or internally from the feel of hunger or tiredness. Conversely, the
motor division transmits signals coming from the CNS to the muscles, essentially
generating a reply to previously received signals.
A more general way to divide the PNS is to decompose it to the somatic and au-
tonomic nervous system. The somatic nervous system comprises the sensory and
motor divisions excluding the autonomic parts. It is the consciously controlled part
of the PNS responsible for the conduction of nerve impulses to skeletal muscles,
thus enabling interaction with the external environment. The autonomic nervous
system, on the other hand, is responsible for the subconscious or involuntary im-
pulses such as blood ﬂow or breathing. The autonomic nervous system itself can be
divided into two categories: the sympathetic and parasympathetic nervous systems
that essentially work in opposite fashion to each other. The sympathetic division
is activated during situations of high stress, basically preparing the body for emer-
gency action. It is responsible for increasing heart rate, releasing adrenaline or other
stress hormones, and increasing sweating. The parasympathetic division acts as its
counterpart, trying to inhibit its effects by decreasing heart rate, conserving energy
and generating other calming effects. The bodily state of a person is essentially the
balance between these divisions.
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3.2 The myelin sheath
Axons are surrounded by a special type of a membrane structure known as the
myelin sheath. It is a multilamellar membrane structure, consisting of proteins and
lipids, that enwraps the axon core in a spiral-like fashion thus insulating it from its
surroundings. The insulation enables fast and uninterrupted propagation of nerve
signals along the axon core. Damage to the myelin sheath or incorrect stacking of
myelin membranes are root causes of many myelin-related diseases. These are often
caused by reduced nerve conduction velocities due to weakened insulation around
the axon.
The composition of the myelin sheath is different in the central and peripheral
nervous systems. The dry weight of CNS myelin is typically 70% lipid and 30%
protein. The lipids are mainly cholesterol and various types of fatty acids. The
main proteins include the proteolipid protein PLP and the positively charged myelin
basic protein MBP, which is considered a major constituent in the stacking of myelin
membranes, holding two opposing membranes together. The dry weight of PNS
myelin is even more lipid-favored, consisting of 80% lipid and 20% protein. The
major proteins of the PNS myelin include P0, accounting for over half of the total
PNS protein, MBP, PMP22, and another positively charged protein, P2 [59]. MBP
is not as prominent in the peripheral nervous system suggesting the possibility that
P2 plays an active role in the myelin membrane stacking process.
Myelination process
The myelination process is also different in the CNS and the PNS. In the CNS,
myelin is constructed by oligodendrocytes, which are able to myelinate parts of mul-
tiple separate axons at once. As a consequence, the myelin sheaths on the opposite
sides of a node of Ranvier in a single axon are generated by a different oligodendro-
cyte [60]. After making contact with the axon, the arms of an oligodendrocyte begin
to wrap themselves inwards toward the axon in order to form a tight sheath of alter-
nating layers of lipids and proteins surrounding the axon. This process is facilitated
by lipid–lipid and lipid–protein interactions and is highly dependent on the protein
composition of the cell [61]. For instance, in the CNS, the cytoplasmic leaﬂets are
held together very tightly by the highly positively charged protein MBP, which is
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Figure 3.2 Illustration of the formation of the myelin sheath in the peripheral nervous system. The
Schwann cell wraps itself around a single axon and rotates itself around it forming alternating
layers of lipids and proteins. The myelin sheath is tight enough to squeeze the cytoplasm
completely to the outer edges of the cell. Figure modiﬁed from Ref. [63].
likely synthesized in the oligodendrocytes themselves for this purpose [9]. Other
myelin proteins, such as CNP, have an opposite effect, hindering myelin formation
[62]. Thus, proper interplay and correct positioning and function ofmyelin proteins
is essential to ensure healthy and functional myelin formation.
In the PNS, the myelin sheath is made by Schwann cells, which interact with only
a single axon. Once the Schwann cells have attached themselves around an axon, they
slowly begin to rotate outwards away from the axon forming the myelin sheath in
a fashion similar to the process in the CNS. The main difference is that the myelin
compacts itself in the opposite direction. The structure is tight enough to squeeze
the cytoplasm completely to the outer edges of the cell (see Fig. 3.2). The nodes of
Ranvier appear between two separate Schwann cells.
It is worth noting that not all axons are myelinated in this fashion. Some shorter
axons both in the CNS and the PNS do not have a myelin sheath surrounding them.
However, in the PNS, even these axons are surrounded by a Schwann cell, though
in an unmyelinated form. Short unmyelinated axons are typically found in areas
where proper insulation is not required to protect the axon or if rapid nerve sig-
nal propagation is not mandatory. Another important factor regarding whether an
axon is myelinated is the axon thickness. In the PNS, a minimum diameter of 1.0
μm is required for myelination. In the CNS, no such limit has been observed, but
oligodendrocytes are able to myelinate axons thicker than 0.2 μm [64].
The differences between PNS and CNS myelination processes can also be seen
when trying to repair possible myelin damage. Schwann cells are incredibly ﬂexible
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in their abilities to convert to cells with regenerative abilities [65]. As a result, dam-
age to peripheral nerves is repaired within a few weeks. The process involves clearing
the damagedmyelin sheathwith aid ofmacrophages after which a newmyelin sheath
is built around the cleared sections [66]. If the axon itself is severed, it is able to cre-
ate new growth processes that along with newly created myelin is able to reconnect
with the target cell [56]. Conversely, the oligodendrocytes of the central nervous
system do not seem to have the same regenerative abilities. The inability to break
down damaged myelin seems to be due to the lack of autophage activation in the
CNS [67]. Other factors hindering nerve healing in the CNS are due to the oligo-
dendrocytes inhibiting neuronal growth and the absence of growth factor chemicals
[56]. As a result, both axon and myelin sheath damage in the CNS is much slower
to heal.
3.3 The peripheral membrane protein P2
One major protein in the human peripheral nervous system is myelin protein P2,
comprising up to 15% of the total protein composition [68]. It is a member of the
fatty acid binding protein (FABP) group and mainly expressed by the Schwann cells
of the PNS [69]. Due to its fatty acid binding properties, it is able to transport
lipids to the myelin membranes through a collision transfer mechanism giving it an
important role in conserving lipid homeostasis in myelin [70]. The bound ligands
may include myelin-speciﬁc phospholipids or cholesterol.
The structure of P2 has been solved using x-ray crystallography to a 0.93 Å res-
olution [11]. The crystal structure consists of a total of 132 amino acids, forming
a beta-barrel of 10 anti-parallel beta-strands (β1–β10) connected to each other via
loops on both sides of the protein. The top of the protein is covered by a lid consist-
ing of two short alpha-helices and a loop. The N- and C- termini can both be found
near the open bottom of the protein. The high resolution of the crystal structure
allows for pinpointing the exact location of every atom of the protein. This in turn
makes the protein a prime candidate for atomistic molecular dynamics studies. A
visualization of the crystal structure of P2 is shown in Figure 3.3.
Traces of a bound ligand were found in the crystal structure further supporting
the fatty acid binding properties of P2. The ligand obtained from the crystallization
process was a palmitate chain, belonging to a bound fatty acid. It is worth noting that
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Figure 3.3 Visualization of the crystal structure of P2. The yellow coloring represents the β-barrel and
the purple helices the alpha-helical lid. The bound palmitate ligand is visible inside the barrel
structure.
the size of the barrel is large enough for a cholesterol molecule. The so-called portal
region of P2, consisting of the helix α2 and its nearby loops between beta strandsβ3-
β4 and β5-β6, has been identiﬁed as a key area of conformational changes during
ligand transfer [71].
In addition to its lipid-binding properties, P2 also has an important role in stack-
ing membrane leaﬂets together in the myelin sheath [72, 73]. The effect is pro-
nounced in the PNS where MBP is not as prominent. As a result, P2 dysfunction can
be a root cause of myelin deformation affecting the rates at which the enclosed ax-
ons are able to transmit nerve signals. Connections between certain neural diseases
and mutations of the P2 protein have recently been uncovered [74, 75, 76]. One
such case is the Charcot-Marie-Tooth neuropathy (CMT), which is among the most
common inherited neuropathies, affecting both motor and sensory nerve conduc-
tion in the PNS [10]. CMT is commonly triggered by abnormal myelin structure,
which reduces both motor and sensory nerve conduction velocities, leading to mus-
cle weakness.
Pointmutations associatedwithCMT and their effect on P2 dynamics are studied
in Paper II of this Thesis. Papers I and III of this Thesis include studies on several
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other point mutants related to increased activity in the lid area and barrel opening.
3.4 Diseases of the nervous system
A properly functioning nervous system is necessary for life. If the propagation of
nerve signals to parts of the human body is hindered or blocked altogether, that part
of the body is unable to follow the commands given by the brain in a reasonable
reaction time. In addition to physical damage that cuts the nerves, such effects can
also happen by many types of neural diseases that target the myelin sheath. Rapid
nerve conduction velocity is reliant of the insulative nature of myelin. Therefore,
damage to the myelin sheath that reveals parts of the axons to the extracellular side
can signiﬁcantly slow down the nerve signals or prevent them from reaching their
targets altogether. Repeated enough along a speciﬁc pathway, this can result in, for
instance, slow reaction times in limbs.
Diseases that target the myelin sheath structure without damaging the axon it-
self are referred to as demyelinating diseases [77]. Generally, the most dangerous of
these diseases are those targeting the central nervous system due to its reduced regen-
erative capabilities, but some diseases of the peripheral nervous system may also be
extremely dangerous. Not all neural diseases are caused directly by demyelination,
but many are involved in reducing nerve conduction velocity in some way. This
can also be achieved by deformation of the myelin sheath. If the myelin sheath is
not folded properly, resulting in bulges or loose contacts, the insulation around the
axon is weakened. This is often due to dysfunction of the proteins involved in the
myelin contraction process. Therefore, myelin proteins are also potential targets for
myelin-related diseases. Other main types of diseases found in the nervous system
are neurodegenerative diseases, where the nerve cells disintegrate over time for some
reason [78]. Neurodegenerative diseases are often incurable. They are usually caused
by genetic mutations, protein misfolding or incorrectly activated programmed cell
death, mainly targeting the central nervous system.
The most common demyelinating disease in the central nervous system is mul-
tiple sclerosis (MS), targeting the myelin sheaths of the nerve cells in the brain and
the spinal cord [8]. The demyelination process is visualized in Figure 3.4. The ef-
fects of MS vary greatly between patients, making it difﬁcult to diagnose without
performing biopsy. Generally, the symptoms include muscle weakness, coordina-
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Figure 3.4 Illustration of the progress of demyelination in the MS disease. Damage to the myelin sheath
reveals the nerve ﬁber and weakens nerve signal transduction. Eventually signals are unable
to be transmitted when the axon is damaged enough. Figure modiﬁed from Ref. [79].
tion trouble, double vision or blindness. The main mechanisms initiating MS are
thought to be the failure of the immune system or the inability to produce myeli-
nating cells in the CNS. The common factor between MS patients is the destruction
of the myelin sheath and the loss of oligodendrocytes [80]. However, the root cause
still remains unknown [81]. The ﬁrst symptoms are typically observed as early as
between ages 20 and 40 and it remains the leading cause for neural non-traumatic
disabilities in young adults [82]. No known cures for MS yet exist, but patients are
being treated both with physical treatment and different types of medication.
One example of a neurodegenerative disease in theCNS is theAlzheimer’s disease
(AD) [83]. It is a slowly progressing disease mainly targeting people over the age of
65. The main symptoms revolve around memory loss, beginning from occasionally
forgetting small details, evolving to greater difﬁculties in remembering words, places
and names, and ﬁnally resulting in loss of thinking and speaking abilities. The main
cause behind AD is relatively unknown, but several theories exist revolving around
CNS protein abnormalities initiating cell death in the neurons of the brain [84, 85].
No cures or deﬁnitive ways to prevent AD currently exist, but intellectual activities
and a healthy diet have been shown to reduce the risk of the onset of the Alzheimer’s
disease [86, 87].
In the peripheral nervous system there are twomajor demyelinating diseases. The
Guillain–Barré syndrome (GBS) is a rapidly progressing neurological disorder where
the peripheral nervous system is attacked by the immune system [88]. The myelin
sheath around the axon, and in some cases the axon itself, can be damaged as a result,
resulting in reduced nerve conduction velocity [89]. The Schwann cells of the PNS
are able to rapidly repair the myelin damage, but by creating shorted internodes,
that leaves the newly created myelin vulnerable for further damage. The symptoms
typically include muscle weakness in the hands and the feet and can intensify signif-
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icantly in a period of a few weeks to both sides of the body. In the most severe cases
of GBS, the nerves of the respiratory system are damaged leading to extreme difﬁcul-
ties in breathing. There are no actual treatments for GBS, but the majority of people
who experience the disease recover fully after intensive supportive care during the
most dangerous period of the disease.
One of the most common inherited diseases of the nervous system is the Charcot-
Marie-Tooth neuropathy (CMT) [90]. It is primarily a demyelinating disease of the
peripheral nervous system which onsets when mutations in the proteins facilitating
myelin sheath formation cause misfolding of the myelin sheath [91]. This results
in reduced nerve conduction velocity in both motor and sensory nerves presenting
itself as a loss of functional muscle tissue, touch sensitivity and slower reﬂexes in
separate parts of the body. CMT usually presents itself at quite a young age, mainly
varying from childhood to early adulthood [92]. The symptoms are usually visible
on the patient, usually initially observed in the foot, where it is characterized with
a loss of muscle, high arch and curved toes. At later stages the disease may spread to
other peripheral parts of the body causing neuropathic pain and severely hindering
day-to-day life. As with many other nervous diseases, there is currently no existing
drug treatments available, and the main suggested therapy is exercise which main-
tains muscle strength in the afﬂicted regions [93].
CMT has been quite well studied. The root causes behind the disease have been
identiﬁed as mutations in the genes (e.g. pmp22, mpz, pmp2) encoding the main pro-
teins of the myelin sheath [10, 75, 94, 95]. The types of the Charcot-Marie-Tooth
disease are named differently depending on the gene from which it originates and
whether it targets the myelin sheath or the axons (e.g. CMT1A-F, CMT2, CMT3).
CMT1 variants target the myelin sheath proteins and recent studies have associated
certain mutations in the pmp2-gene with the CMT1A-variant of the disease, typi-
cally associated with the protein PMP22 [7]. The pmp2-gene encodes the peripheral
myelin protein P2, which has been a main point of focus in this Thesis. The point
mutants related to CMT1A are further discussed in Section 7.2 of this Thesis along
with the research published in Paper II.
Most of the CMT variants cause demyelination in the myelin sheath, but some
can also cause damage to the axon itself. The regenerative capabilities of Schwann
cells help the myelin sheath rapidly reconstruct around the axon, but the mutations
in the myelin proteins reduce the effectiveness of the protein-lipid interplay, essen-
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tially resulting in a looser structure. This in turn results in a deformed myelin struc-
ture, or in some cases, a so-called onion bulb structure caused by repeating episodes
of demyelination and remyelination, eventually causing thinning of the total func-
tional myelin sheath. This in turn leads to a loss of functional nerve ﬁbers in parts
of the PNS [96].
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4 SCRAMBLASES AND LIPID FLIP–FLOP
The second part of this Thesis focuses on another type of signaling where dysfunc-
tioning proteins are also at the root of several serious diseases. Cellular signaling
is often dependent on a certain lipid composition on the outer side of a cellular bi-
layer. This lipid composition is regulated by speciﬁc types of proteins known as
ﬂippases and scramblases. Their function is to facilitate lipid translocation across
the membrane interior, which is intrinsically a rare event. In addition to cellular
signaling, rapid lipid translocation is necessary for other cellular activities as well.
Failure to transport lipids from one side of the bilayer to the other, or transport of
the wrong types of lipids, usually has severe consequences for the cell. In Paper IV
of this Thesis we present extensive discussion on the roles lipids have in cellular sig-
naling. The author contributed to the publication by studying the scramblase prop-
erties of rhodopsin and the mechanisms with which it transports lipids across the
bilayer. In this chapter, we discuss transbilayer lipid motion, the roles of scramblase
proteins and the potential diseases that occur if this process is somehow hindered.
4.1 Transbilayer lipid motion
One important factor in controlling cellular life are the signaling processes that oc-
cur between cells. Information is gathered from the surface of a cell, on the extra-
cellular side of a lipid bilayer, and transported to other cells via speciﬁc transporter
molecules. Errors in the signaling process can have severe consequences in cellular
function possibly resulting in diseases or other health problems in the long term.
As the information used in signaling is typically closely related to the conﬁgura-
tion of lipids on the cellular surface, it is of great interest to understand the mecha-
nisms with which these conﬁgurations are achieved. The lipid compositions of dif-
ferent types of bilayers are typically ﬁxed in a speciﬁc manner, so in order to change
these compositions, lipids must migrate from one part of a cell to the other.
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Lipid transfer between cellular components (from one bilayer to the other) is gen-
erally achieved with the help of transporter proteins or by exocytosis and endocyto-
sis – mechanisms by which lipids can exit and enter a bilayer surface. One example
emphasizing the importance of lipid transfer is the sustainability of the plasma mem-
brane surrounding the cell. The majority of all cellular lipids are synthesized in two
sites within a cell: the endoplasmic reticulum and the Golgi apparatus [97]. In order
to preserve cellular integrity, lipids synthesized in these two locations must be trans-
ferred to the plasma membrane, which is unable to create new lipids by itself. This is
achieved by transporting lipids across the cytoplasm of the cell to the cytosolic side
of the plasma membrane. From there, half of the transported lipids must transfer
across the bilayer onto the cell surface in order to balance the number of lipids on
both leaﬂets. This transbilayer lipid motion is often referred to as lipid ﬂip–ﬂop.
Lipid ﬂip–ﬂop has major importance in cellular physiology. It is vital for sustain-
ing the asymmetric nature of many biological membranes. As mentioned before,
phospholipid synthesis occurs only on the cytoplasmic side of the endoplastic retic-
ulum. For the ER to grow in a proper manner, half of the synthesized lipids must
ﬂip–ﬂop across the ER bilayer to the lumenal side [98]. Flip–ﬂops are also neces-
sary to sustain the asymmetrical lipid compositions of various cellular organelles
[99, 100]. For instance, the curvature of a membrane increases when lipids with
smaller headgroups on the inner leaﬂet oppose lipids with larger headgroups on the
outer leaﬂet, signaling a target for scaffolding proteins to attach to, resulting in ex-
ocytosis [101]. Programmed cell death, or apoptosis, also occurs due to lipid asym-
metry. When a high concentration of phosphatidylserine appears at the surface of a
cell, it serves as a signal for phagocytes to destroy the sick cell in a controlled fashion
[3, 102].
The mechanisms behind lipid ﬂip–ﬂop are very different from lateral lipid mo-
tion occurring in a bilayer due to the amphipathic nature of lipids. The amphi-
pathic nature is also the reason why cellular membranes take their form with the
hydrophilic headgroups of the lipids forming bonds with water molecules on the
outside of a lipid bilayer and the hydrophobic tails facing the inside of the bilayer
where they are not in contact with water [103]. In physiological temperatures, the
structure of a lipid bilayer can be considered a ﬂuid where lipids and embedded pro-
teins are able to traverse laterally with relative ease. Lateral diffusion is energetically
very easy as the polar headgroups of the lipids are able to remain in constant contact
54
with water and there are no clear energetic barriers blocking the motion.
Transverse diffusion, or lipid ﬂip–ﬂop, is another matter entirely. For a lipid to
cross the membrane interior, its polar headgroup must ﬁrst deattach itself from the
surroundingwatermolecules and other lipid headgroups, and enter the hydrophobic
core of the membrane, from where it will eventually reach the water located on the
other side of the membrane. The lipid tails must also turn around in the process,
moving against the lateral ﬂowof the structure. All this effort creates a high energetic
barrier the lipid undergoing ﬂip–ﬂop has to overcome, resulting in a slow and rare
process when undertaken by a lone lipid.
The height of the energy barrier is dependent on both the properties of the translo-
cating lipid and the surrounding lipid bilayer. The thickness of the bilayer affects
the free energy proﬁle of the ﬂip–ﬂopping lipid, the height of the energy barrier in-
creasing along with the bilayer thickness. For instance, bilayers constituted of pure
DLPC and DPPC were shown to have a ﬁvefold difference in the height of the free
energy barriers for ﬂip–ﬂops of their respective lipids (16 kJ/mol for DLPC and 80
kJ/mol for DPPC), even though the lengths of the lipid tails differ only by four car-
bon atoms [104]. Lipid size also affects the rate of the ﬂip–ﬂop process, as shown by
the ease with which cholesterol molecules are able to cross a lipid membrane, with
free energy barrier heights generally below 30 kJ/mol [105]. The size and charge
of the lipid headgroup are also important factors, with larger and more polar head-
groups having greater difﬁculties penetrating the membrane surface [106]. Other
relevant factors include the phase behavior of the bilayer [107] and the concentra-
tion of membrane packing elements such as cholesterol [108].
There are several ways of reducing the free energy requirements of lipid ﬂip–ﬂop.
Defects in the bilayer may induce the formation of a small water pore, which creates
a hydrophilic environment inside the bilayer for the translocating lipid to use. For
protein-free membranes, thinner bilayers in particular have been shown to allow a
water pore to form across the bilayer with relative ease, providing a convenient hy-
drophilic path for the lipid headgroup to traverse [109]. These types of pore forma-
tions have been shown to occur spontaneouslywithout any external stimuli, albeit at
a slow rate [110]. As spontaneous pore formation is the rate-limiting step when con-
sidering lipid ﬂip–ﬂops in a defect-free membrane system, high enough rates of lipid
ﬂip–ﬂop required for cellular sustainability are not possible to maintain by sponta-
neous effects alone.
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In the presence of external inﬂuences such as transmembrane peptides or various
types of proteins, when the surface of the membrane is disturbed, these types of
membrane defects occur more often, increasing the rate of pore formation [111].
Mechanical or electrical stress applied on the membrane surface also inﬂuences the
rate with which water pores appear [112].
The energy requirements for lipid ﬂip–ﬂops can also be reduced by other means.
The following example is related to the modiﬁcation of the membrane lipids. Oxida-
tive stress is a chemical disturbance in the body where toxic reactive oxygen species
are generated in excess resulting in extensive oxidative damage to lipids and proteins
in a cellular environment [113]. This oxidative damage includes lipid peroxidation,
often truncating the tail of a lipid with a double bond, fundamentally changing the
characteristics of the lipid within the bilayer. Its effect on the free energy of lipid
translocation has been studied, and the free energy barrier of POPS ﬂip–ﬂop in a
pure POPC bilayer was found to reduce by 20 kJ/mol when 20 mol-% of the POPC
molecules were substituted with oxidiced variants [114]. Such an energy reduction
meant a 103 – 104-fold increase in the ﬂip–ﬂop rates of POPS. Another recent study
revealed a correlation between the decrease in the free energy of POPS ﬂip–ﬂop with
increased concentrations of peroxidiced POPC molecules in a similar system [115].
Oxidative stress has implications in many neurogenerative diseases [116], or apop-
tosis, where rapid PS translocation to the cellular surface is the trigger [117].
4.2 Scramblase proteins
A more common way for cellular structures to improve the rate of lipid ﬂip–ﬂops is
through speciﬁc types of proteins known as ﬂippases or scramblases (see Fig. 4.1).
Flippases are specialized transporter proteins generally activated by external energy
obtained from ATP [118]. They are able to translocate phospholipids with selected
headgroup types unidirectionally from one membrane leaﬂet to the other. They
function in a controlled manner with the goal of preserving lipid asymmetry be-
tween the two leaﬂets.
Flippases can be divided into several subcategories, depending on the direction of
lipid translocation and the lipid selectivity. P-type ﬂippases have an important role in
transferring lipids from the cellular surface back to the cytosolic side [119]. Themost
extensively studied subfamily of P-type ﬂippases are the P4 ATPases, lipid ﬂippases
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Figure 4.1 Four different types of transbilayer lipid motion. Spontaneous ﬂip–ﬂop is slow, bidirectional
and requires no external energy. P-type ﬂippases facilitate inward movement of phospholipids
with external energy obtained from ATP. Likewise, ABC ﬂippases facilitate outward movement
of phospholipids by the use of ATP. Scramblase proteins are bidirectional and require no
external energy sources, but can be activated by calcium binding. Figure adapted from [123].
involved in transferring excessive PS away from the cellular side of the membrane in
order to prevent unwanted apoptosis [120, 121]. ABC transporters function in the
opposite direction, transferring a large variety of lipids from the inner leaﬂet to the
extracellular side [122].
The third subgroup of ﬂip–ﬂop-inducing proteins are referred to as scramblases,
due to their role of non-selectively scrambling the lipid composition between the two
membrane leaﬂets. They are a group of elusive membrane proteins mainly located in
the plasmamembrane surrounding the cell, where they participate in various cellular
activities, or in the endoplasmic reticulum, where they ensure that lipids synthesized
on the lumenal leaﬂet are efﬁciently transferred to the cytosolic side. They are able
to function without external energy from ATP and are able to ﬂip lipids of all types
in both directions [13].
Scramblase activity is mainly initiated as a response from external signals that call
for cell activation, blood coagulation or apoptosis [124]. It may involve a mass inﬂux
of Ca2+-ions into the cell through the many ion channel proteins on the cellular
surface, which in turn switches the scramblase proteins on and subsequently destroys
the lipid asymmetry of the plasma membrane [125]. Binding of calcium-ions to a
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protein interface is proposed to change the conformation of the scramblase protein
in a way that the surrounding lipids are able to access a translocation pathway with
greater ease. However, a number of scramblase proteins, especially in the ER, are
proposed to function without calcium [126].
Despite the fact that the existence of scramblase proteins have been known for a
few decades, their structures and mechanisms are still relatively unknown. The ﬁrst
x-ray structure of a known scramblase protein, TMEM16, was only reported several
years ago [16]. A signiﬁcant breakthrough was also achieved in the last decade when
opsin, a protein of the GPCR family, was reported to exhibit scramblase activities
in reconstituted vesicles along with its holo-form rhodopsin [12]. With no clear
calcium-binding motifs, it was proposed that the scramblase activities of opsin were
due to its intrinsic properties. This led to the suggestion that all GPCRs, having
very similar central structures, could have scramblase properties in addition to their
main roles as signaling proteins. Later, three other GPCRs, β1-adrenergic recep-
tor, β2-adrenergic receptor, and adenosine A2A receptors were shown to scramble
phospholipids, supporting the suggestion [44].
A major point of interest regarding scramblase activity is the mechanism with
which they translocate lipids from one leaﬂet to the other. As of now, these mech-
anisms are relatively unknown, but signiﬁcant progress has been made by studying
GPCR-mediated lipid ﬂip–ﬂop [5]. Over the years, several different mechanisms
have been suggested on how lipids might cross the hydrophobic membrane interior
with the aid of transmembrane proteins. The ﬁrst involves the lipid headgroup glid-
ing across the membrane along the protein surface with the transmembrane helices
and a transient water pore reducing the free energy barrier to an acceptable level [4].
The second is a so-called credit card model where the lipid headgroup enters the hy-
drophilic transmembrane channel of the scramblase, possibly via a conformational
change in the protein, and exits on the other leaﬂet [127]. A third option involves
the lipid fully submerging into the transmembrane channel and emerging out on the
other side [4], though unlikely as a general mechanism due to the non-selectivity of
scramblase proteins. It has also been suggested that transient disturbances caused by
transmembrane helices may cause the lipid headgroup to slip into the bilayer inte-
rior in a hydrated state near the lipid-helix interface, from where it will eventually
pop out onto the other side [128].
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Figure 4.2 Visualization of the crystal structure of rhodopsin. The seven transmembrane alpha-helices
are colored in purple. The retinal ligand is colored orange. The two palmitate chains attached
to the cytosolic cysteine residues are also pictured in cyan.
4.3 Rhodopsin
Among the most studied proteins in the human body is rhodopsin, a key protein of
the visual sense. It is a light-sensitive protein belonging to the GPCR superfamily,
constituting around 90 % of all known GPCR proteins [129]. It is a derivative of
opsin, differing from its apo-form by an additional 11-cis-retinal covalently bound
inside its transmembrane channel. An absorption of a single photon by the retinal
ligand changes the isomerization of the retinal to an all-trans-conﬁguration, which
activates the signaling pathway of the protein and leads to sight. The crystal structure
of rhodopsin is visualized in Figure 4.2.
Due to its abundance in the retina, the crystal structure of rhodopsin has been
solved to a 2.2 Å resolution [17]. It comprises a total of 348 amino acids that form
a typical GPCR structure consisting of seven transmembrane alpha-helices (I-VII)
connected to each other by short loops on both sides of the protein. The retinal
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ligand is covalently bound to the lysine residue 296 within the transmembrane chan-
nel, and surrounded by a number of conserved water molecules. The extracellular
side is home to the N-terminal along with a few short interhelical loops and beta
sheets. The cytosolic side hosts the C-terminal and three interhelical loops. Notable
amino acid residues include two cysteines 322 and 323 on the cytosolic side, which
are able to bind palmitate chains acting as membrane anchors or targeting sites for
other membrane proteins controlling the localization of rhodopsin [130].
Due to the high resolutionwithwhich the crystal structure of rhodopsin has been
obtained, a complete model of the protein can be built with knowledge of the exact
location of every single atom. This is extremely helpful for molecular dynamics
simulations where rhodopsin can be simulated at an atomistic level for increased
accuracy and deeper insight. We conducted simulations on rhodopsin embedded in
a lipid bilayer in order to gain knowledge on its lipid scrambling mechanisms. These
mechanisms are discussed in Paper IV of this Thesis.
4.4 Scramblase dysfunction in diseases
Due to their roles in sustaining lipid asymmetry and ensuring cellular growth, efﬁ-
cient function of ﬂippase and scramblase proteins is essential for life. Changes in the
activity of these proteins, through mutations or signals received from diseased cells,
can often have severe consequences. Scramblase dysfunction is most visible in the
loss of the apoptotic abilities of a sick cell, preventing their removal at the onset of a
disease.
Apoptosis is the programmed mechanism with which the human body disassem-
bles diseased or dysfunctional cells. In a healthy functional cell, there are only min-
imal amounts of phosphatidylserine located on the cellular surface due to the activ-
ity of P4 ATPases that ﬂip any scrambled PS lipids back to the cytosolic side of the
plasmamembrane [121]. When a cell becomes ill or dangerous due to viruses or gene
mutations, internal mechanisms of the cell deactivate the inward ﬂippases and acti-
vate new scramblases in order to express high amounts of PS on the cellular surface.
This in turn acts as a signal for phagocytes – large external cells capable of attaching
to and subsequently devouring the sick cell and decomposing it back to its cellular
components, nucleotides and amino acids [131]. By destroying a cell in a controlled
manner, the release of potentially harmful cellular components to the extracellular
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space can be prevented. As radical as it sounds, apoptosis is in fact a very common
cellular phenomenon with 50 to 70 billion cells both dying and born each day in a
healthy adult [132].
Problems occur when apoptosis can not be triggered on demand. In case of muta-
tions or other hindering factors acting on the scramblase proteins, sufﬁcient amounts
of PS can not be translocated to the cellular surface for the cell to be recognized by
the passing phagocytes. Left alone, a sick cell will die on its own and subsequently
release its noxious cellular components to the extracellular space where it will cause
inﬂammation in the nearby tissue [125]. Especially dangerous is the lack of apop-
totic response in cancerous cells. Cancer occurs due to genetic mutations resulting
in abnormal rate of growth in dysfunctional cells due to rapid cell division. Can-
cerous cells are unresponsive to external signals, will eventually form solid tumors
and may spread to other parts of the body. The suppression of apoptotic signals in
the early stages of cancer due to mutations in scramblase or other tumor-preventing
genes is often the reason cancerous cells are able to survive [133]. By inhibiting
the expression of apoptotic proteins, controlled degradation of cells is impossible
to achieve. As a result, many anti-cancer drugs and radiation treatments target the
apoptotic pathway in order to restore the ability to remove cancerous cells [54]. Fur-
ther knowledge on scramblase function could be a helpful factor in improving the
treatment of cancer patients in the long term.
Uncontrolled apoptosis can be dangerous as well as can be seen in many neu-
rodegenerative diseases such as Alzheimer’s disease, where nerve cells of the brain
are rapidly destroyed by apoptotic responses [134]. Despite the fact that the main
causes behindAD are unknown and the cells do not express typical apoptotical signs,
it is treated with anti-apoptotic drugs [135]. However, there are many reasons ex-
cessive apoptosis may occur, including overexpression of proteins with scramblase
characteristics in the nerve cells. Some links have already been established between
neuronal GPCRs and the pathology of AD, and many of these GPCRs are targeted
by drugs attempting to prevent the effects of the disease [136]. It might be interest-
ing to see whether the recently discovered scramblase properties of the GPCR core
structure could play a role in the excessive apoptotic response.
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5 MOLECULAR DYNAMICS SIMULATIONS
AND ANALYSIS
In recent years, computing facilities have evolved rapidly allowing us to perform
higher numbers of calculations in a shorter time period than before. This in turn
has enabled us to perform simulations on larger and more highly detailed models of
molecular systems. These developments have made molecular dynamics simulations
a viable and dependable method for studying cellular events at an atomistic level.
When complemented by wet lab studies such as studying a cell membrane system at
a larger scale, they can provide very insightful information on biological processes
occurring in the system.
The basic ideas behind molecular dynamics simulations are quite simple to un-
derstand. First, we create a model of the system under study, then we let it run in
environmental conditions of our choice for a set time. After some time has passed,
we can analyze the results found in the simulation through a large variety of analysis
programs. This chapter discusses these methods in more detail.
5.1 Building the model
The starting point for any MD simulation is the structure of the system under study.
Whether it is a fully solvated lipid bilayer or a simple protein in a box, we have
to know how all the atoms are initially positioned and which atoms are coupled
together and how. High-resolution crystal structures of proteins obtained through
x-ray crystallography, nuclear magnetic resonance or other similar methods, that
are deposited into external data banks such as the RCSB Protein Data Bank [137],
are generally used as initial structures. Similar methods are also used for obtaining
structures of lipids and other cellular components.
There are several types of simulation approacheswe can take, all depending on the
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size of the system under study, the desired detail of the results and the computational
resources we have available. Depending on all those factors, we can either choose a
coarse-grained model, an atomistic model or a sub-atomic quantum level model.
Probably the easiest model to understand is the classical atomistic model, where
every single atom of the system is assigned a value for their mass and electric charge.
They are also given initial coordinates, which when put together, represent the sys-
tem under study. Classical atomistic models are often referred to as ball-and-stick-
models due to the simple nature of their appearance: the balls describe the atoms and
the sticks holding the balls together are the elastic bonds between the atoms.
A more approximate model suitable for larger systems and longer timescales is a
coarse-grained model. A coarse-grained model typically has several atoms of a single
molecule combined into a larger bead, which in turn reduces the total number of
units in the system. For instance, a hundred-atom lipid can be typically described by
about ten beads. The properties of these united atoms are averaged as a single value
for the bead. The reduction in system size results in less inter-atom interactions that
have to be calculated thus requiring less computing power than an all-atom model
of the same system. As a result, however, there is the loss of atomistic detail in the
simulation results.
The most detailed description of a system is the quantum mechanical represen-
tation, in which the molecular structures and energy states of atoms are derived
through quantum mechanical calculations. As a result, the electronic behavior of
atoms can be accounted for. The calculations required in these types of structures
are extremely heavy and thus are rarely used in larger systems. A typical target for a
quantum mechanical approach could, for example, be the computation of the exact
partial charges of a single lipid molecule.
It can be very time consuming to build a coordinate ﬁle of a system from scratch
especially if it includes many types of lipids and proteins. However, the are many
reliable repositories for coordinate and force ﬁeld ﬁles of known substructures (pro-
teins, lipids, etc.) where these basic building blocks can be downloaded and used for
system creation. With the existing coordinate ﬁles, the construction of a model can
be done quite easily. One can also use CHARMM-GUI, an interactive web-based
platform for creating membrane systems and preparing simulation inputs for many
widely used simulation packages [138]. A simple way to examine these models in a
three-dimensional format is through a visualization program (such as VMD) [26].
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All of the studies included in this Thesis have been built in a classical all-atom
model. Therefore, from now on all further discussion will be related to a classical
model. The coarse-grained approach has many similarities, but there the atoms are
replaced by larger beads.
5.2 Force ﬁelds and topologies
In addition to the coordinate ﬁle, which describes the positions of the atoms, we
also need information on how atoms interact with each other and how they act as
a function of time as a result. The interactions are calculated through forces that
atoms have on each other. The forces in turn are calculated from a potential energy
function according to basic Newtonian mechanics. This potential energy function
V and the derived mathematical equations describing how the atoms of a system
interact with each other is known as the force ﬁeld. The force ﬁeld also includes
other relevant parameters such as cut-off distances of interactions.
Equations of motion
The potential function V (	r1, 	r2, ..., 	rN ) represents the potential energy of a system
of N interacting atoms as a function of their position 	ri = (xi , yi , zi ). The force 	Fi
applied on a given particle i can be calculated from the potential function as
	Fi =−dVd 	ri . (5.1)
Once we have calculated the forces applied on all i particles of the system, we can
use them to solve the Newton’s equations of motion
mi
d 2	ri
d t 2
= 	Fi , (5.2)
from which we can integrate the motions of the atoms with an algorithm of our
choice [139]. By repeating the previous steps, we can see how the system evolves
with time.
The most common algorithm for calculating the equations of motion is the leap-
frog algorithm, which is a third-order numerical integration method [140]. It has
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several major advantages in mechanics problems including time reversibility and
subsequently the conservation of the equation of the system. Its equations can be
written as
	vi

t +
1
2
Δt

= 	vi

t − 1
2
Δt

+
	Fi (t )
mi
Δt , (5.3)
	ri (t +Δt ) = 	ri (t )+ 	vi

t +
1
2
Δt

Δt , (5.4)
where 	vi is the velocity of the particle, 	ri is its position, and Δt is the length of
the time step.
The coordinates and velocities at each time step can be saved to a trajectory ﬁle,
which can then be analyzed to give a detailed look on the behavior of the system
over time. The time reversibility is a product of the fact that the positions and the
velocities are calculated in a symmetrical way – one can always return to a previous
time step by reversing the algorithm.
Potential function
The potential function is typically divided into two categories – bonded and non-
bonded interactions – depending onwhether the two atoms are connected by a chem-
ical bond or if they only interact through long-range interactions [141].
The bonded interactions include the stretching of covalent bonds, the vibration
of bond angles, and proper and improper dihedral angles, which describe the angles
between adjacent planes and whether the molecules around the bond stay in their
cis- or trans-conﬁgurations.
The potential function of a covalent bond is typically described by a harmonic
potential
Vbond

ri j

=
1
2
k ri j

ri j − r 0i j
2
, (5.5)
where i and j are the two bonded atoms, k ri j the force constant of the bond, ri j
the distance between the two atoms, and r 0i j the reference distance, where the energy
of the bond is the lowest. Small deviations from the reference distance increase the
potential energy and cause harmonic stretching.
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The angles between two covalent bonds are also susceptible to change and this
is typically represented by another harmonic potential function. The harmonic po-
tential for bond angle vibration on a triplet of connected atoms i – j – k is described
by
Vangle

θi j k

=
1
2
kθi j k

θi j k −θ0i j k
2
, (5.6)
where θi j k is the angle between the bonds i – j and j – k, k
θ
i j k is the force constant
of the angle, and θ0i j k is the reference angle, where the potential energy is the lowest.
In order to deﬁne internal rotations, a function for torsional dihedral angle poten-
tial is also required. These are referred to as potential energy functions for dihedral
angles. A typical way to deﬁne such a function for four connected atoms i – j – k –
l is by a periodical function
Vdihedral

φi j k l

= kφ

1+ cos

nφi j k l −φs

, (5.7)
where n is an integer deﬁning the periodicity, kφ the force constant, φi j k l the
angle between the two planes i j k and j k l , and φs the reference angle. If the atoms
i and l are on the same side of the bond j – k, the dihedral angle is zero and it
corresponds to a cis conﬁguration. Likewise, if they are on the opposite sides of the
bond, the dihedral angle is 180 degrees, which corresponds to a trans conﬁguration.
In order to force planar atom groups to stay planar, or to prevent molecules from
ﬂipping to their mirror images, a group of improper dihedral functions can be de-
ﬁned. They can be periodic, in which case their form is identical to the proper peri-
odic dihedral, or more usually of a harmonic type, where their potential function is
deﬁned by
Vid

ξi j k l

=
1
2
kξ

ξi j k l − ξ 0i j k l
2
, (5.8)
where ξi j k l corresponds to the angle between the planes i j k and j k l , ξ
0
i j k l is the
reference angle, and kξ is the force constant.
The non-bonded interactions of a force ﬁeld are calculated as the sum of the elec-
trostatic interactions and the van der Waals forces between two interacting atoms.
They are long-range interactions and thus, unlike in bonded interactions, these atoms
can interact with thousands of other atoms in the system.
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The electrostatic term is depicted with the Coulombic potential
VC

ri j

=
qi q j
4πε0εr ri j
, (5.9)
where qi and qj are the charges of the two interacting atoms, ε0 is the permittivity
of the vacuum, εr is the relative permittivity of the medium, and ri j is the distance
between the two atoms.
The van der Waals forces are a sum of an attractive and repulsive term, usually
depicted with the Lennard-Jones potential
VLJ

ri j

= 4εi j

σi j
ri j
12
−

σi j
ri j
6	
, (5.10)
where εi j is the minimum energy of the potential well and σi j is the van der
Waals distance, deﬁning the point where the potential energy turns from repulsive
to attractive.
Calculating all of the non-bonded interactions between every atompair of the sys-
tem at each time step would be computationally extremely heavy. However, as the
strength of long-range interactions weakens as the distance ri j between two atoms
increases, it may be possible to use a certain cut-off radius to speed calculations up.
The Lennard-Jones potential has an extremely fast decay rate, so short cut-off radii
(of around 2 nm) can be used without creating unnecessary artifacts.
On the other hand, the Coulombic potential does not decay as rapidly, so a sin-
gular cut-off radius would produce inaccurate results. One typically used method
for approximating long-range Coulombic interactions is the Particle Mesh Ewald
method (PME), which greatly improves the calculation rates of these interactions
[142]. There we employ a cut-off range after which the electrostatic energies are cal-
culated in an efﬁcient way with the Ewald method by utilizing Fourier transforms
into reciprocal space and back with the help of periodic boundary conditions. PME
is an improvement of the basic Ewald method, using a charge grid in the reciprocal
space, improving both accuracy and computational speed.
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Temperature and pressure coupling
After creating a system, it can be studied in the microcanonical ensemble, where the
number of particles, the volume and the total energy are constant. While this ensem-
ble is appealing, it can, however, be problematic since quite often the total energy
of the system studied in experiments is not conserved. If one would like to compare
the results of simulations to the results of experiments as directly as possible, then
one obvious way is to carry out the simulations at constant temperature. In our
simulations we used this approach, that is, the NpT ensemble with a set number of
particles (N ), pressure (p) and temperature (T ). In order to keep these conditions
close to the desired value, external barostats and thermostats are included. These
are algorithms which control the pressure and temperature of the system preventing
them from drifting due to external forces or computational errors.
The temperature coupling in this work was performed with the velocity rescale
thermostat, which is a modiﬁed version of the Berendsen thermostat [143]. The
Berendsen algorithm uses an external heat bath set at a reference temperature T0,
and corrects the deviation of the system temperature as
dT
d t
=
T0−T
τT
, (5.11)
where T is the temperature of the system and τT is the time constant for the
exponential decay of the temperature deviation. The strength of the coupling can
be adjusted by changing the time constant, which can be useful, for example, for a
quick equilibration of the system.
The velocity rescale thermostat differs from the Berendsen thermostat only by
an additional stochastic term in its algorithm for the kinetic energy of the system.
The function of this additional term is to ensure correct kinetic energy distribution
in the system in order to produce a correct canonical ensemble.
Several different methods also exist for controlling the pressure of the system.
We used the popular Parrinello-Rahman barostat [144], which forces the box vectors
(vectors determining the size of the simulation box) denoted by a matrix b to follow
an equation of motion
db2
d t 2
=V W−1b′−1 (P −P ref) , (5.12)
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thus controlling the pressure matrix P by changing the volume V of the box.
The pressure is directed towards the reference pressure P ref by the matrix parameter
W , which deﬁnes the strength of the coupling. The coupling parameter is deﬁned
as


W−1

i j =
4π2βi j
3τ2pL
, (5.13)
where βi j are the isothermal compressibilities, τp the pressure time constant,
and L the largest box matrix element. The pressure is presented as a 3× 3 tensor,
which allows non-isotropic handling of the system pressure, which is desirable in
the case of lipid bilayers. The Parrinello-Rahman barostat also produces a true NpT
ensemble.
Periodic boundary conditions
To minimize the computational costs of a large system, molecular dynamic simula-
tions are typically conducted in a ﬁnite box. In order to avoid artifacts caused by
the sides of the box, periodic boundary conditions (PBCs) are often introduced in
the simulations. Periodic boundary conditions place an inﬁnite number of identical
copies of the simulated system around itself. For bilayer systems, this basically ex-
tends a bilayer placed on the xy-plane to inﬁnity. As a result, every particle in the
simulated box can interact not only with the other particles placed in the same box,
but also their images projected to adjacent boxes. In a similar fashion, when a parti-
cle crosses the box boundary, a replica of the same particle appears on the opposite
side of the original box. As a result, the amount of particles N in the system remains
constant.
Due to the nature of periodic boundary conditions, the simulation box has to
be large enough to avoid artifacts that could arise from interactions with the images
of particles. The size requirements are thus dependent on the employed cut-off val-
ues for non-bonded interactions. Even though the original box is copied numerous
times, only the properties of the original simulation box need to be calculated. This
makes PBCs a fast and reliable method for handling the boundaries of a simulation
box.
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5.3 Analysis methods
Root mean square deviations and ﬂuctuations
During a simulation, a protein rarely keeps its original structure completely. During
the crystallization process fromwhich a protein structure is obtained, the conditions
are extremely different compared to conditions where the protein is in its natural
habitat inside a cell. Most simulations begin by inserting a structure of a crystallized
protein into a system with cellular conditions which in turn induce changes in the
protein structure.
When equilibrating a system with a protein, the compact crystallized structure
will typically expand, causing the distances between the protein atoms to increase.
Therefore, one important factor to follow during the equilibration process is the
root mean square deviation of the atomic positions of the protein atoms. The root
mean square deviation (RMSD) is deﬁned as
RMSD=
√√√√ 1
N
N∑
i=1
σ2i , (5.14)
where N is the total number of atoms and σ is the distance between atom i and
its reference structure. The RMSD of a protein structure typically approaches a
certain value and once it is adequately equilibrated, the RMSD value will remain
approximately constant.
The root mean square deviations can also be used in order to analyze the behavior
of different parts of a protein. For instance, by comparing the atomic position of
each amino acid to its initial position over a long simulation period, we gain insight
into protein dynamics during the simulation. These values are often referred to as
root mean square ﬂuctuations (RMSF) and are calculated as
RMSF=
√√√√ 1
N
N∑
n=1
(xn(t )− xn(0))2, (5.15)
where N is the number of atoms or residues we want to average, xn(t ) is the
current position of the residue and xn(0) its initial position. Calculating the root
mean square ﬂuctuations for each amino acid residue of the P2 protein played an
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important role in the investigation of P2 dynamics in Papers I – III.
Dynamic cross-correlation maps
One method for investigating protein dynamics is through looking at how differ-
ent parts of the protein move in relation to each other. This can be achieved through
analysing the cross-correlation coefﬁcients of atomic displacements which can be ob-
tained from the trajectory data [145]. These cross-correlation coefﬁcients can be dis-
played as a two-dimensional dynamical cross-correlation map (DCCM) which gives
a clear visual indicator on how the dynamics of protein domains are connected to
each other. For instance, the effects a point mutation has on protein dynamics can be
easily seen by comparing the cross-correlation maps of wild type and a point mutant.
The cross-correlation coefﬁcients are calculated as
Ci j =
〈Δ	ri (t ) ·Δ	r j (t )〉t
〈‖Δ	ri (t )‖2〉t ·
〈‖Δ	r j (t )‖2〉t , (5.16)
where 	ri (t ) denotes the coordinate vector for atom i as a function of time, 〈·〉t is
the time ensemble average and the atomic displacements are calculated as Δ	ri (t ) =
	ri (t )−〈	ri (t )〉t [146].
The cross-correlation coefﬁcients can have values between -1 and 1, the posi-
tive values denoting correlation and the negative values anti-correlation between the
movements of the two domains. For instance, a high positive value between two
domains indicates that the movement of one domain causes similar movement in
the other domain (same period and phase). For values close to zero, there is no cor-
relation between the two domains. Anti-correlated movement occurs in the same
period but within the opposite phase.
5.3.1 Free energy and umbrella sampling
On the concept of free energy
One important concept discussed in this Thesis are the free energy requirements for
certain types of cellular events such as lipid ﬂip–ﬂop. Lipid ﬂip–ﬂop can be consid-
ered a diffusion-like reaction where the initial state involves the lipid in its starting
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position, the transition state the headgroup in the hydrophobic membrane interior,
and the ﬁnal state has the lipid in the other leaﬂet [147]. Thermodynamic free energy
is a useful quantity for measuring thermal and chemical processes as every chemical
reaction involves a change in the free energy of the system. It is based on the prin-
ciple that all chemical reactions strive towards equilibrium. The internal energy or
the absolute free energy of the system is rarely of great interest in chemical reactions,
so here when talking about free energies, we refer to the energy differences between
the initial state and the ﬁnal state [148].
Changes in the Gibbs free energy G are deﬁned asΔG =Gfinal−Ginitial. In other
words, a reaction is spontaneous if ΔG is negative and some additional energy is
required for the reaction to occur ifΔG is positive. Assuming constant pressure and
temperature, theGibbs free energy can be decomposed intomeasurable components,
enthalpy H and entropy S by
ΔG =ΔH −TΔS, (5.17)
where T is the temperature of the system. Temperature is important in free en-
ergy reactions – the entropic term plays a greater role at higher temperatures and is
not as signiﬁcant at lower temperatures. The enthalpic component can be associated
with the heat of the system and is deﬁned as
ΔH =ΔU + pΔV , (5.18)
where U is the internal energy of the system, p the pressure, and V the volume.
A positive enthalpic component means the absorption of heat and a negative en-
thalpic component means heat is transferred to the surroundings. The enthalpic and
entropic components together can be used to assess the spontaneity of the reaction
– when ΔS < 0 and ΔH > 0, ΔG > 0 always, but in all other cases the spontaneity
of the reaction is greatly affected by temperature.
One additional free energy concept is the Helmholtz free energy F , deﬁned as
ΔF =ΔU −TΔS. (5.19)
In other words it can be deﬁned as the Gibbs free energy without the expansion
term ΔF =ΔG− pΔV , basically meaning the amount of energy usable in the sys-
tem once spontaneous expansion work has been performed. Helmholtz free energy
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can be used for the calculation of the free energy proﬁles of lipid ﬂip–ﬂop through a
method known as umbrella sampling as there is no driving enthalpic force facilitating
the translocation of membrane lipids [147].
The free energy proﬁles of lipid ﬂip–ﬂop can further be decomposed into its en-
tropic and enthalpic components. This can be performed with a centered difference
method applied to the entropic portion of the free energy proﬁle. Then the entropic
contribution can be estimated as
−TΔS ≈ T
2ΔT
[ΔG (T +ΔT )−ΔG (T −ΔT )] , (5.20)
where in order to obtain the entropic contribution on the free energy proﬁle at
temperature T , two additional free energy proﬁles for the same system must be ob-
tained at temperatures T +ΔT and T −ΔT [149]. The enthalpic component of
the reaction can then be calculated from Equation (5.17). For instance, past research
has shown the activation free energy for lipid ﬂip–ﬂop to consist of large opposing
enthalpic and entropic contributions [105, 150]. According to the basic laws of ther-
modynamics, entropy tends to spontaneously increase [148]. Therefore, in normal
temperatures, when the entropic component plays a higher role, entropically driven
chemical reactions are favorable and happen spontaneously. Enthalpically driven
chemical reactions, in turn, generally require external energy to occur.
The energy requirements of lipid ﬂip–ﬂops can be associated with the rate with
which lipid ﬂip–ﬂops occur. The rate constant kf is dependent on the height of the
energy barrierΔG through an Arrhenius-like relation
kf =
kBT
h
exp

−ΔG
RT

, (5.21)
where kB is the Boltzmann constant, h the Planck constant, and R the molar
gas constant [151]. Through the equation, estimates of the effect a reduced free en-
ergy barrier has on the ﬂip–ﬂop rate can be made, and experimental measurements
compared to simulated ones. However, obtaining accurate absolute values for the
ﬂip–ﬂop rate or conversely on the free energy barrier through the equation is not
as straightforward due to the fact that there are many unquantiﬁable factors such as
transition probabilities related to the lipid position affecting lipid ﬂip–ﬂop.
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Umbrella sampling – measuring the free energy proﬁles
Chemical processes are driven by free energy differences between two states. For
example, certain proteins can be found in closed or open states. In order to move
from one state to the other, the protein must overcome a free energy barrier. An-
other example can be found in lipid translocation, where in order to ﬂip–ﬂop across
a bilayer, a lipid must cross an exceptionally high free energy barrier. One major
challenge in molecular dynamics is the calculation of these free energy differences.
Due to the fact that free energies are thermal quantities, as kinetic energy is de-
pendent on the temperature, free energy differences between two states can not be
directly measured from the simulation data unlike work [152]. A main alternative
method is the probability-based umbrella sampling, which uses bias potentials to
help drive the system from one state to the other [153]. The basic concept of um-
brella sampling is visualized in Figure 5.1.
The equations behind this method originate from the basic concepts of thermo-
dynamics, according to which the amount of work W performed to the system is
greater than the Helmholtz free energy difference ΔF when the system is trans-
formed from one state to the other at a ﬁnite rate, so that 〈W 〉 ≥ ΔF [154]. The
inequality is related to dissipated work associated with entropy and can be replaced
by an equality 〈exp (−βW )〉= exp (−βΔF ), which can be solved for the free energy
ΔF =−1/β ln〈exp (−βW )〉, (5.22)
where β = 1/ (kBT ) is the inverse temperature and kB the Boltzmann constant
[154]. The amount of work can be directly measured from MD simulations and
implemented into the equation. Such a direct calculation, however, can give very
inaccurate results as in many cases an external force has to be applied to the system
in order to facilitate transformation from one state to the other along a set reaction
path.
A way to equilibrate these instabilities caused by the application of an external
force is to divide the reaction path into windows and consider each of them as a
separate simulation. External bias is applied to each window in order to keep the
reaction close to its desired state inside the window and the windows are selected at
such intervals that two neighboring windows may overlap at a small probability at
any given time.
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Figure 5.1 Illustration of the basic idea behind umbrella sampling. The reaction, represented by the cyan
circle, propagates along the reaction coordinate ξ . The reaction path is divided into a number
of sampling windows and each window is used as a starting point for a new independent
simulation. In each window, the reaction is conﬁned near its new starting point by using
a bias potential. When the positions of the windows and the bias potentials are selected
properly, there should be a small probability that the reaction will be found in the same phase
in two adjacent windows. Therefore, the probability distributions of the reaction path for two
adjacent windows will overlap. As a result, the continuous free energy can be integrated over
the whole reaction path. Figure adapted from Ref. [123]
.
The total free energyAof a reaction path can then be integrated over the probabil-
ities of ﬁnding the system at any given state along a reaction path over all i windows,
as
Ai (ξ ) =− 1β lnP
b
i (ξ )−wi (ξ )+ Fi , (5.23)
where P bi is the biased probability distribution, wi are the bias potentials and
Fi is the free energy obtained from the previous equation. The combined umbrella
sampling simulations can then be analyzed, for instance, by the weighted histogram
analysis method (WHAM), which aims to minimize the statistical errors and pro-
duces the free energy proﬁle [155].
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6 OVERVIEW OF THE SIMULATED SYSTEMS
Paper I
In the ﬁrst paper, MD simulations were conducted on the P2 protein in a solvated
box. Models for both the wild type protein and its P38G mutant were constructed.
The planwas to investigate the dynamics of thewild type protein and see how a point
mutation in the hinge of the lid of the barrel structure would affect the dynamics and
structure of the protein especially around the lid area.
The simulations were conducted with the GROMACS 4.6 simulation package
[156]. The model for the P2 wild type was obtained from the RCSB Protein Data
Bank [137] under the PDB entry 4BVM [11], and the point mutant was constructed
from the wild type by changing the amino acid at the point of the mutation. The
modeling was done using the CHARMM36 force ﬁeld [157] which gave an all-atom
representation of the protein and the palmitate chain. All bonds were constrained
with the LINCS algorithm [158]. Water was modeled with the TIP3P three-point
model [159].
The simulationswere carried out inNpT conditionswith the Parrinello–Rahman
barostat for pressure coupling [144] and the velocity-rescale method for temperature
coupling [143]. The systems consisted of the wild type and P38G variants of the P2
protein both with and without the bound palmitate chain in a solvated box with
added counter-ions to negate the charge of the protein. After an initial equilibria-
tion period of 500 ns, the systems were simulated for an additional 2.5 μs in order
to obtain enough data for reliable analysis.
For mean square deviation analysis of the protein hydrogens, we carried out ad-
ditional simulations, selecting seven starting points from the original 3 μs simula-
tion, the ﬁrst at 500 ns and the following ones taken at 200 ns intervals for sufﬁcient
sampling. These systems were simulated for a short period of 3 ns while saving the
trajectories at every time step (2 fs) in order to capture the rapid motion of the hy-
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drogen atoms. The ﬁrst nanosecond of each simulation was then used to average the
MSDof bothCH3 andCH2 hydrogens of each protein system as it provided accurate
enough data.
Paper II
In the second paper, we conducted MD simulations in a similar manner to the ﬁrst
paper while exploring the effect of the CMT1 associated point mutations on the dy-
namics of the P2 protein. The simulations were conducted with the GROMACS 4.6
simulation package and the three point mutants were obtained in the same fashion.
The simulations were carried out in NpT conditions using the Parrinello–Rahman
barostat and the velocity-rescale thermostat. All-atomistic representation of the sys-
tem was done using the CHARMM36 force ﬁeld.
A total of eight systems were investigated; the P2 wild type and its I43N, T51P
and I52T mutants with and without the bound palmitate chain. These proteins were
simulated in a solvated boxwith counter-ions to negate the total charge of the system.
The total simulation time for each system was 2.5 μs of which the ﬁrst 500 ns was
used for equilibration.
Paper III
In the third paper, we investigated another point mutant of the P2 protein, F57A
through atomistic MD simulations. The F57 amino acid has a central role in regu-
lating the opening of the barrel region of the P2 protein. The simulation parameters
were exactly the same as in the previous publication.
The dynamic cross-correlation map (DCCM) analysis of the P2 mutants were
performed with Bio3D, an R package for analysing trajectory data [160]. In addi-
tion to P2 wild type and the F57A mutant, DCCM analysis was performed on all
previously (Paper I and II) simulated P2 mutants as well.
Paper IV
In the fourth paper, we performed molecular dynamics simulations on two different
systems with the main goal of uncovering a protein-mediated mechanism for lipid
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ﬂip–ﬂop. The free energy requirements for both rhodopsin-mediated ﬂip–ﬂop and
that of a protein-free system were calculated. As the attached paper is a review article
referencing mainly unpublished data from the author, the simulation details related
to these results are described here in greater detail.
The main system consisted of a lipid bilayer with a composition of 50% POPC,
25% SSM and 25% cholesterol (162, 81 and 81 lipids respectively), mimicking a lipid
raft system. Embedded in the bilayer was rhodopsin obtained from the RCSB Pro-
tein Data Bank [137] under the PDB entry 1U19 [17]. The ligands 11-cis-retinal
and the two palmitoyl chains attached to rhodopsin were re-parametrized by calcu-
lating the partial charge values of the atoms using quantum mechanical derivation
through the RESP ESP charge Derive (R.E.D.) package [161]. The system was then
adequately solvated with approximately 28000 water molecules and the salt concen-
tration was set to a physiological level of 150 mmol/l by addition of NaCl molecules.
The protein-free system had the same lipid composition, but was smaller in size (64,
32 and 32 lipids). It was solvated with approximately 4000 water molecules and had
the same salt concentration.
The simulations were conducted using the GROMACS 4.5.5 simulation package.
The modeling was done at atomistic level using modiﬁed OPLS-AA representation
[162, 163]. The water molecules were represented with the TIP3P model [159].
Simulations were mainly carried out in NpT conditions using a semi-isotropical
Parrinello-Rahman barostat for pressure coupling and the velocity rescale method
for temperature coupling. Energyminimization runswere performedwith the steep-
est descent algorithm with LINCS constraints on all bonds and the molecular dy-
namics simulations were conducted with the leap-frog algorithm with time steps of
2 fs.
Steered molecular dynamics simulations were performed in order to move lipids
from one place to the other. This was done by applying a force of 1000 kJ mol−1
nm−2 to the lipid head group, forcing the lipid to move into a certain direction. The
rates of movement for the lipids varied from 0.1 to 1.0 nm/ns. This was especially
useful for establishing a favorable path for the lipid to traverse across the bilayer inte-
rior in both systems. Snapshots were taken at 0.1-0.2 nm intervals along the ﬂip–ﬂop
route, which were later used as the windows for umbrella sampling. These simula-
tions were repeated for both POPC and cholesterol with and without the presence
of rhodopsin.
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A total of 33 umbrella sampling windows were used for POPC and 21 for choles-
terol ﬂip–ﬂop in the system with rhodopsin. For the protein-free system, free energy
proﬁles for both POPC and cholesterol ﬂip–ﬂops were calculated using 21 umbrella
sampling windows. The free energy proﬁles involving lipid approach towards the
protein had 30 umbrella sampling windows for POPC and 25 for cholesterol. The
windows were equilibrated for 20 ns followed by a 50 ns data gathering period –
the equilibration period long enough for the system to revert the effects caused by
forced steering of the lipid, and the data period short enough for the system not to
completely relax into its present state. During the umbrella simulations the lipids
were held in place by a harmonic force constant of 4000 kJ mol−1 nm−2 during the
equilibration period and 1000 kJ mol−1 nm−2 during the data gathering period. The
lower harmonic force constant allowed the lipid to ﬂuctuate more freely within the
short time period resulting in a wider probability distribution ensuring continuity
along the reaction path.
The obtained free energy proﬁles were later decomposed into their enthalpic and
entropic components. The decomposition required repetition of the umbrella sam-
pling simulations performed at two additional temperatures as per Eq. 5.20. We
chose a temperature difference of 15 K, resulting in a set of umbrella sampling sim-
ulations at temperatures 295 K, 310 K and 325 K, for obtaining the enthalpic and
entropic contribution at T = 310 K.
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7 RESULTS AND DISCUSSION
The key results obtained in the publications included in this Thesis are discussed in
detail in this chapter. Even though the majority of the papers had experimental wet
lab collaboration with additional insight into the results of the research, we mainly
focus on the results obtained from the molecular dynamics simulations thereby fo-
cusing on the author’s contribution.
7.1 Point mutation in P2 lid hinge increases protein
dynamics
The myelin protein P2 is a main structural component of the myelin sheath in the
peripheral nervous system. Its main role is to help stack lipid membranes together
to form a functional myelin structure around an axon. In vitro studies of a P38G
point mutation have shown that the P38G-variant of P2 increased its lipid stacking
capacities while still remaining functional and not changing the overall structure of
the protein [51]. The crystal structures of the two variants were found to be prac-
tically identical. The core reasons for functional differences were not reachable by
conventional experimental means. Therefore, computational models were used to
provide insight into the underlying dynamics of the P2 protein and its P38G mutant.
The proline residue 38 is found in the hinge region of P2, between the rigid barrel
structure and the ﬂexible lid. Previous assumptions have linked P38 with the open-
ing of the helical lid of P2 during the binding and releasing processes of the protein
ligand found inside the barrel [11]. The cyclic structure of the proline side chain has
a signiﬁcant effect on the rigidity of the protein structure around the residue. By
mutating the proline into a glycine, we remove the cyclic structure which in turn
weakens the protein structure in the hinge region, increasing the ﬂexibility of the
lid. Presumably, this should allow the lid to open more easily, facilitating the rate of
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Figure 7.1 Root mean square ﬂuctuation per residue for all four simulated systems. For the systems
without a ligand, black corresponds to the wild type and red to the P38G mutant. For the
systems with the bound palmitate, green corresponds to the wild type and blue to the P38G
mutant. Larger RMSF values indicate a more mobile region. The lid region can be found
between residues 16-36 and the two apposing loops at residues 74-78 and 97-99.
ligand transfer.
In Paper I, we constructed and simulated models of the P2 protein and its P38G
mutant with and without a bound ligand that was found in the crystallized structure
we used as a base model [11]. As the main focus of the publication was to observe the
main dynamical differences of the two protein variants, the proteins were simulated
in a simple solvated box without the presence of a lipid membrane.
The simulations provided insight into the dynamics of the P2 protein. By ex-
amining the root mean square ﬂuctuations of every residue of the protein variants
(Figures 7.1 and 7.2), we see which parts of the protein are the most ﬂexible and how
the dynamics of the protein variants compare to each other. The most mobile re-
gions of P2 are found in the two loops (residues 74-78 and 97-99) apposing the lid
region. The lid itself (residues 16-36) seems to be quite stable. This suggests that
maybe the lid is not the opening part of the protein, but instead the two beta-strands
on the opposite side give way for the ligand (a point further investigated in following
publications).
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Figure 7.2 A visualization of the RMS ﬂuctuations in the P38G mutant with the palmitate chain inside the
binding pocket. The yellow color corresponds to the mutated amino acid G38. The colorbar
indicates the RMSF values, with bright magenta corresponding to the most ﬂexible parts of
the protein.
Comparing the protein variants to each other, we can see that the dynamics of the
ligand-free P2 and its P38G mutant are quite similar, with maybe a slight decrease
of ﬂexibility upon mutation. However, when we add the palmitate ligand into the
barrel, the dynamics change signiﬁcantly. Firstly, the lid region is extremely stable
in the wild type, likely due to strong interactions between the lid, the palmitate and
the cyclic structure of proline. Upon changing the proline into glycine, we weaken
these interactions, and the lid region and also the palmitate chain become more mo-
bile. This can also be observed by examining the trajectory data. Secondly, the data
shows that the wild type with the palmitate is considerably more stable than either
of the two palmitate-free variants, especially in the loop regions. Conversely, the
P38G mutant with the bound palmitate is the most mobile variant, especially in the
aforementioned loop regions. The increased ﬂexibility of the P38Gmutant could ex-
plain the previously observed increase in membrane binding activity of the variant
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Figure 7.3 The averaged mean square deviations of CH3 (top) and CH2 (bottom) hydrogens. Proteins
without palmitate are shown in black (wild type) and red (P38G mutant). Proteins with palmi-
tate are shown in green (wild type) and blue (P38G mutant).
along with an enhanced ability to interact with lipids.
A secondary goal for the molecular dynamics simulations was to provide support
for the use of elastic incoherent neutron scattering (EINS), which is a powerful ex-
perimental tool for investigating quantitive protein dynamics, for instance, as a func-
tion of temperature. For this reason, we performed additional simulations where the
main focus was the dynamics of the protein hydrogens, separated into hydrogens of
both CH3 and CH2 groups. The mean square deviations of both hydrogen groups
depicted in Figure 7.3 show that the methyl hydrogens are much more mobile than
the other hydrogens both in the travel distance (MSD values) and the rate of mo-
tion (tangents of curves). The mean square deviations also show that the hydrogens
in the palmitated proteins are more constrained than in the palmitate-free protein
conﬁrming earlier observations that the bound fatty acid restricts P2 dynamics [11].
The results also support dividing P2 hydrogens into methyl and non-methyl groups
for EINS analysis.
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7.2 CMT1–associated point mutations affect P2 dynamics
As P2 is a major component of the peripheral myelin sheath, issues in its encoding
may also lead to mutations which have harmful consequences. Often these muta-
tions cause the protein to function in a different manner, which in turn affects its
fatty acid binding capabilities leading to improper stacking of the myelin leaﬂets.
One such case is the Charcot-Marie-Tooth neuropathy, which has been linked to
certain point mutations found in P2 [75, 76].The point mutations in question are
I43N, T51P and I52T, all found near each other in the β2- and β3-strands of the
barrel structure.
In Paper II, we performedmolecular dynamics simulations on these three variants
with and without the bound palmitate ligand found inside the crystallized structure
of the protein. Included was the simulation data of the protein wild type from Paper
I. The main goal of these simulations was to gain insight on how the point mutations
affect the dynamics of P2 at an atomistic level. Coupled with experimental studies
we were able to perform a detailed characterisation of the CMT1-linked P2 point
mutations.
Rootmean square ﬂuctuations (shown in Figure 7.4) can again be used to compare
the mobility of the different parts of the protein over the course of the simulation.
By comparing the dynamics of the point mutants to the wild type, we can gain valu-
able information from their different behavior. From the data we can see that in
the ligand-free protein, all point mutants are more stable than the wild type. I43N
and T51P are extremely rigid, with the former showing slight movement around the
lid area. On the other hand, I52T is quite mobile at the two loops opposite the lid.
Upon introducing the bound palmitate ligand, there is signiﬁcant change in the dy-
namics. T51P suddenly becomes the most dynamic of all the variants especially in
the lid region and the following beta-sheets, contrary to its behavior in the absence
of the ligand. I52T also shows larger ﬂuctuations than the wild type in certain areas.
Minimal differences can be seen in the I43N mutant. Generally in other areas, the
protein is more stable in the palmitate-bound form. It seems that the presence of the
palmitate destabilizes these certain areas while increasing stability elsewhere.
Differences in the point mutants can also be seen by observing the amount of
water inside the beta-barrel of each variant. Over the course of the simulation, the
average numbers of water molecules found inside the barrel were 27.7, 30.5, 23.7 and
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Figure 7.4 Root mean square ﬂuctuation per residue for all eight simulated systems. The empty protein
is shown in the top graph and the liganded P2 in the bottom. The corresponding point mutants
are indicated by colorization.
30.4 for unliganded P2 wild type, I43N, T51P and I52T mutants respectively. For
P2 with the bound palmitate, the respective numbers were 21.0, 22.1. 29.1 and 22.0.
In general, the number of water molecules found inside the barrel was smaller in the
presence of the ligand. The only exception was the T51P mutant, where the number
of water molecules was much higher in the liganded form. This was explained by
early opening of the T51P structure, allowing a larger number of water to enter the
barrel (see Figure 7.5). Compared to the wild type, the Ile mutants I43N and I52T
showed similar, higher amounts of water. These values are in accordance to previous
FABP studies, where liganded proteins were found to have a higher water exchange
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Figure 7.5 The structure of P2 wild type superimposed on the open conformation of the T51P mutant.
The location of the three mutations are shown in green. The red dot indicates the hinge area
of the barrel opening.
rate than their empty counterparts [164].
In addition to the T51P mutant, also the two other point mutants showed signs
of opening during the simulation. The common factor in the barrel opening was the
location. The β5- and β6-strands of the barrel ﬂip away from the protein creating
a large enough gap for a ligand to pass through. This movement can also be seen
in the RMSF graphs at the area of highest ﬂuctuations. At the root of these two
beta-strands is a conserved glycine residue, a common theme in all human FABPs.
It is therefore possible that the observed motion is a general mechanism for opening
of all fatty acid binding proteins, a mechanism that has been suggested earlier, but
not observed so far [165]. There may be several factors affecting the barrel opening,
such as the presence of a ligand, mutations or a cell membrane. It is also possible that
this increased instability may be a main factor in misfolding or deformation of the
myelin sheath, amain cause behind theCharcot-Marie-Tooth neuropathy. It is worth
noting that no spontaneous ligand transfer was observed in the simulations even
though the palmitate chain drifted towards the gap on several occasions. External
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inﬂuences such as a lipid membrane or other proteins may be required to facilitate
the dissociation of the ligand.
7.3 P2 barrel opening is regulated by a conserved residue
in the portal region
In the ﬁrst two papers included in this Thesis, we observed an increase in protein
dynamics of P2 upon introduction of certain point mutations, especially around
the portal region. Opening of the beta barrel is critical for ligand transfer, which is
thought to be a secondary function of P2. The barrel is large enough for a small lipid,
such as cholesterol, one main component of the myelin sheath, and thus P2 might
be able to function as a lipid transporter during the myelination process [166, 167].
However, the question of the opening mechanism has been elusive even when we
know ligand transfer is an intrinsic property of FABPs.
In Paper III we delve deeper into the mechanisms behind the opening of the P2
portal region by investigating a conserved residue Phe57 located near the root of the
barrel lid. The residue in question is prevalent in many FABPs and has been consid-
ered a gatekeeper for portal region opening during ligand transfer [168]. Phe57 has a
ring structure that has been found to ﬂip from inside the barrel towards the solvent
and back in different FABP structures, and its position might play a central role in
the opening of the portal region [168]. The point mutation considered in Paper III
was simply to remove the ring structure, and mutating the residue to alanine in order
to disrupt its central role in regulating the opening of the portal region, highlighting
its importance in the opening process and giving us further insight on the opening
mechanism.
We began by comparing the root mean square ﬂuctuations for each residue of the
F57A point mutant to the wild type protein. Again, we see higher dynamics for
the mutant in the absence of the bound palmitate chain, while the differences are
minimal in its presence (see Figure 7.6). It appears that the presence of the palmitate
ligand stabilizes all lost contacts caused by the mutation due to the similarity of
the RMSF curves of the liganded P2. The main differences in protein dynamics
are again observed in the β5-β6-loop opposite the lid. Compared to the previously
studied point mutants, the effects are even more profound, also denoted by clear and
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Figure 7.6 Top: Root mean square ﬂuctuation per residue for the wild type P2 (black) and its F57A mu-
tant (red). Thick lines indicate unliganded P2 and the thin lines P2 with a bound fatty acid.
Bottom: The closed and open structures of the F57A mutant of P2 taken from the simula-
tions. The location of the F57A mutation is shown in green.
prolonged opening of the protein between the β4- and β7-strands.
Here, we further investigated the causes and effects of the opening process. One
way to analyze the simulation trajectories and look for intramolecular interactions
within the protein is through dynamic cross-correlation networks. By comparing
the dynamic cross-correlation matrices of the wild type P2 to its point mutants, we
can see which interactions are disrupted by the point mutations. Speciﬁcally, the
coordination of barrel opening may be observed.
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Figure 7.7 DCCM analysis of the simulations of the F57A point mutant. The maps for the unliganded wild
type (a) and wild type with palmitate (b) show two main regions of anti-correlation denoted by
the arrows. In the unliganded F57A (c) and the F57A with palmitate (d) this anti-correlation is
absent.
The dynamic cross-correlation maps (Figure 7.7) for the wild type show areas of
signiﬁcant anti-correlation between the β5-β6-loop (residues 74-77) and the lid re-
gion (residues 16-36) and the adjacent β3-β4-loop (residues 55-58) denoted by the
two arrows. This anti-correlation is also present in the wild type with the bound
palmitate. We believe this anti-correlation to reﬂect the coordinated open-closemove-
ments of the β5-β6-ﬂap upon ligand transfer. The DCCM analysis also shows that
upon point mutation these areas of anti-correlation disappear, which indicates that
themutation removes the ability of the protein to regulate its opening. Upon further
examination of the previously studied point mutants (P38G and the CMT-disease
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mutants) with higher dynamics in the portal area, we also perceived similar changes
through their dynamic cross-correlation maps. The common denominator for the
increased protein dynamics seems to be the loss of regulatedmovement in the protein
caused by a mutation.
With the results published in Paper III, combined with the re-analyzed data from
the Papers I and II, we believe to have observed the general mechanism for P2 barrel
opening. The barrel opening of FABPs through two adjacent β-strands has long
since been suggested [169], but not shown at an atomistic level until now. Due to
high structural similarities between all FABPs, we believe thismechanism to be likely
to work for other FABPs as well.
7.4 Rhodopsin functions as a non-selective lipid scramblase
The fourth paper included in this Thesis is a review article discussing cell signal-
ing and the roles lipids serve within the signaling processes. The approach taken to
research this subject includes atomistic and multiscale molecular dynamics simula-
tions. Several different studies are referenced in the review article including rhodopsin-
andβ2-adrenergic receptor-mediated lipid ﬂip–ﬂop, the role of polyunsaturated fatty
acids and cholesterol in oxidative stress, and how lipid messengers bind to receptors
or target proteins and function in receptor activation. The author contributed to
this review article by studying the scramblase properties of rhodopsin and the ener-
getics of rhodopsin-mediated lipid ﬂip–ﬂop which allows lipids to translocate back
and forth across the membrane at a relative ease. As a consequence of non-selective
lipid scrambling, a large number of different types of lipids are able to reach the
cell surface where they are recognized by target proteins and enzymes, resulting in
a large variety of cellular processes. Therefore, lipids undergoing ﬂip–ﬂop are major
contribuents in cellular signaling, where information from within the cell has to be
sent rapidly to the extracellular side. The main unpublished results related to the
lipid ﬂip–ﬂop segments referenced in the review article, as well as the background
behind the research, are discussed in depth within this subchapter.
Lipid ﬂip–ﬂop is an extremely slow process when no proteins, peptide chains or
other membrane defects are present, with typical rates of one phospholipid ﬂip–
ﬂop per day [170]. However, rapid lipid ﬂip–ﬂop is required for many physiological
events such as sustaining cellular growth and maintaining lipid asymmetry in mem-
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branes. During the past few decades, certain types of proteins – ﬂippases and scram-
blases – have been identiﬁed, their function to greatly facilitate the ﬂip–ﬂop process
in cellular membranes. One of the latest discoveries on the subject established a link
between G protein-coupled receptors and non-selective lipid scrambling across the
lipid bilayer [12]. Also, until now, the only existing x-ray structure of a veriﬁed
scramblase is from a few years ago of transmembrane protein TMEM16 [16]. As
a result, the molecular mechanisms behind protein-mediated lipid ﬂip–ﬂop are still
relatively unknown. The main goal of our study was to utilize molecular dynamics
simulations on lipid bilayer systems with an embedded rhodopsin – a well-known
GPCR shown to exhibit scramblase activities – and to uncover the molecular mech-
anisms with which it facilitates lipid ﬂip–ﬂop.
Considering the central structures of all GPCRs – seven transmembrane helices
crossing the membrane interior – three possible pathways seem likely candidates for
lipid translocation and have been suggested by previous studies [12, 44, 128]. The
ﬁrst involves the lipid migrating across the membrane outside the protein and along
the surface of the transmembrane helices. The second candidate mechanism has the
lipid headgroup in a hydrophilic environment inside the transmembrane channel
of the protein while the lipid tails remain outside in the hydrophobic membrane
interior. The third possible mechanism has the lipid entering the transmembrane
channel completely on one surface of the membrane and exiting only on the other
side. However, the last one seems unlikely as lipid scrambling facilitated by GPCRs
is nonselective, and especially lipids with larger headgroups may have trouble sub-
merging into the transmembrane channel entirely.
Our studies focused on the ﬁrst candidate with the lipid translocating along the
protein surface. Thiswas decided aftermany attempts of steeredmolecular dynamics
where we tried to force the headgroup of a POPC molecule through the membrane
along a large number of different pathways with the aforementioned mechanisms.
From the initial results, POPC ﬂip–ﬂop along the surface of rhodopsin next to trans-
membrane helices II, III and IV seemed the easiest. This was also supported by mul-
tiple studies where even single peptide chains – with no hydrophilic transmembrane
channels – were able to facilitate lipid ﬂip–ﬂop to an acceptable level [151, 171, 172],
and that the ﬂip–ﬂop rates depend on the hydrophilicities of the central residues of
the chain [173]. Also, the fact that the scrambling abilities of opsin remain in many
of its holo-forms where the transmembrane channel is blocked by a ligand – such
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Figure 7.8 Snapshots from selected parts of the steered molecular dynamics simulations for POPC
(above) and cholesterol (below) ﬂip–ﬂop. The ﬁgures are taken after a short equilibration pe-
riod. The lipid bilayer and water are not shown for clarity with the exception of water molecules
within 0.5 nm of the lipid undergoing ﬂip–ﬂop. The headgroup of POPC translocates across
the membrane interior with a water pore that is formed during the ﬂip–ﬂop event.
as retinal in rhodopsin – imply that the main translocation path does not involve
the central core of the protein [44]. However, it is worth noting that a recent sim-
ulation study successfully explored the second mechanism for opsin with the lipid
headgroupmigrating along a hydrophilic path between two adjacent transmembrane
helices, insinuating that multiple translocation mechanisms do exist for a single pro-
tein [50].
The ﬂip–ﬂopmechanisms in the presence of rhodopsin for both POPCand choles-
terol are illustrated in Figure 7.8. By applying a downward force to the lipidmolecule
headgroup, the lipid was steered from the upper leaﬂet of the bilayer to the lower
leaﬂet along the protein surface. Interestingly, a water pore formed next to the pro-
tein surface during POPC ﬂip–ﬂop, giving the polar headgroup easier access to the
hydrophobic membrane core. A similar water pore also formed during POPC ﬂip–
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ﬂop in a protein-freemembrane, the amount of watermolecules in the vicinity of the
lipid headgroup differing only by a few. However, no water molecules were present
during the translocation process of cholesterol – likely due to the small size of the
cholesterol headgroup. Cholesterol is known to spontaneously ﬂip–ﬂop at a rapid
rate even in protein-free membranes, making their translocation process indepen-
dent of ﬂippases and other membrane defects such as water pores [105].
The free energy proﬁles for POPC and cholesterol ﬂip–ﬂop were calculated by
umbrella sampling and are presented in Figure 7.9. The approximate height of the
free energy barrier caused by the hydrophobic core of the membrane is 60 kJ/mol
for POPC and 10 kJ/mol for cholesterol when ﬂip–ﬂop occurs along the surface
of rhodopsin. In the protein-free system the respective values were 130 kJ/mol for
POPC and 20 kJ/mol for cholesterol. Translocation from one leaﬂet to the other
along the surface of rhodopsin reduced the height of the free energy barrier ΔG
by a total of ∼60 % (or ∼70 kJ/mol) for POPC and ∼50 % (or ∼10 kJ/mol) for
cholesterol when compared to a protein-free system. This is a signiﬁcant reduction
in free energy and is supported by previous experimental results where the presence
of rhodopsin in large unilamellar vesicles greatly increases the scrambling rate of
phospholipids [12]. The fact that the free energy barrier was also reduced for choles-
terol further supports the suggestion that the scramblase properties of GPCRs are
not lipid selective.
Umbrella sampling was also utilized in order to calculate the free energy proﬁles
of both POPC and cholesterol approaching rhodopsin along the membrane surface
(see Figures 7.10 and 7.11). The free energy proﬁle for POPC was calculated at the
initial stages of the study and thus only includes the approach towards the protein
interface with helices VI-VII on the cytosolic side, containing the gap into which
the lipid headgroup might enter as per our initial candidate mechanism for ﬂip–ﬂop.
The free energy proﬁles for cholesterol were calculated later towards the interface
with helices II-IV on both leaﬂets.
Both free energy proﬁles of POPC and cholesterol indicate a preferable position
near rhodopsin towards which the free energy decreases. For POPC, near helices
VI-VII, the free energy minimum occurs at approximately 2.5 nm from the protein
center of mass. For cholesterol, the free energy minima can be found approximately
at 1.5 – 2.0 nm from the protein center of mass on both leaﬂets. GPCRs such as
rhodopsin or β2AR are also known to bind cholesterol at certain locations, where
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Figure 7.9 (a): Figure illustrating the lipid translocation path along the protein surface. Rhodopsin-
mediated POPC ﬂip–ﬂop occurred along the transmembrane helices II, III and IV with the
lipid headgroup following the blue line. Cholesterol translocation occurred along a similar
path a little farther from the protein surface. (b): Free energy proﬁles of POPC (blue) and
cholesterol (red) translocation along the rhodopsin-membrane interface. (c): Free energy
proﬁles of POPC (blue) and cholesterol (red) in a protein-free membrane. The shaded areas
represent statistical error. The reaction coordinate (z) refers to the distance between the lipid
headgroup and the center of mass of the bilayer calculated along the membrane normal.
they induce packing of helices or modulate GPCR function [31], thus it is under-
standable that cholesterol is able to reach the protein surface with ease. The favor-
able distance for POPC may also be close enough to allow the protein to aid in the
translocation process.
We analyzed the energetics behind the ﬂip–ﬂop process by calculating the inter-
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Figure 7.10 The free energy proﬁle of POPC approaching rhodopsin on the cytosolic side of the bilayer.
The green area indicates the area outside the protein surface and the red area the protein
interior.
action energetics between the lipid headgroup and its surroundings. During choles-
terol translocation, we observed high electrostatic interactions between the hydroxyl
headgroup of cholesterol and certain charged amino acids of rhodopsin. During
POPC translocation, these types of electrostatic interactions were heavily quenched
by the surrounding water pore, but the interaction energies were still higher than for
cholesterol. Both POPC and cholesterol showed the highest amount of electrostatic
interaction energies with the rhodopsin upon entering and exiting the membrane
interior. We also calculated the amount of hydrogen bonds the lipid undergoing
ﬂip–ﬂop formed with its surroundings. POPC formed no hydrogen bonds with ei-
ther the protein or the membrane in either system, but instead had an average of
4.63 and 5.16 hydrogen bonds with the surrounding water pore in the original and
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Figure 7.11 Free energy proﬁles of cholesterol approaching rhodopsin on the cytosolic side (blue) and
on the extracellular side (red). The green area indicates the distance with the energy minima
and the distance from protein when cholesterol ﬂip–ﬂop was initiated.
the protein-free system respectively. The hydroxyl group of cholesterol formed an
average of 0.94 hydrogen bonds with the protein in the original system, and 0.50
hydrogen bonds with the membrane in the protein-free system. Again, we see the
mitigating effect the water pore has on headgroup interactions with the surround-
ings.
We further analyzed the water pore by calculating the amount of water molecules
in the vicinity of the POPC headgroup during ﬂip–ﬂop in both systems. Surpris-
ingly, the number of water molecules was very similar with the protein-free system
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having only a few more water molecules present in the pore. The difference is very
small when compared to the free energy difference of the whole translocation pro-
cess. It is clear that the presence of a water pore is necessary for ﬂip–ﬂop of lipids
with larger headgroups, and its size is not signiﬁcantly reduced in the presence of
a scramblase. Therefore, it is likely that the protein disturbs the membrane in a
way that a water pore can form more easily in the membrane interior. The protein
may also stabilize the water pore enough that the translocating lipid has favorable
conditions to ﬂip–ﬂop along the protein surface. This is one likely explanation for
the large difference in the free energy proﬁles even though the ﬂip–ﬂop process is
quite similar to when no protein is present. For lipids with small headgroups, such
as cholesterol, when no water pore is formed, we believe membrane perturbations
and electrostatic interactions with the protein surface to be the main facilitator of
lipid translocation. Analysis was also performed on the membrane-perturbing ef-
fects of rhodopsin through examining the order parameters of nearby lipids and the
thickness and the density of the membrane. However, the results showed no clear
indication on how rhodopsin causes such effects.
We also performed further analysis on the free energy proﬁles of rhodopsin-
mediated ﬂip–ﬂop by decomposing them into their enthalpic and entropic compo-
nents according to the method described in Ref. [105], where similar analysis was
done for cholesterol ﬂip–ﬂop in a DPPC bilayer. In order to achieve this, we per-
formed two additional sets of umbrella sampling simulations for both POPC and
cholesterol ﬂip–ﬂop at temperatures of 295 K and 325 K. The entropic contribution
to the free energy proﬁle at 310 K was calculated through Eq. (5.20) with ΔT = 15
K, and the enthalpic contribution was then calculated through Eq. (5.17). The de-
composed proﬁles are shown in Figure 7.12.
The decomposition of free energy for cholesterol ﬂip–ﬂop shows a clear separa-
tion into enthalpic and entropic components for the whole duration of the translo-
cation process. The whole free energy proﬁle consists of a positive enthalpic compo-
nentΔH increasing ﬁrst to 50 kJ/mol and eventually to 120 kJ/mol upon entry into
the membrane interior, and decreasing back to zero when exiting to the other leaﬂet.
The entropic component −TΔS mirrors the behavior of the enthalpic component
remaining negative throughout the translocation process. A similar graph was ob-
tained in a previous study for cholesterol ﬂip–ﬂop in a protein-free DPPC system in
Ref. [105] and is another way of presenting why external energy needs to be given to
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Figure 7.12 The enthalpic (green) and entropic (blue) contributions to the free energy proﬁle of
rhodopsin-mediated lipid ﬂip–ﬂop at T = 310 K (black). The proﬁle for POPC (above) shows
the ﬂip–ﬂop process being a sum of alternating enthalpic and entropic contributions. The
translocation process for cholesterol (below) has a positive enthalpic contribution and a neg-
ative entropic contribution for the whole duration of the ﬂip–ﬂop.
a translocating cholesterol in the formof its internal energyΔU (enthalpy increases),
and why a lipid headgroup in the middle of a membrane will spontaneously exit into
one leaﬂet (entropy increases).
The decomposed proﬁle for POPC ﬂip–ﬂop consists of alternating enthalpic and
entropic contributions increasing up to 200 kJ/mol near the middle of the mem-
brane. It is difﬁcult to discern a single reason behind this behavior, but there are
many factors different between the translocation processes of both POPCand choles-
terol, which had a clear separation in these two contributions. Firstly, the transloca-
tion of POPC headgroup is accompanied by a number of water molecules whereas
no water was present during the ﬂip–ﬂop process of cholesterol (see Figure 7.8).
Therefore, the cholesterol headgroup has to dissociate from water (in addition to
the other polar headgroups) upon entry to the membrane interior, likely causing
the initial increase in the enthalpic contribution, only interacting with water upon
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entry into the other leaﬂet. For the POPC headgroup, no such dissociation is nec-
essary and it is entirely possible that the initial entry into the membrane interior is
entropy-driven requiring very little external energy due to the favorable hydrated
environment created by the high number of interactions between the water pore
and the protein. The free energy proﬁle only clearly seems to increase near the 1.2
nm distance from the bilayer centre when the enthalpic and entropic contributions
switch signs. It may be that the water pore that eventually follows the POPC head-
group dissociates with bulk water at this point causing the high enthalpic contribu-
tion. Secondly, the larger headgroup of POPC is more prone to interacting with its
surroundings through electrostatics when compared to cholesterol. The transmem-
brane helices II-IV of rhodopsin host a number of charged amino acids and formation
of new electrostatic interactions, along with breaking them, naturally has an effect
on the entropic and enthalpic contributions. Even though the electrostatic interac-
tions between POPC and rhodopsin were heavily quenched by the water pore, the
water pore itself may orient itself towards these charged amino acids.
All in all, the scramblase research presented in this article treads on previously
unexplored ground where the true mechanisms facilitating lipid ﬂip–ﬂop along a
protein surface are not known. Therefore, some of the results obtained here still
need more research including experimental collaboration in order to clarify the fun-
damental reasons for our observations. Multi-protein complexes or mutated amino
acids along the translocation path could give deeper insight on the translocation
mechanisms, but the computational costs often limit the research possibilities. For
now, our results seem to indicate that rhodopsin-mediated ﬂip–ﬂop is non lipid-
selective conﬁrming earlier ﬁndings of rhodopsin acting as a potential scramblase.
There seem to be multiple viable translocation paths, one of which is located on the
protein surface near transmembrane helices II-IV. The exact translocation mecha-
nisms are unknown, but they seem to involve a charge stabilized water pore on the
protein surface giving polar lipid headgroups easy access into the membrane interior,
and require no conformational changes in the protein.
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8 CONCLUSIONS
In this Thesis, we presented new research on two proteins with vital functions in cel-
lular life. Molecular dynamics simulations were shown to be a valuable companion
to more traditional wet lab studies, giving additional insight on the phenomena oc-
curring beyond visible range. Certain phenomena such as short-term ﬂuctuations of
theβ barrel of P2 or the translocation paths of ﬂip–ﬂopping lipids can be extremely
difﬁcult to observe in real time, but are made relatively simple through computa-
tional modeling. Through our simulations, we produced atom-scale understanding
on both the function of P2 and the scramblase properties of rhodopsin that can be
expanded upon in later research.
On P2 and myelin sheath
In Papers I-III, we studied the myelin protein P2, one of the major components of
peripheral myelin sheath. P2 is known to have a signiﬁcant role in holding two ap-
posing layers of myelin together along with its fatty acid binding properties. Past ex-
periments have found the protein to have increased activity when certain amino acid
residues aremutated, leading to changes in its lipid stacking abilities [11]. Mutated P2
has also been identiﬁed as a major contribuent in Charcot-Marie-Tooth disease, one
of the main demyelinating diseases of the peripheral myelin sheath [74, 76]. How-
ever, structural information on the increased activity, namely on the mechanisms of
the β-barrel opening has been lacking.
Our studies involved introducing a molecular dynamics approach on the prop-
erties of point mutated P2. To our knowledge, P2 had not been extensively studied
with MD before. Also, complementing our simulation studies with the experimen-
tal research led by the Kursula group produced wide insight on the properties of var-
ious P2 point mutants. As the focal point of all three publications was the activity
and function of the protein itself, the simulations were performed in a simple solvent
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box in the absence of a lipid bilayer. However, simulations investigating P2 binding
to a membrane with the lipid composition of a myelin bilayer, and its activity on
the membrane surface are work in progress and should be published shortly. As the
myelin sheath involves two lipid bilayers on both sides of the protein, molecular dy-
namics simulations on systems with two apposing bilayers could be performed to
investigate the membrane stacking capabilities of P2 and its point mutated variants.
Through our research we discovered a mechanism by which the P2 barrel struc-
ture is opened through unﬂapping of two adjacent β-strands. This mechanism has
long since been suggested [169], but has not been shown to occur before. The protein
opened widely enough to allow a small ligand, such as the palmitate chain embed-
ded in the crystal structure, or possibly a cholesterol molecule to ﬁt through to the
protein interior. Spontaneous escape of the bound ligand was not observed, and the
presence of a membrane (or two) might be necessary for it to occur. The opened
protein structures can be used later as starting points for a set of umbrella sampling
simulations measuring the free energy barrier of ligand escape. Again, differences
are likely to occur between the point mutated variants.
On rhodopsin and lipid ﬂip–ﬂop
Molecular dynamics simulations really excel in studies like the ones performed in
Paper IV. Flippases and scramblases have been studied for many decades now, but
the translocation mechanisms have remained elusive due to the fact that real-time
tracking of the movement of single lipids in a bilayer is not possible through a mi-
croscope. Experimental studies have veriﬁed a number of potential lipid translocat-
ing proteins by using labeled lipids in artiﬁcally created vesicles. By inserting these
marked lipids on only one leaﬂet of the bilayer, and observing their general progress
to the other side, it has been shown that certain transmembrane proteins – such as
opsins or β1AR – greatly increase the rate of lipid ﬂip–ﬂop [12, 174]. Recent im-
provements in the ﬁeld of protein crystallization have also made increasing numbers
of crystal structures of transmembrane proteins available, which naturally aids in
their research.
Another factor relating to the slow progress in the study of the translocation
mechanisms of potential scramblases are the computational resources required for
such simulations. For a model of a studied system to be accurate enough – that is, to
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represent real life as closely as possible – it must contain hundreds of lipids and be
solvated with tens of thousands of water molecules, all of which is computationally
extremely heavy to simulate at an atomistic detail. Coarse-grained models would
lower the computational cost by quite a bit, but the loss of atomistic detail such
as atom-atom interactions between lipid and protein can create signiﬁcant artifacts
in the simulation data. Still, lipid ﬂip–ﬂops in protein-free systems have been stud-
ied at great depth and have yielded accurate results even with coarse-grained models
[105, 175]. Only in the last decade have computational capacities available to re-
search groups increased and the computing algorithms evolved to such a level that
over microsecond simulations are feasible for larger systems. As a related subject,
the force ﬁelds used to describe molecular interactions have also evolved greatly, re-
sulting in more accurate representations of systems containing proteins and lipids.
Force ﬁeld development has also allowed these interactions to be calculated in a more
rapid fashion.
The aforementioned improvements in the ﬁeld have resulted in several success-
ful studies on the scrambling mechanisms of opsin and β2AR in the past few years.
Our studies, published in Paper IV, showed that the surface of rhodopsin provides
favorable conditions for non-selective lipid translocation across the membrane in-
terior, greatly increasing the rate of ﬂip–ﬂop. Similar results were also observed for
β2AR in our yet unpublished publication. Another simulation study byMorra et al.
explored a different translocation path for opsin, where the lipid headgroup translo-
cated between two transmembrane helices [50]. Their results, combined with ours,
conﬁrm that lipid translocation aided by opsins is not conﬁned to a single path – a
result that can possibly be generalized to other GPCRs as well.
As new crystal structures ofGPCRs are obtained in the future, similar simulation
studies can be performed on them in order to ﬁnd out whether the scramblase activ-
ities truly are universal properties of GPCRs. The simplicity of creating models for
molecular dynamics simulations when accurate structures for proteins are lipids are
available, combined with the atomistic accuracy of the results, make simulations a
highly desirable method for studying small-scale biological phenomena. Combined
with constant improvements in computational methods, the next decades are deﬁ-
nitely going to increase the viability and credibility of molecular simulation studies
in biological sciences.
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Abstract
Myelin protein P2 is a fatty acid-binding structural component of the myelin sheath in the pe-
ripheral nervous system, and its function is related to its membrane binding capacity. Here,
the link between P2 protein dynamics and structure and function was studied using elastic
incoherent neutron scattering (EINS). The P38Gmutation, at the hinge between the β barrel
and the α-helical lid, increased the lipid stacking capacity of human P2 in vitro, and the mu-
tated protein was also functional in cultured cells. The P38Gmutation did not change the
overall structure of the protein. For a deeper insight into P2 structure-function relationships,
information on protein dynamics in the 10 ps to 1 ns time scale was obtained using EINS.
Values of mean square displacements mainly from protein H atoms were extracted for wild-
type P2 and the P38Gmutant and compared. Our results show that at physiological temper-
atures, the P38G mutant is more dynamic than the wild-type P2 protein, especially on a
slow 1-ns time scale. Molecular dynamics simulations confirmed the enhanced dynamics of
the mutant variant, especially within the portal region in the presence of bound fatty acid.
The increased softness of the hinge mutant of human myelin P2 protein is likely related to
an enhanced flexibility of the portal region of this fatty acid-binding protein, as well as to its
interactions with the lipid bilayer surface requiring conformational adaptations.
Introduction
In the vertebrate central (CNS) and peripheral nervous systems (PNS), selected neuronal
axons are covered by a protecting layer of myelin. The myelin sheath is a unique multilayered
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membrane, wrapped around PNS axons by Schwann cells. Myelin in the CNS is made by oligo-
dendrocytes. Myelin enables the rapid saltatory conduction of nerve impulses along axons,
which can be up to a meter long in the PNS [1]. The myelin membrane contains 75–80% lipids
by dry weight, with a high, 30–40%, cholesterol content [2], and it is enriched in myelin-specif-
ic proteins that are expressed by myelinating cells [3,4]. The myelin proteome has been under
investigation for decades [5,6], but the structure and function of several myelin proteins are
still poorly understood [3].
Myelin protein P2 is one of the quantitatively major proteins of human peripheral nerve
myelin. P2 has been reported to comprise up to 15% of total myelin protein [7]; however, it is
only present in selected myelin sheaths [8,9]. The crystal structure of human P2 [10] has been
solved at atomic (0.93 Å) resolution: 10 antiparallel β strands form a barrel, which is covered
by a lid-like motif formed of two α helices (Fig 1) [11]. P2 belongs to the fatty acid binding
Fig 1. Crystal structure of human P2. (a) Superimposed structures of human wtP2 (cyan) and P2-P38G (green) before neutron scattering experiments and
wtP2 after the experiment (magenta). Pro38 is indicated with the red arrow. (b) The P38Gmutation site. Note how the main-chain hydrogen bonding (dashed
lines) remains conserved at the edge of the β sheet also in the mutant. (c) Locations of the residues with side-chain methyl groups in P2 are shown as sticks.
(d) A top view of the barrel-shaped P2 with bound fatty acid and stationary water molecules at cryo temperatures in the high-resolution crystal structure [11].
doi:10.1371/journal.pone.0128954.g001
Myelin Protein P2 Dynamics by Neutron Scattering
PLOS ONE | DOI:10.1371/journal.pone.0128954 June 11, 2015 2 / 20
City of Hamburg (http://www.hamburg.de/bwf/
forschungs-und-wissenschaftsstiftung-hamburg/)(all
to PK), as well as the Academy of Finland (Center of
Excellence programme) and the European Research
Council (Advanced Grant CROWDED-PRO-LIPIDS)
(both to IV). The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
protein (FABP) family; it has the ability to bind lipids and possibly plays a role in lipid trans-
port and homeostasis in myelin, as indicated by the phenotype of P2-deficient mice [9]. While
myelin appears normal in these animals, they have decreased nerve conduction velocity and an
altered myelin lipid composition during development [9]. The β barrel of P2 contains a large
(1000 Å3) ligand-binding pocket that is filled with a fatty acid and water molecules in the crys-
tal structure [10]. Among myelin lipids, one natural ligand for P2 could be cholesterol, which is
present in myelin at high concentrations and would fit into the cavity by size and by its electro-
static properties [10].
P2 binds phospholipids and stacks lipid bilayers together [11,12]. We previously reported
decreased overall proton dynamics in liposomes in solution at physiological temperatures
upon the addition of the P2 protein [13], as well as effects of bound P2 on multilayered lipid
membrane structure [14]. P2 has been suggested to stack membrane layers together by binding
to phospholipids through its positively charged surface residues, hydrophobic side chains from
the α-helical lid partially penetrating the membrane [10,11]. Despite detailed mapping of the
structural properties and physiological activity of the P2 protein, its role in healthy and dis-
eased myelin remains unclear.
An insight into molecular motions and flexibility is important for understanding structure-
function relationships in proteins [15,16]. Elastic incoherent neutron scattering (EINS) is a
powerful tool for investigating quantitative protein dynamics [17–20]. EINS allows inspection
of mean square displacements (MSD) of atoms as a function of external parameters, such as
temperature, revealing information about eventual transitions occurring in proteins and the
force constants required for protein motion activation. Using cold and thermal neutrons with
energy resolutions from 70 to 0.9 μeV, atomic fluctuations on the time scale from 10 ps to 1 ns
can be observed.
The effects of point mutations on protein dynamics have been studied using EINS before.
When a mutation led to a nonfunctional enzyme or partial unfolding of the protein, the flexi-
bility of the protein increased [21,22]. We previously reported an initial characterisation of the
properties of human peripheral myelin protein P2 by studying protein dynamics on a fast dy-
namics scale (10 ps) using EINS [23]. We used wild-type P2 protein (wtP2) and its proline-
38-to-glycine (P2-P38G) point mutant to investigate the dynamics of pure proteins as hydrated
powders. P2-P38G showed increasing dynamics compared to wtP2 above 220 K [23]. Pro38 is
a conserved residue located at a predicted hinge region, assumed to be involved in the opening
of the helical lid of P2 upon ligand binding and release [11].
The aim of the present work was to extend earlier investigations on human P2 dynamics
[23], expanding the time scale to 100 ps and 1 ns. We also carried out a thorough structural
and functional characterisation of the samples to link the observed differences in dynamics to
biomolecular function, and to confirm sample stability during the lengthy neutron scattering
experiments. The results indicate that using EINS, we can obtain functionally relevant informa-
tion on protein proton dynamics and the differences therein between the wild-type protein and
a functional mutant.
Materials and Methods
Protein purification and EINS sample preparation
Human myelin wtP2 and P2-P38G [24] were expressed recombinantly in E. coli Rosetta (DE3)
cells. The proteins were purified using Ni-ion affinity and size-exclusion chromatography, as
previously described [10,24].
To get rid of buffer and salt traces in the protein sample, the purified protein was dialyzed
three times against a large volume of H2O. The protein was then lyophilised to remove all the
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water and rehydrated with heavy water (D2O) to h = 0.28 g/g (where h is defined as gD2O/
gprotein) in a dessicator in a N2/D2O atmosphere. Due to the large excess of solvent deuterium
atoms and the long equilibration time, this procedure guaranteed that most of the exchange-
able hydrogen atoms in the protein sample were replaced by deuterium. The hydration level
was controlled by weighing the sample during the hydration process. To obtain comparable
wild-type and mutant protein samples, both samples were prepared in parallel.
Circular dichroism spectroscopy
Circular dichroism (CD) spectroscopy was used to study the folding and the secondary struc-
ture content of the sample proteins in solution. CD spectra were measured in H2O at 0.25 mg/
ml before and after the neutron scattering experiments using a Chirascan Plus spectropolari-
meter (Applied Photophysics, United Kingdom) and a 0.5-mm quartz cuvette. Melting curves
were measured from 293 to 363 K with a heating rate of 1 K/min at 0.25 mg/ml, in a buffer con-
taining 0.8 mMHEPES (pH 7.5), 6 mM NaCl, and 0.4% glycerol.
Protein crystallography
P2-P38G was crystallised by vapour diffusion at 277 K using a well solution containing 3.15 M
ammonium sulphate and 100 mM Tris (pH 8.5). X-ray diffraction data were collected at 100 K
on beamline X12 at the DORIS storage ring, EMBL-Hamburg/DESY. wtP2 that had been used
for neutron scattering experiments was resolubilised in protein buffer (0.8 mMHEPES (pH
7.5), 6 mM NaCl, 0.4% glycerol) and crystallised with vapour diffusion at 281 K, over a well so-
lution of 28% PEG6000 and 0.1 M sodium citrate (pH 5.5). The diffraction experiment was
done at 100 K on the I911-3 beamline, MAX-Lab (Lund, Sweden).
All data were processed with XDS [25], and the structures were solved with molecular re-
placement using wtP2 [10] as the search model. Refinement was carried out in phenix.refine
[26] and model building in coot [27]. Molprobity [28] was used for structure validation. The
structure factors and final refined coordinates were deposited at the Protein Data Bank with
entry codes 4D6A (wtP2 after neutron scattering experiments) and 4D6B (P2-P38G).
Molecular dynamics simulations
The crystal structures of wtP2 and P2-P38G were subjected to atomistic molecular dynamics
simulations, in order to pinpoint possible regions of differential dynamics linked to the muta-
tion. Simulations were carried out in the presence and absence of bound fatty acid, and hydro-
gen dynamics were specifically addressed in the analysis.
The protein and the palmitate group were modeled by the CHARMM36 force field [29].
The protein model including palmitate was obtained from the PDB entry 4BVM [11] and con-
verted to the CHARMM36 force field. The topology for wt-P2 was obtained directly from the
conversion. P2-P38G was constructed from the wild type topology by changing the amino acid
at the point of mutation. The three-point TIP3P model was used for water.
Four different protein systems were considered: wt-P2 and the P2-P38G, both with and
without palmitate inside the binding pocket. The proteins were added to a solvated simulation
box of approximately (8 x 8 x 8) nm3 with 16000 water molecules. Ten Cl- ions were included
to neutralise the total charge of the protein that had a palmitate in its pocket (in systems with-
out palmitate, the number of Cl- ions was 11 due to the charge of the palmitate).
The simulations were carried out under NpT conditions. Pressure coupling was done using
the isothermal Parrinello-Rahman barostat [30] at a reference pressure of 1 bar, with a cou-
pling time constant of 2.0 ps and isothermal compressibility of 4.5 x 10–5 bar-1. Temperature
coupling was done with the velocity-rescale method [31], with separate temperature coupling
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groups for the protein and the solvent. The reference temperatures were set as 300 K, with cou-
pling time constants of 2.0 ps. Periodic boundary conditions were used. All bonds were con-
strained with the LINCS algorithm. The cut-off radii for the neighbor list, the Lennard-Jones
interactions, and non-bonded interactions were set at 1.0 nm. For long-range electrostatics, we
used the Particle-Mesh Ewald (PME) method with cubic interpolation (PME order 4) and a
spacing of 0.16 nm for the Fourier grid.
The simulations were conducted using the GROMACS 4.6 simulation package [32]. The
time increment used in integrating the equations of motion was 2 fs. The systems were first en-
ergy-minimised with the steepest descent algorithm and then simulated for a total of 3 μs each.
The systems were allowed to equilibrate for 500 ns, and the remaining part of the trajectory—
over a period of 2.5 μs—was used for analysis. The coordinate files for the trajectory were saved
at a rate of (50 ps)-1, except in simulations used for the calculation of the MSD, see below.
For analysis of MSDs of the protein hydrogens, we used additional simulations, since the dy-
namics of hydrogen movement are very rapid. As a starting point, we used the full 3-μs trajec-
tories discussed above. After the 500-ns equilibration period, seven different starting structures
for each system were taken at 200-ns intervals, to obtain sufficient sampling over the whole
simulation period. Each starting structure was then simulated for 3 ns, while saving the system
coordinates every 2 fs to make sure that all the information of the rapid hydrogen movement
would be accounted for in the analysis of MSDs. The root-mean square (RMS) fluctuation was
calculated for each protein residue with the GROMACS tool g_rmsf.
MSDs of the protein hydrogen atoms were calculated to compare hydrogen mobility be-
tween the different systems. To this end, hydrogen mobility was explored for two different
groups separately: i) hydrogens in CH3-groups, and ii) hydrogens in CH2- and CH-groups. For
analysis (after the simulations had been completed), the protein was centered, and the rotation
and translation of the protein backbone were fitted to the center of the simulation box, thus
constraining protein movement during the analysis. The MSDs of the hydrogen atoms, com-
pared to the initial starting structures, were then calculated from each of the 3-ns simulations
with the GROMACS tool g_msd, using all the data in the trajectories. The final MSD curve for
each case was obtained by averaging over the seven separate curves. In the results, we show the
MSD behavior up to 1 ns, where the data are most accurate.
Functional assays
The lipid stacking properties of P2 were measured by following the turbidity resulting from
vesicle aggregation, essentially as described [11]. 0–10 μM P2 was mixed with 0.5 mMDMPC/
DMPG (1,2-dimyristoyl-sn-glycero-3-phosphocholine/1,2-dimyristoyl-sn-glycero-3-phospho-
glycerol) vesicles in 10 mMHEPES pH 7.4, 150 mMNaCl, and turbidity was measured at 600
nm using an Infinite M200 plate reader (Tecan, Switzerland).
In order to follow stacked membrane domain formation induced by P2 in living mammali-
an cells, a previously established method [11,33] was used. Briefly, wtP2 and P2-P38G were ex-
pressed in Ptk2 cells as fusions with green fluorescent protein and a transmembrane domain,
and the cellular membrane organisation was followed by fluorescence microscopy. The forma-
tion of brightly fluorescent membrane domains is an indication of membrane stacking in this
experimental system [33].
EINS data collection
To investigate protein dynamical properties, temperature-dependent EINS scans were per-
formed on the thermal and cold neutron high resolution backscattering spectrometers IN13
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and IN16, respectively, as well as on the time-focusing time-of-flight spectrometer IN6, all lo-
cated at the Institut Laue-Langevin (ILL), Grenoble, France.
With a nearly Q-independent energy resolution of δE = 8 μeV (full width at half maximum,
FWHM) and an accessible momentum transfer range of 0.2< Q< 4.9 Å–1, IN13 allows the in-
vestigation of molecular motions on a time scale up to 100 ps and with an amplitude from 1.3
Å to ~ 31 Å [34].
IN16 [35] is situated on a guide looking at one of the cold sources of the ILL. The Si(111) re-
flection of the monochromator is used to select a wavelength of λ = 6.27 Å from the incoming
neutrons. The instrumental setup results in a very narrow elastic energy resolution of 0.9 μeV
(FWHM), corresponding to a time window of1 ns and a momentum transfer range of
0.19< Q< 1.89 Å-1.
IN6 was used at an incident wavelength of λ = 5.1 Å, providing an energy resolution of
70 μeV (FWHM) and proton dynamics on the 10-ps time scale. The setting allows to access the
momentum transfer range 0.3< Q< 2 Å-1.
In all experiments, neutron scattering spectra were collected over a wide temperature range
(20–310 K), with heating rates properly chosen to optimise the signal-to-noise ratio: 0.6 K/min
from 20 K to 100 K, 0.4 K/min from 100 K to 220 K, and 0.15 K/min from 220 K to 310 K.
Data were then binned using 5-K steps. As the same samples were used for data collection at all
the instruments, the temperature scans were limited to 310 K to prevent the proteins from irre-
versible unfolding. To control sample integrity, protein structure was also analyzed after the
neutron scattering experiments (see above).
The program LAMP [36] was used for data correction. The elastic scattered intensities were
corrected for the empty cell contribution and normalised with respect to the lowest tempera-
ture scan (T = 20 K) to compensate for differences in detector efficiency and geometry. In
order to avoid corrections from multiple scattering events, cell thickness and geometry were
properly chosen to minimise neutron absorption by the sample. A typical transmission of
*95% was guaranteed using standard flat aluminium sample holders with a thickness of 0.4
mm. No Bragg peaks from ice were detected in any of the spectra, which excludes the presence
of free water in the samples.
EINS data analysis
Based on the atomic composition of P2, coherent scattering is estimated to correspond to less
than 8% of the total scattering. Thus, in the following, it will be neglected, and we will focus ex-
clusively on the behaviour of the incoherent scattering contribution.
The normalised incoherent elastic neutron scattering Sinc(Q,ω = 0) can be fitted using the
Gaussian approximation within the region of its validity [17]:
S ¼ I0e
hu2iQ2
6
 
; ð1Þ
where〈u2〉/6 is the normalised MSD, and〈u2〉 is deﬁned as
hu2i ¼ hu2r  u220Ki: ð2Þ
In protein samples, incoherent scattering is dominated by hydrogen atoms, because hydro-
gen comprises approximately 50% of all protein atoms and the incoherent scattering cross sec-
tion of hydrogen (80.27 barn) is significantly larger than that of other atoms in biological
macromolecules (nitrogen 0.5 barn, carbon and oxygen 0.001 barn) [37]. With a hydration of
h = 0.28 g/g, the scattering contribution arising from the solvent (D2O) is 1% of the total scat-
tering (deuterium: 2.05 barn), which can be neglected.
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Proteins are inhomogeneous macromolecules, each having a main chain of defined length
and a unique side chain sequence and composition. Thus, one possibility is to describe protein
dynamics using a bimodal distribution model [38,39]. In this model, hydrogen atoms are de-
scribed as two different populations of homogeneously fluctuating atoms: methyl group hydro-
gen atoms and all other (non-methyl) non-exchangeable hydrogen atoms. Both populations
can be described by a Gaussian function with a different width and the bimodal distribution of
hydrogen atomMSD by
f ðhu2iÞ ¼ a1dðhu2i  hu2i1Þ þ a2dðhu2i  hu2i2Þ; ð3Þ
where δ(x) is a delta function, a1 and a2 (with a2 = 1–a1) represent the population fractions
(temperature-independent), and〈u2〉1 and〈u
2〉2 are the average MSDs of the hydrogen
atoms in each fraction.
Using the Gaussian distribution function, the bimodal scattering function becomes
SðQ;o ¼ 0Þ ¼ I0 a1e
hu2i1Q2
6
 
þ a2e
hu2i2Q2
6
  
: ð4Þ
〈u2〉represents the full amplitude of atom dynamics in three dimensions, and atom displace-
ment from the mean position is given by〈u2〉/6.
On the other hand, at low temperatures, protein dynamics are harmonic and can be de-
scribed as a set of quantitated Einstein harmonic oscillators [40]:
hu2i=3 ¼ hhvi
2k
coth
hhui
2kBT
 1
 
; ð5Þ
where kB is the Bolzmann constant and h and〈v〉 are the average frequency and the average
force ﬁeld constant of the oscillators, respectively.
Results and Discussion
Effects of the P38Gmutation and neutron scattering experiments on
protein structure
In order to enable the linking of experimentally measured protein dynamics to biomolecular
structure and function, we carried out a characterisation of wtP2 and P2-P38G in vitro. These
experiments were also aimed at studying any possible changes in protein structure or stability
during and after the extensive neutron scattering experiments. Such a detailed sample charac-
terisation allows to conclude, whether differences between samples are caused by large-scale
structural re-arrangements, or if they can safely be assumed to result from real dynamical
properties.
The human myelin protein P2 has a structure typical for FABPs, where β strands form a
10-stranded barrel covered by an α-helical lid [10,11]. Proline 38 lies at a putative hinge be-
tween the barrel and the lid (Fig 1a), and the P38G mutation would intuitively be expected to
make the hinge more flexible, perhaps aiding lid opening motions or making the portal region
less stable [11]. The crystal structure of P2-P38G (Table 1) indicates that the overall structure
of P2 in the crystal state does not change due to the point mutation from an amino acid with
the most rigid (Pro) to the one with the most flexible (Gly) backbone. The fatty acid palmitate
is bound in the same mode in both forms of P2, and the flexible loops at both ends of the barrel
are also in similar conformations. The helical lid is also closed in the mutant protein in the
crystal state (Fig 1b).
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wtP2 and P2-P38G have indistinguishable folding in solution as well, as shown by CD spec-
troscopy (Fig 2a). The melting curves for both proteins have similar trends: complete unfolding
happens slowly between 310 and 350 K, the melting temperature being 331 K for wtP2 and 325
K for P2-P38G. This difference of 6 K in temperature stability is also likely to be reflected in the
respective dynamics of wtP2 and P2-P38G, indirectly suggesting a more dynamic nature for
the mutant protein.
To perform a neutron scattering experiment, the protein samples need to survive harsh con-
ditions that are far from a physiological environment: dialysis to pure water, lyophilisation, re-
hydration with D2O, time-consuming cycles of cooling and heating between 20 K and 310 K,
and long neutron beam exposures. Therefore, the P2 protein quality before and after the neu-
tron scattering experiment was analyzed. The P2 secondary structure content did not change,
as seen in CD spectra (Fig 2a). To further check for the integrity of the sample during the ex-
periments, wtP2 was resolubilised and crystallised after the neutron scattering experiments,
and its crystal structure was refined at high resolution. The structure is essentially identical to
that of fresh P2 (Fig 1a), proving that the P2 sample remains stable during the preparation of a
hydrated powder and the neutron scattering measurements.
Simulation of P2 dynamics
As the crystal structures of wild-type and mutant P2 were essentially identical, we looked for
differences in their dynamics with computer simulations. In addition to the expected increase
in dynamics at the site of the mutation, the entire portal region—which must open, when a
fatty acid enters—was expcted to be more flexible in the mutant. This concerns especially the
Table 1. Crystallographic data collection and refinement statistics.
Dataset wtP2 after EINS P2-P38G
Data collection
Beamline I911-3 (MAX-Lab) X12 (DESY)
Unit cell dimensions a = b = 57.7 Å, c = 100.7 Å a = b = 64.3 Å, c = 101.4 Å
Space group P41212 P41212
Resolution (Å)a 20–1.45 (1.49–1.45) 20–2.12 (2.17–2.12)
Rmerge (%) 4.9 (147.8) 5.1 (75.6)
<I/σI> 21.9 (1.3) 23.5 (1.7)
Completeness (%) 99.8 (99.9) 97.8 (84.9)
Redundancy 7.0 (6.5) 7.7 (4.2)
CC1/2 (%)
b 100 (40.4) 100 (70.8)
Reﬁnement
Rwork/Rfree (%) 14.7/18.4 21.9/27.3
RMSD
Bond lengths (Å) 0.009 0.004
Bond angles (°) 1.3 0.7
Molprobity score (percentile)c 1.04 (99th) 0.77 (100th)
Ramachandran most favoured (%)c 100 100
Ramachandran outliers (%)c 0 0
PDB code 4D6A 4D6B
a The numbers in parentheses refer to the highest-resolution shell.
b CC1/2 is deﬁned as the correlation coefﬁcient between two random half-datasets [41]
c Validation was carried out using Molprobity [28]
doi:10.1371/journal.pone.0128954.t001
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Fig 2. Folding and dynamics of P2. (a) CD spectra of wtP2 (red) and P2-P38G (blue) in solution. Solid lines
represent the samples before neutron scattering experiments and dashed lines the samples after these
experiments at 293 K. Dashed dotted lines are denatured samples at 363 K. The melting curves at 201
(dashed line) and 217 nm (solid line) as a function of temperature are shown in the inset. (b) Root-mean
square fluctuation (RMSF) per residue analyzed for all the four simulated systems from the final 2500 ns of
the simulation trajectory. Data for P2 without palmitate are shown in black (wild type) and red (P38Gmutant).
The results for P2 with palmitate are depicted in green (wild type) and blue (P38G). Large RMSF values
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second helix of the helical lid, which we predicted to unfold upon lipid membrane binding
[11]. Our earlier simulations, furthermore, suggested effects on the lid dynamics by the bound
fatty acid [11]. The effect of the fatty acid was confirmed by the 2.5-μs simulations here, as
wtP2 was clearly stabilised by the bound fatty acid. On the other hand, bound ligand appeared
to destabilise the portal region in the mutant protein.
The P2 protein is a β barrel with four loops at the top and at the bottom, and a lid consisting
of two short α helices connected by a loop. The palmitate ligand resides inside the barrel, with
its hydrophobic tail facing the lid. Pro38 lies in a short turn between the end of the second α
helix and the subsequent β strand.
P2 crystal structure consists of a total of 132 amino acids. The lid consists of two α helices
(16–23 and 27–36) and the loop between them. The loops on the lid side of the protein contain
residues 55–58, 74–78, 97–99, and 119–122. The loops at the bottom of the protein are formed
by residues 46–47, 65–68, 88–89, and 110–111. Apart from the N and C termini, the rest can
be considered to be a β sheet structure, which forms a barrel.
RMS fluctuations characterise the dynamics of the protein (Fig 2b and 2c). The most flexible
parts of P2 can be observed to reside on the side of the lid, i.e. within the portal region. The two
loops apposing the lid (residues 74–78 and 97–99) are the most mobile parts of the protein (Fig
2c). Surprisingly, the lid itself does not move as much, as one might expect.
Comparing the different systems to each other, there do not seem to be significant differ-
ences in the dynamics of the palmitate-free proteins, though wt-P2 seems to be slightly more
flexible than the P38G mutant. However, when palmitate is present, wt-P2 is considerably
more stable than either of the palmitate-free proteins. Conversely, P2-P38G with bound palmi-
tate is much more flexible, especially in the two loops apposing the lid. A point mutation at the
root of the lid, therefore, renders the lid much more apt to open. This conclusion is supported
by observations that the palmitate chain attempted multiple times to escape the barrel of the
P38G mutant during the simulation (data not shown).
Functional assays
P2 is likely to stabilise the myelin structure and stack membrane layers together in compacted
PNS myelin [43]. In vitro, membrane stacking and stabilisation by P2 have been observed earli-
er using different methods [11,13,43]. P2 was also shown to stack lipid bilayers in a vesicle ag-
gregation assay, the hydrophobic Leu residue at the tip of the α-helical lid of P2 being crucial
for membrane binding [11]. The latter experiment was also carried out for P2-P38G. The
P38G mutation in the hinge region actually enhances the lipid stacking property of P2, which
can be seen as increasing turbidity of a DMPC/DMPG vesicle solution at low P2 concentrations
(Fig 3a).
In cultured Ptk2 cells, the overexpression of wtP2 causes the formation of stacked mem-
brane domains, while the membrane binding-deficient mutant L27D failed to form such do-
mains [11]. P2-P38G induces the formation of similar membrane domains as wtP2, also
resulting in the extrusion of cell surface glycoproteins from the affected areas, proving the func-
tionality of this variant also in a cellular environment (Fig 3b). Taking all the structural and
functional characterisation together, P2-P38G is functional, and it is also stably folded in the
represent regions with high flexibility. The most flexible parts of the protein are found at the two loops
opposing the lid. (c) A visualisation in VMD [42] of the RMS fluctuations in the P38Gmutant with the palmitate
chain inside the binding pocket. The yellow color corresponds to the mutated amino acid Gly38. The most
flexible parts of the protein are pictured in bright magenta color. The colour bar at the bottom describes the
range of RMSF values (light blue for low, violet for high).
doi:10.1371/journal.pone.0128954.g002
Myelin Protein P2 Dynamics by Neutron Scattering
PLOS ONE | DOI:10.1371/journal.pone.0128954 June 11, 2015 10 / 20
crystal state and in solution, like the wild-type protein. Hence, any differences in mutant vs.
wild-type protein dynamics will not be caused by large conformational differences between the
samples or by misfolding of the mutant protein.
Elastic incoherent neutron scattering
Changes in P2 dynamics upon the introduction of the P38G point mutation were experimen-
tally monitored as a function of sample temperature using EINS. The analysis of IN6 data in
terms of a bimodal distribution was the subject of our earlier investigation, showing that the
data, unlike those from IN13 and IN16, were best fitted using the Gaussian approximation
[23]. The temperature dependence of the elastic scattering intensity, S(Q,ω = 0), of wtP2, nor-
malised to 20 K temperature data, is reported in Fig 4 with fitting using the bimodal distribu-
tion model (Eq 4) and the Gaussian model (Eq 1).
The observed protein dynamics depend on the distance and time scales explored. Indeed,
data at 200 K clearly show a deviation from a linear behaviour on IN16, which is less enhanced
on IN13 in the low-Q region, but more evident at the fully explored Q-interval (Fig 4). This ob-
servation is more pronounced at higher temperatures. The deviation is absent in IN6 data,
which is a sign of certain motions detectable in the 100 ps—1 ns time scale, indistinguishable
within the 10-ps time window of IN6. These motions are likely to be fast methyl group rota-
tions and slower amino acid side chain fluctuations [19,39].
A first insight into protein dynamics from EINS data was obtained from the sum of elastic
incoherent scattering intensities over a Q-range as a function of temperature from 20 K to 305
K. The normalised summed elastic scattering intensities of P2 samples from data acquired on
IN6, IN13, and IN16, grouped over the Q-range 0.2< Q< 2 Å-1, as well as IN13 data binned
over the whole accessible Q-range (0.2< Q< 4.9 Å-1), are shown Fig 5. IN13 data are binned
in 10-K steps to improve the statistics.
A deviation from a linear decrease of the summed elastic intensities vs T, i.e. a change in the
slope, is a clear sign of the activation of a motion falling within the time scale accessible through
Fig 3. Functional assays. (a) Overexpressed wtP2 (top) and P2-P38G (bottom) both form stacked membrane domains in cell culture. The scale bar is
10 μm. Cell surface glycoproteins (visualised by concanavalin A; red) are depleted from the stacked membrane domains containing fluorescent P2 (green).
(b) wtP2 (red) and P2-P38G (blue) both induce vesicle aggregation, which can be observed as increasing turbidity.
doi:10.1371/journal.pone.0128954.g003
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the energy resolution of the used instrument. For wtP2, in IN6 data, the first change in the
slope can be seen at 180 K, in IN13 data at 150 K, and in IN16 data at 130 K. A second, now in-
strument-independent, transition is seen at 240 K, above which the elastic signal is reduced for
P2-P38G compared to wtP2 on all three instruments. In IN16 data, P2-P38G has a very rapid
decrease in elastic signal at 240 K, but from 245 K on, the elastic signal continues with the same
slope as wtP2. The same step can be seen on IN13, when the elastic signal over the full Q-range
0< Q< 4.9 Å-1 is taken into account (Fig 5, right panel).
Gaussian approximation was used to estimate the total MSD of P2 samples on different
time scales. IN6 data were fitted over the full Q-range to Q2 = 4 Å-2 (Fig 4, right panel), IN13
data to Q2 = 3.5 Å-2 (Fig 4, middle panel, inset), and IN16 data to Q2 = 0.77 Å-2 (Fig 4, left
panel, inset) using Eq 1. The Q2 region for Gaussian validity is instrument-dependent, being
strictly linked to the MSD. Indeed, the Gaussian approximation is valid in the low-Q region,
where log(S(Q,ω = 0)) is linear as a function of Q2, and, generally, when Q2〈u2〉 2 [17].
However, it depends heavily on the geometry of the motion. In a protein, the dynamics of an
atom can be defined as localised motions within an ellipsoidal shape with axes 1:1:1.7 [44]. For
elliptically moving atoms in proteins, the Gaussian approximation is valid to
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Q2 u2h ip  3
[45]. The determined averaged MSDs are presented in Fig 6. The Gaussian approximation is
valid up to the highest measured temperatures (305 K) on IN6, IN13, and IN16, whereﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Q2 u2h ip of P2-P38G reaches the maximum values 1.6, 2.3, and 2.0, respectively.
At low temperatures, proteins vibrate locally, and their dynamics can be described using the
Einstein harmonic oscillator function [40]. The estimated MSDs of IN6 and IN13 data were
Fig 4. Temperature dependence of the normalised elastic scattering intensities. Data from wtP2 were acquired on IN16 (left), IN13 (middle), and IN6
(right). Data are shown for the temperatures 20, 100, 150, 200, 240, 260, 280, and 300 K (from top to bottom). Solid lines represent the best fitting to IN16 and
IN13 data using Eq 4 and to IN6 data using Eq 1. Insets: magnification of the fitting region using Eq 1.
doi:10.1371/journal.pone.0128954.g004
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fitted from 20 to 150 K, and the MSD of IN16 data to 130 K, using Eq 5 (Fig 6, Table 2). The av-
erage harmonic vibration for both wtP2 and P2-P38G varies within error bars, reaching
〈u2〉 = 0.05 Å2 at 300 K on all three instruments. The fitted average oscillation frequencies v
are around 2.5 ps-1 for IN6 and IN13 data, and approximately half of that for IN16 data. The
estimated average force field constants (k) are 3–4 N/m. While the values of both k and v are
comparable to those estimated for artificial membranes [40], no significant difference can be
observed between wtP2 and P2-P38G.
The first deviation of MSD from harmonic oscillation occurring at 120–180 K is thought to
be the hydration-independent thermal activation of methyl proton rotations [46,47]. The
methyl group activation (MGA) temperature has been shown to be instrument resolution-de-
pendent [39]. The frequency of methyl group rotation depends on the amino acid side chain
and its chemical environment [48] and increases as a function of temperature. Therefore,
methyl rotations become observable at lower temperatures on instruments with the narrowest
energy resolutions and longer time scales. In particular, the MGA temperatures of IN6, IN13,
and IN16 have been determined as 180 K, 150 K, and 110 K, respectively, for a hydrated alanine
polypeptide and albumin [39]. These temperatures are in good agreement with our P2 data,
where MSD values deviate from the purely harmonic behavior fit at the MGA temperatures
(Fig 6).
The transition at 240 K is generally called the protein dynamical transition (PDT). The ori-
gin of PDT has been under debate, but it is generally agreed that PDT is not dependent on in-
strument resolution but strongly depends on protein hydration [19,39,49]. In data from P2
samples, P2-P38G is systematically more dynamic than wtP2 above the PDT at all three mea-
sured energy resolutions (Fig 6). A steeper slope of MSD at high temperatures indicates in-
creasing protein flexibility and softening of the protein [20].
Within a protein, atom dynamics do not correspond to free diffusion, but instead, all the
atoms and their fluctuations are connected to their neighbouring atoms. The degree of freedom
Fig 5. Normalised sums of intensities. Left: Normalised sum over S(Q,ω = 0) at 0 <Q < 2 Å-1 on IN6 (triangles), IN13 (squares), and IN16 (circles). Right:
Sum over S(Q,ω = 0) at 0 <Q < 4.9 Å-1 on IN13. wtP2, red; P2-P38G, blue.
doi:10.1371/journal.pone.0128954.g005
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of hydrogen dynamics depends on the location of the hydrogen atom in the amino acid, such
that the outermost side-chain hydrogen atoms are in general more mobile. The side chain dy-
namics depend on the length and polarity of the amino acid residue, as well as on the chemical
environment of the side chain, which in turn is determined by the folding of the entire protein
chain. Accordingly, an unfolded polypeptide chain is more flexible than a tightly folded globu-
lar protein [50,51].
A model that could univocally describe protein dynamics does not exist. Several different
models have been introduced [39,52,53] to elucidate the main dynamical processes occurring in
Fig 6. Temperature dependence of the MSD. Data from wtP2 (red) and P2-P38G (blue) were evaluated
from the fit of data acquired on IN6 (top), IN13 (middle), and IN16 (bottom) using Eq 1. The low-temperature
fits using the Einstein harmonic oscillator function (Eq 5) are shown as solid (wtP2) and dashed lines
(P2-P38G).
doi:10.1371/journal.pone.0128954.g006
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a protein molecule. Here, in the bimodal model chosen by us, the hydrogen atoms of P2 were di-
vided into methyl and non-methyl hydrogens, with the population fractions a1 = 0.26 (methyl)
and a2 = 0.74 (non-methyl), corresponding to the calculated number of non-exchangeable hy-
drogen atoms in the P2 protein. It should be noted that these fractions are expected to be tem-
perature-independent. We also tested the fitting procedure allowing the population fractions to
vary (data not shown); a slight, negligible, effect on the observed methyl group fraction can be
seen with increasing temperature, and the fractions converge to a1 = 0.26 (wt-P2) and a1 = 0.32
(P2-P38G) at room temperature (293 K)—very close to the values calculated based on chemical
composition. In general, protein main-chain atoms are the most rigid, and the hydrogen atoms
of long amino acid side chains furthest away from the main chain have the largest degree of
freedom. Protein folding into secondary, tertiary, and quaternary structures, as well as protein
interactions with binding partners, prohibits side chain rotations, reducing the possible side
chain conformations [54,55]. Hydrogen atoms in methyl groups present an exception, as they
have a high degree of freedom of rotation. Hydrogen atoms in a methyl group are chemically
equivalent, and being uncharged, methyl groups do not form classical polar interactions [55].
Hence, methyl group dynamics are expected to provide the main contribution to global protein
hydrogen dynamics.
Using a bimodal model for EINS data analysis, a distinction has previously been made be-
tween hydrogen atoms on the protein surface and in the core [21]. Unlike other proteins stud-
ied earlier by incoherent neutron scattering, P2 is a hollow barrel with a large cavity inside.
Therefore, most of the side chains of P2 are in contact with solvent or the ligand inside the cav-
ity (Fig 1c). The water molecules surrounding the P2 protein and within its internal cavity at
cryo temperatures in the crystal state are shown in Fig 1d. According to protein dynamics sim-
ulations [56], the location of a residue—on the surface or in the core—has no remarkable effect
on residue rigidity. Therefore, the distinction of hydrogen atoms between core and surface
groups is not needed, and classification as methyl and non-methyl groups is justified in the
current analysis.
Molecular dynamics trajectories were further analysed to validate the experimental model
and data. MSDs were used to quantify the dynamics of the protein hydrogens separately for hy-
drogens in CH3-groups, and for hydrogens in CH2- and CH-groups. Fig 7a depicts that the
methyl hydrogens are much more mobile than other hydrogens both in terms of the distance
Table 2. EINS data fitting parameters.
Instrument Sample wtP2 P2-P38G
Gaussian approximation
IN6 k [N/m] 3.7±0.3 3.7±0.2
ν [ps-1] 2.5±0.4 2.5±0.3
IN13 k [N/m] 3.2±0.4 4.3±0.8
ν [ps-1] 2.5±0.4 2.7±0.6
IN16 k [N/m] 2.9±0.4 3.9±0.6
ν [ps-1] 1.5±0.4 1.3±0.4
Bimodal distribution model
Hmethyl Hnon-methyl Hmethyl Hnon-methyl
IN13 k [N/m] 2.0±0.5 5±1 2.1±0.8 6±2
ν [ps-1] 2±1 3±1 2±1 3±1
IN16 k [N/m] 0.6±0.1 20±2 0.6±0.1 25±4
ν [ps-1] 2.3±0.7 2.8±0.5 2.1±0.9 2.6±0.7
doi:10.1371/journal.pone.0128954.t002
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they travel (magnitude of MSD), and in their rate of diffusive motion (tangents of the MSD
curves). The hydrogens in the palmitated proteins are found to be more constrained than
in their palmitate-free counterparts. In palmitate-free proteins, the hydrogens in wt-P2 are
slightly more mobile than in P2-P38G. Conversely, in the proteins with bound palmitate, the
hydrogens of the P38G mutant are more mobile than in wt-P2. The results confirm earlier indi-
cations of effects of bound fatty acid on P2 dynamics [11], and they justify the division of P2
hydrogens into methyl and non-methyl groups for the analysis of EINS data.
Similarly to the MSD defined by Gaussian approximation on IN13 and IN16, there is no vis-
ible difference between wtP2 and P2-P38G dynamics below 220 K in non-methyl hydrogen
atoms, when the data are analyzed using the bimodal distribution model (Eq 4; Fig 7b, bottom).
As expected, no MGA can be seen for non-methyl hydrogen atoms, and MSD follows the fitted
harmonic oscillation contribution up to 200 K. The non-methyl hydrogen contribution seen
on IN13 is close to the total dynamics seen on IN6 (Fig 6), with similar fitting parameters for
low-temperature fluctuations (Table 2). On IN16, the non-methyl hydrogen contribution is
very small below 200 K, resulting in force constant k values higher than 10 N/m. The short and
fast fluctuations of non-methyl hydrogens occurring at low temperatures are probably out of
the instrument resolution window and thus cannot be detected on IN16. Overall, there is no
difference in the non-methyl hydrogen MSD values between wtP2 and P2-P38G samples
obtained on IN13 and IN16 below 240 K, above which P2-P38G is more dynamic and its
MSD higher.
The methyl proton contributions seen on IN13 and IN16 oscillate at low temperatures with
frequencies v of 2 ps-1 (Table 2), and estimated force constants k are 0.6 N/m for IN16 time
scale vibrations and approximately three times higher for the dynamics seen on IN13. The
MSD determined on IN13 faces MGA at 150 K, after which dynamics of the wild-type and mu-
tant protein increase similarly up to the 240 K PDT temperature (Fig 7, left, top). On IN16, the
MGA occurs at 130 K. Differently to IN13 data, at IN16 resolution, P2-P38G is more dynamic
than wtP2 already between the MGA and PDT. In IN13 and IN16 data, the MSD of methyl
Fig 7. Simulated and experimental hydrogen MSDs. (a) The averaged MSD of i) hydrogens in CH3-groups (top group of curves with higher MSD values)
and ii) hydrogens in CH2- and CH-groups (bottom group with lower MSD values) for all the four systems studied by MD simulations. Data for P2 without
palmitate are shown in black (wild type) and red (P38Gmutant). The results for P2 with palmitate are depicted in green (wild type) and blue (P38G). (b)
Experimentally determined MSD contributions frommethyl (upper panels) and non-methyl hydrogens (lower panels) for wtP2 (red) and P2-P38G (blue) using
the bimodal model. Left: IN13; right: IN16. Solid (wtP2) and dashed (P2-P38G) lines represent the low-temperature harmonic vibrational contributions.
doi:10.1371/journal.pone.0128954.g007
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hydrogens of P2-P38G increases more rapidly at PDT (240 K). This is in good agreement with
the clear change in the slope of the sum of elastic intensities (Fig 5) at 240 K.
The total MSD of P2 is dominated by dynamics of the methyl hydrogens (Fig 7). Methyl
groups are nonpolar moieties that are located outermost in amino acid residues, having less
neighbouring atoms and more space to rotate freely. In P2, methyl groups are scattered
throughout the protein (Fig 1c) and often have contact to the solvent.
The point mutation P38G in the hinge between the barrel and lid of P2 does not affect P2
folding (Fig 1a) or render it inactive (Fig 3a), but it increases the total flexibility of the protein
(Fig 6). The dynamics experimentally observed above the PDTmay be related to such function-
al dynamics of P2. Using EINS, only averaged total dynamics can be observed, and additional
experiments and molecular dynamics simulations will be needed for understanding the results.
Inside the P2 β barrel, there is a bound fatty acid from the bacterial expression host. While
P2, although being a folded protein, has no clearly defined hydrophobic core, the bound ligand
could provide such a core, possibly playing a role in P2 stability. Could the differences between
wild-type and mutated forms of P2 be partially related to the bound fatty acid? Firstly, the dy-
namics contributed by the fatty acid can be ignored from data analysis, because its hydrogens
correspond to only 3% of the protein hydrogen atoms; the scattering from the fatty acid would
be hidden by the much larger protein dynamics contribution. Secondly, an absence of bound
fatty acid could increase the amount of water inside the barrel, which in turn could change the
protein dynamics. In the crystal structures, though, the fatty acid is bound, and its interactions
with the protein are similar. Possible differences in fatty acid binding between the two samples
could lead to differential flexibility of the portal region. Thus, also in this situation, the ob-
served increased dynamics of P2-P38G would be explained with an increasing flexibility of the
hinge that allows the lid to move more freely in the mutant molecule. Intriguingly, our extend-
ed MD simulations revealed that while the wild-type protein was stabilised by bound fatty acid,
the mutant actually became more dynamic, especially within the portal region. The P2-P38G
simulation trajectory reveals that the tail of the fatty acid is extended throughout the portal re-
gion during the simulation, which would mimic eventual dissociation of the ligand; this is ex-
pected to happen, when P2 binds to a membrane surface [11]. The simulations, thus, both
confirmed the increased dynamics of P2-P38G and justified the use of the bimodal model in
EINS data analysis.
Conclusions
In order to fully understand structure-function relationships in proteins, an insight into pro-
tein dynamics is crucial. EINS allows the inspection of changes in total protein dynamics as a
function of an external parameter, such as temperature. We used neutron scattering and com-
plementary methods to study the link between P2 protein dynamics and its structure-function
relationships. P2 is a structural component of myelin, and its function is most likely related to
its membrane binding capacity. The P38G mutation increased the lipid membrane stacking ca-
pacity of P2 in vitro, and the mutated protein was also correctly folded and active in cells. How-
ever, neutron scattering indicated that the P38G mutant is more dynamic than the wild-type
protein, especially on a slow 1-ns time scale. The fact that the mutation causes significantly in-
creased dynamics of the portal area in P2 enabled us to use EINS in this study to experimentally
observe differential dynamics of a wild-type and a mutant protein. Earlier, we have shown that
binding to membranes induces changes in P2 structure, mainly partial unfolding of α-helices
of the lid [11]. The increased membrane binding activity of P2-P38G could be explained by in-
creasing protein flexibility and an enhanced ability to interact with lipids. While EINS allows
the inspection of the total dynamics, it is limited with respect to analysis of the origin and type
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of dynamics. Therefore, other methods, such as quasielastic neutron scattering and atomistic
simulations on membrane binding, can be used in the future to provide more detailed informa-
tion about functionally relevant protein dynamics in P2.
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Charcot-Marie-Tooth (CMT) disease is one of the most common inherited neuropathies. Recently, 
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A multilamellar membrane structure, myelin, enwraps selected axons in the nervous system, enabling the prompt 
transmission of nerve impulses along the axonal membrane. Myelin contains a compact lipid-rich compartment 
with a unique set of membrane-associated proteins, such as myelin protein zero (MPZ), peripheral myelin protein 
of 22 kDa (PMP22), myelin basic protein (MBP), and myelin protein P2, and more loosely packed regions that 
also encompass cytoplasm. Close interplay between myelin proteins is important for the formation of cytoplasmic 
channels within myelin1. In the peripheral nervous system (PNS), Schwann cells envelop axons and form insulat-
ing myelin sheaths. Defects in this fundamental structure result in chronic, severe neuropathological conditions, 
affecting nerve conduction velocity and neuron viability.
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited human neuropathies (prevalence 
of 1:2500), affecting both motor and sensory nerve conduction in the PNS2. Several types of CMT exist; the most 
common form, autosomal dominant CMT1, influences Schwann cells and myelin. In CMT1, motor and sensory 
nerve conduction velocities are remarkably reduced, leading to muscle weakness and atrophy in the feet and occa-
sionally also in upper limbs. Demyelination and onion bulb formation are present in most CMT1 patients. Most 
commonly, CMT1a is caused by a duplication of or a point mutation in the pmp22 gene, and 70–80% of all CMT1 
cases are associated with pmp22 mutations3. CMT1b results from mutations in the mpz gene and comprises 4% of 
all CMT1 cases. A number of other CMT1-associated genes have been described2. Recently, three point mutations 
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in the pmp2 gene, coding for the myelin P2 protein, were linked to autosomal dominant CMT1. The I43N muta-
tion was discovered in two families4,5 and T51P and I52T each in one family6. All patients with these mutations 
have reduced motor and sensory nerve conduction velocities, thinner myelin sheaths, and demyelinating axons 
with onion bulb formation. Symptoms also include progressive hand and foot muscle weakness and atrophy, as 
well as foot deformity and sensory loss in limbs4–6. Although the pathological features of different CMT1 types 
are comparable, the molecular pathomechanisms are different7.
P2 is mainly expressed by Schwann cells in the PNS8. It is located in compact myelin, stabilizing the multilay-
ered lipid membrane assembly. P2 is a small 15-kDa protein with a β barrel structure covered by an α-helical lid9,10. 
It belongs to the conserved family of fatty acid-binding proteins (FABPs) and can transfer fatty acids from and 
to lipid membranes using a collision transfer mechanism, indicating a functional role in the lipid homeostasis of 
myelin11. P2 may also bind cholesterol; a CRAC cholesterol binding motif is found at its C terminus9,12.
Here, we show that the crystal structures of CMT1-associated P2 mutant forms remain nearly unaltered, but 
the stability of the mutant proteins is remarkably reduced. Mutant proteins show decreased solubility, T51P trig-
gering the most significant effect. T51P has a reduced membrane stacking activity, while I43N and I52T maintain 
their ability to bind and stack lipid membranes. On the other hand, protein dynamics, as well as fatty acid and 
membrane binding kinetics, of all P2 mutants differ from those of wild-type P2 (P2wt). The mutations may cause 
defects in protein folding and the regulation of functional conformational changes, and they provide clues into 
ligand binding dynamics in the FABP family.
Results
In order to explore the functional and structural effects of CMT1-linked mutations in P2, we expressed and puri-
fied all three mutant proteins; I43N, T51P, and I52T. We used a range of experimental techniques together with 
atomistic simulations to study the effects of the mutations on P2 structure, function, and dynamics.
͸ơǤ In a prokaryotic 
expression system, all mutants showed a higher tendency to form insoluble aggregates than P2wt (Fig. 1A). Only 
~5% of T51P was soluble, despite optimised cell lysis conditions. Also both I43N and I52T showed reduced 
solubility compared to P2wt. However, soluble forms of all mutants could be purified and eluted as a single 
monomeric peak in size exclusion chromatography (SEC). We used dynamic light scattering (DLS) to further 
investigate the aggregation tendency of P2. P2wt, I43N, and I52T remained 100% monomeric for 24 h after SEC, 
while T51P was 98.3% monomeric, and high-molecular-weight forms were already present (Fig. 1B). The hydro-
dynamic radius (Rh) of monomeric T51P was also larger compared to the other variants (Table 1).
Small-angle X-ray scattering (SAXS) data were collected to monitor possible variation in the solution struc-
tures of the patient mutants (Fig. 1C). Scattering patterns of all mutants resemble those of P2wt. Nevertheless, 
the radius of gyration (Rg) and maximum dimension (Dmax) of I43N and T51P slightly deviate from P2wt, while 
I52T gave similar results (Table 1). The shape of the distance distribution function (Fig. 1D) differs between the 
variants, T51P and I52T being most divergent. This could be related to the position of the α-helical lid, the overall 
structure of the β barrel, and/or the level of saturation with fatty acid inside the barrel.
To address structural consequences of the mutations, we determined the respective crystal structures at high 
resolution (Table 2). All mutated residues are well defined in electron density. The mutations are located in the 
middle of the strands β2 and β3, in close proximity to the core of the β barrel (Fig. 1E,F). However, the overall 
fold of the structures is nearly identical to P2wt, with RMS deviations of 0.1–0.2 Å (Cα atoms). Considering the 
differences in solution conformations, this is a reflection of the selection of a single low-energy conformer into 
the crystal lattice, closely resembling the wild-type crystal structure. All structures present a gap in the β barrel 
between the strands β4 and β5, with no hydrogen bonds formed between the strands. This is a common feature 
of the FABP family13–17, and it is noteworthy that all the CMT1-linked P2 mutations lie close in space to this gap 
(Fig. 1E). The largest difference is triggered by the T51P mutation, which decreases the area of the β sheet β1–4 
(Fig. 1G). The mutation hinders the carbonyl group of Ile50 from forming a hydrogen bond with the amino 
group of Phe65 in the β4 strand; Pro51 also cannot form a hydrogen bond to Ser44 in the strand β2 (Fig. 1H). 
Two water molecules in close proximity to the residue 51 and the β2 and β3 strands are not found in the crystal 
structure of T51P, but they exist in all other structures. I43N and I52T do not alter the main chain conformation, 
and neither side chain generates steric clashes. These changes from a non-polar to a polar residue do not induce 
large structural changes in the crystal structure. However, the amino group of the Asn43 side chain of I43N forms 
an extra hydrogen bond to the main chain carbonyl group of Phe5, located at the end of the short α helix at the 
N terminus of P2.
͸Ǥ Due to increased aggregation tendency, the folding of the 
P2 variants was examined using synchrotron radiation circular dichroism spectroscopy (SRCD). Spectra were 
recorded in water and in phosphate buffer (Fig. 2A). The intensity of both the positive (at 198 nm) and negative 
(at 218 nm) peaks varied, P2wt giving the highest and T51P the lowest signal, suggesting formation of soluble 
aggregates of the mutant proteins. Minor variations were also observed in the shape and x axis intersections of the 
spectra, mainly for T51P, indicative of lower secondary structure content or altered conformation.
In the presence of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC): 1,2-dimyristoyl-sn-glycero-
3-(phospho-rac-(1-glycerol)) (DMPG) or 1,2-dioleyl-sn-glycero-3-phosphocholine (DOPC): 1,2-dioleyl- 
sn-glycero-3-phosphatidyl-rac-glycerol (DOPG) vesicles, the spectra of P2 clearly changed (Fig. 2A). This phe-
nomenon is more pronounced in water (Fig. 2A, right), where competition between lipid head groups and phos-
phate does not exist. In phosphate buffer (Fig. 2A, left), the positive peak at 198 nm decreased with P2wt and I52T, 
while I43N and T51P show opposite behavior. In water, the shape of the P2wt, I43N, and I52T spectra change 
considerably upon adding lipid vesicles, especially when DOPC:DOPG vesicles are introduced.
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Figure 1. Structure and stability of P2. (A) Solubility analysis. (B) Dynamic light scattering indicates 
aggregation of T51P. Note that the curves for P2wt and I43N nearly overlap in panels B and D. (C) The SAXS 
scattering curve. (D) Distance distribution functions. (E) Crystal structure of P2 with the mutant positions 
labelled. The bound fatty acid is shown in orange and the anion binding site with a chloride ion (green). (F) The 
mutation hot spot viewed from the bottom. (G) The crystal structure of T51P. Note the decreased area of the 
β sheet close to the mutation; compare the circled area with the corresponding area in panel E. (H) Hydrogen 
bonds near residue 51 in wild-type (green) and T51P (pink); the shown region corresponds to the circled area 
in panel G. Three hydrogen bonds are labeled: 1) main-chain H bond that is lost in the mutant protein, 2) side-
chain hydrogen bond lost in the mutant protein, 3) main-chain H bond that is in an unfavorable conformation 
in the mutant protein (orange).
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We further studied the thermal stability of P2 mutants using conventional CD spectroscopy (Fig. 2B). Tm 
analysis and CD spectra illustrate a drastic reduction of the stability of all patient mutants compared to P2wt 
(Tm = +65 °C); T51P has the lowest Tm, +41 °C, and already at +38 °C, the conformation of T51P changed 
and unfolding started. I43N has a Tm at +48 °C and I52T at +52 °C. Therefore, both of these mutants also have 
decreased thermal stability compared to P2wt.
͸Ǥ Root mean square fluctuation (RMSF) 
analysis from atomistic molecular dynamics (MD) simulations was used to examine P2 dynamics with and with-
out bound palmitate inside the β barrel. Palmitate-bound P2wt is generally more dynamic than its empty counter-
part. The most mobile parts of P2wt are located in the loops and, to some extent, in the helical lid (Fig. 3A); these 
segments correspond to the portal region of FABPs. Similar behaviour was seen with palmitate-bound I43N. In 
MD simulations, palmitate-bound T51P is overall much more dynamic than the other P2 variants and shows 
strong fluctuations in the lid region as well as in the β sheets β2-5 and the loops connecting them. The lid region 
and the β3-β4 loop of I52T also fluctuate more heavily than those of P2wt. However, when the fluctuations of 
ligand-free P2 are compared, P2wt seems to be the least dynamic variant. I52T shows some fluctuations at certain 
parts, while I43N and T51P are rather rigid. Surprisingly, T51P is the least dynamic of the apo forms (Fig. 3A). 
The apo form of T51P is overall less dynamic than palmitate-bound T51P. The lid region of I52T and the β5-β6 
loop of I43N are also destabilised by palmitate, while other parts of the mutants show reduced fluctuation upon 
palmitate binding.
In simulations of P2, especially in the case of apo T51P, opening of the β barrel at the gap is observed (Fig. 3B). 
The hinge for this movement lies at Gly68 in the β4-β5 loop, which is one of the two absolutely conserved Gly 
residues across all human FABPs10. At the hinge also lies a buried water molecule, which is conserved in FABPs 
and was suggested to be relevant for correct folding18. It is possible that the conserved Gly residues and the water 
molecule also play roles in functional conformational changes in FABPs, including P2. Rg for all eight systems 
(four P2 forms, +/−palmitate) was estimated based on the MD simulations. The obtained values (Table 1) are 
in good agreement with those derived from SAXS. Ab initio modeling of T51P based on the SAXS data provides 
Protein
DLS SAXS MD simulations
Rh (nm) Monomeric (%) Rg (nm)
Dmax 
(nm)
Vporod 
(nm3)
Rg apo 
(nm)
Rg holo 
(nm)
wt 2.11 100 1.45 3.9 14 1.45 1.44
I43N 2.18 100 1.55 4.0 18 1.43 1.44
T51P 2.40 98.3 1.56 4.2 13 1.50 1.45
I52T 2.22 100 1.45 3.9 12 1.43 1.45
Table 1. DLS, SAXS, and MD simulation parameters.
Mutant I43N T51P I52T
Data collection
Beamline I04/Diamond I03/Diamond I04/Diamond
X-ray wavelength (Å) 0.9795 0.9762 0.9795
Space group P41212 P41212 P41212
Unit cell dimensions a, b, c (Å) 65.0,65.0,101.1 66.0,66.0,100.9 64.8,64.8,101.1
α, β, γ (°) 90,90,90 90,90,90 90,90,90
Resolution range (Å) 46–1.59 (1.69–1.59) 46–1.72 (1.87–1.72) 46–1.53 (1.63–1.53)
No. unique reflections 29518 (2710) 44944 (7154) 33053 (3233)
Completeness (%) 98.7 (89.2) 99.6 (97.5) 99.6 (99.6)
Redundancy 6.6 (6.4) 6.1 (6.1) 6.0 (5.9)
Rsym (%) 6.7 (300) 7.4 (267) 5.1 (265)
Rmeas (%) 7.0 (327) 8.1 (292) 5.3 (257)
<I/σI> 18.4 (0.7) 12.8 (0.8) 22.0 (0.7)
CC1/2 (%) 100 (73.4) 99.9 (67.8) 100 (72.8)
Wilson B (Å2) 29.3 31.2 29.2
Structure refinement
Rcryst/Rfree (%) 18.4/21.4 16.9/19.1 17.0/20.1
RMSD bond lengths (Å) 0.007 0.006 0.007
RMSD bond angles (°) 1.0 1.0 1.1
Molprobity score 1.24 1.57 1.97
Ramachandran favoured/ 
outliers (%) 100/0 98.7/0 100/0
Table 2. Crystallographic data collection and structure refinement.
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a shape very similar to that observed in the MD simulation (Fig. 3C), confirming the presence of an open, more 
extended conformation, of P2 in solution. In addition, multicomponent analysis of the SAXS data indicates a 7% 
fraction of open conformation of T51P in solution, while the other P2 forms exist in the closed conformation.
We also calculated the number of water molecules inside the P2 barrel during each simulation. The average 
number of water molecules inside unliganded P2 was 27.7, 30.5, 23.7, and 30.4 (for P2wt, I43N, T51P and I52T, 
respectively). For palmitate-bound P2 forms, the respective numbers of water molecules were 21.0, 22.1, 29.1, 
and 22.0. In both cases, T51P differs from the other variants, interestingly having less water molecules within 
the β barrel without than with palmitate inside. Here, the behaviour of the Ile mutants resemble each other but 
slightly differ from P2wt. These values are in accordance with studies on FABP, whereby faster exchange of water 
was observed for liganded FABP than for apo-FABP19 - a major route for water flow between bulk solvent and the 
internal cavity was suggested to be the gap between the strands β4 and β5. Both the apparent lower water content 
of apo T51P as well as its low RMSF during the MD simulation can be explained by the observation that the unli-
ganded T51P structure opens up early in the simulation and remains in the open conformation.
	͸Ǥ P2 belongs to the family of FABPs, and in all crystal structures 
of human P2, there is a fatty acid inside the β barrel9,10,20,21. Also in the crystal structures of all mutant proteins 
studied here, a fatty acid, modelled as palmitate, is visible inside the β barrel. P2 captures abundant fatty acids 
during expression in E. coli9,10. With our earlier atomic-resolution crystallographic data, we modelled the fatty 
acid component as a mixture of palmitate and cis-vaccenate10.
Figure 2. SRCD analysis of P2 folding and membrane interactions. (A) Left: SRCD in phosphate buffer 
with and without DMPC:DMPG vesicles. Right: SRCD in H2O and with DMPC:DMPG (dashed lines) and 
DOPC:DOPG (dotted lines) vesicles. (B) Temperature scans of all variants. Temperatures between +40–50 °C 
are shown in red for clarity.
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To study fatty acid binding, we performed end-point binding assays with a fluorescent fatty acid derivative 
probe, 11-dansylaminoundecanoid acid (DAUDA)22. The peak maxima clearly increase and shift in the pres-
ence of P2, indicating an interaction involving a non-polar environment between DAUDA and all P2 variants 
(Fig. 3D). This phenomenon is most pronounced with T51P, but also I43N and I52T show higher fluorescence 
than P2wt. In this experimental setup, T51P seems to bind to DAUDA more effectively than the other mutants or 
P2wt, which might be related to its higher tendency to open.
Since the structure and dimensions of DAUDA diverge from natural fatty acids, we used liquid 
chromatography-mass spectrometry (LC-MS) to investigate the fatty acids bound to P2. Fatty acids with 16–20 
carbons without or with a double bond were monitored. The total amount of bound fatty acids was similar 
between all the P2 variants, and C16 and C18 fatty acids together comprise nearly 100% of the total fatty acid con-
tent. We compared the amount of saturated and non-saturated C16 and C18 fatty acids, and noted the fatty acid 
content of all variants was nearly identical (Fig. 3E). P2 contains more C18 (60–70%) than C16 fatty acids (30–
40%). Palmitate is the preferred C16 ligand, while for C18, nearly equal amounts of saturated and non-saturated 
fatty acid are observed. The result validates our high-resolution model10, in which we earlier built in palmitate 
(C16:0) and cis-vaccenate (C18:1) with partial occupancies.
͸Ǥ The binding of P2 onto lipid membrane surfaces was studied 
using surface plasmon resonance (SPR) with two different lipid compositions, differing only in the identity of 
the hydrocarbon chains of the lipids (Fig. 4). SPR was not carried out with the T51P mutant due to its tendency 
Figure 3. Dynamics, open conformation, and fatty acid binding. (A) RMS fluctuation of apo (top) and liganded 
(bottom) forms. Above the graphs, the secondary structure elements of P2 are shown (black, strand; orange, 
helix). (B) Structure of P2wt (light brown) superimposed on the open conformation of T51P seen in simulations 
(blue). The two conserved FABP Gly residues in the β2-β3 and β4-β5 loops are shown in magenta, the positions 
of the mutations in green, and the “structural” water molecule bound inside the β4-β5 loop in FABPs in red. 
(C) Comparison of the open conformation (cartoon) and the SAXS envelope from T51P data (blue transparent 
surface) from two orientations. (D) Fluorescence spectra of DAUDA with 10 μM proteins. (E) LC-MS fatty acid 
analysis. All P2 variants prefer either palmitate (C16:0) or 18-carbon fatty acids (C18:0 and C18:1) Recombinant 
P2 carries more C18 than C16 fatty acids.
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to aggregate. P2wt and the I43N and I52T mutants all bound to membranes with affinities in the 2–6 μM range, 
irrespective of the lipid composition (Table 3). Despite similar apparent affinity, the kinetics of the wild-type 
and mutant proteins were different, and in fact, more of the mutant proteins eventually bound to the membrane, 
giving a continuous increase in response during the injection (Fig. 4A). This could be a sign of aggregation of 
the mutants onto the lipid bilayer after initial binding. P2wt, on the other hand, bound rapidly to the membrane, 
reaching a plateau by the end of the injection, and dissociated fast. All these features were similar between mem-
branes made of DMPC:DMPG and DOPC:DOPG. The result is an indication of possible membrane-induced 
aggregation of mutant P2 forms. The behaviour of the P2 mutants resembles somewhat the kinetics shown by 
another major myelin protein, MBP, which folds onto the membrane surface, forming an amorphous phase of 
protein, and dissociates very slowly23,24.
ǡͻͷǤ In compact myelin, P2 is located in 
the cytoplasmic leaflet, interacting with two apposing membranes. An important feature of P2 is to bind lipid 
membranes and to stack them into multilayered systems. To test whether the mutant variants are able to attach 
lipid membranes together, we used a lipid vesicle aggregation assay and measured the increase in the turbidity of 
a lipid vesicle solution caused by P2. The results demonstrate that both Ile mutants can bind and stack lipid mem-
branes as efficiently as P2wt (Fig. 5A). However, T51P showed a reduced capability to stack lipid membranes; 
the turbidity of the vesicle-T51P mixture was approximately half of that of the other samples (Fig. 5A). With 
Figure 4. Membrane surface binding. (A) DMPC:DMPG (top) and DOPC:DOPG (bottom) sensorgrams with 
injection of 4 μM protein. (B) DMPC:DMPG (top) and DOPC:DOPG (bottom) fits for a protein titration.
P2 variant P2wt I43N I52T
Lipid DMPC:DMPG DOPC:DOPG DMPC:DMPG DOPC:DOPG DMPC:DMPG DOPC:DOPG
Two-state reaction 6.03 ± 1.05 2.44 ± 0.54 3.77 ± 0.11 3.48 ± 2.64 6.37 ± 1.01 2.53 ± 1.28
Sigmoidal model 4.78 ± 0.45 2.59 ± 0.62 3.25 ± 2.69 5.24 ± 1.22 0.95 ± 0.06 3.12 ± 0.65
Table 3. Membrane surface affinity of P2 deduced from SPR data. The values are apparent Kd in μM, based on 
two separate experiments.
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extended incubation, the Ile mutants slowly lost the turbidity, as opposed to P2wt, hinting at different stability 
of the proteolipid complex (Fig. 5B). We also visualised membrane stacks induced by P2 using transmission 
electron microscopy (TEM) and negative staining. In contrast to a control sample with only single unilamellar 
DMPC:DMPG vesicles (Fig. 5B), all P2 variants induced the formation of large clusters of multilamellar mem-
brane stacks (Fig. 5C–F).
Discussion
Recently, three P2 point mutations were shown to result in the most common heritable human peripheral neu-
ropathy, CMT. All P2 patient mutations trigger an autosomal dominant form of demyelinating CMT14–6. P2 
mutations are located near each other in the structure, in close proximity to the fatty acid binding pocket and 
the gap between the strands β4 and β5. Comparing the sequences of all 12 human FABPs, it can be seen that the 
mutated residues are conserved in most human FABPs, especially those with a collision-type ligand transfer 
mechanism10. Based on our work, all CMT1-associated P2 mutant forms maintain their overall fold in the crystal 
state, but their stability is significantly reduced, and fatty acid and lipid membrane binding altered, compared to 
P2wt.
Most forms of CMT1 are caused by duplication or mutation of the pmp22 gene, thought to lead to misfolding 
and aggregation of PMP22 in the ER of myelinating Schwann cells25. The three P2 mutations (I43N, T51P, and 
I52T) studied here increase the tendency of P2 to form insoluble aggregates, when expressed in E. coli. Even 
though the prokaryotic expression system differs from the natural environment inside human Schwann cells, it 
can provide relevant information when comparing disease-associated forms of human proteins.
The secondary structure content of T51P in solution was lower than for the other variants. All forms of P2 
showed conformational changes upon lipid vesicle binding. These changes, also seen before with P2wt10, may 
originate from the α-helical lid, which interacts with the head groups of lipids and may be partially buried inside 
the lipid membrane. The changes could also result from a membrane-induced opening of the β barrel, leading to 
possible ligand exchange with the membrane. The results indicate that all P2 variants interact with lipid mem-
branes, but as seen with SPR, the mutants are different in their respective lipid binding dynamics.
Figure 5. Membrane stacking by P2. (A) Top: end-point turbidity assay with all P2 variants. Bottom: time 
dependence of turbidity for P2wt and the Ile mutants. (B–F) Negatively stained TEM images of DMPC:DMPG 
vesicles (B) with P2wt (C) and mutants (D-I43N, E-T51P, F-I52T). Scale bar: 100 nm.
www.nature.com/scientificreports/
9SCIENTIFIC REPORTSȁͽǣ6510ȁǣͷͶǤͷͶ͹;ȀͺͷͻͿ;ǦͶͷͽǦͶͼͽ;ͷǦͶ
Importantly, the thermal stability of all three CMT-linked P2 variants is dramatically reduced compared to 
P2wt. This finding supports the results from the solubility studies; reduced protein stability leads to partial or 
complete unfolding and the formation of protein aggregates. Overall, the T51P mutation has the most striking 
effect on the biophysical properties of P2. These results raise a question whether these mutants are able to fold 
properly in Schwann cells, or if the mutations lead to misfolding and protein accumulation.
The crystal structures of the disease-associated mutants are highly similar to P2wt, also regarding the fatty acid 
binding pocket9,10, and differences are limited to 1–2 hydrogen bonds near the mutation site. Nevertheless, the 
fatty acid binding properties of all mutants differ from those of P2wt. Based on fluorescent probe assays, all three 
mutants bind fatty acids more effectively than P2wt, and T51P causes the highest change in DAUDA fluorescence. 
As DAUDA has a fairly large and rigid dansyl group at one end of the molecule, these results may suggest that 
T51P favours larger ligands than P2wt; the result can also reflect the increased open/close dynamics of the T51P 
variant. Different kinds of kinetics may come to play when the fatty acid ligand is replaced in this experiment, 
including affinities towards various ligands and different conformational dynamics.
RMSF analysis of MD simulations demonstrates altered dynamic properties for all disease mutants. Fatty 
acid-bound T51P is clearly more dynamic than P2wt and the other two mutants, and liganded T51P has more 
water molecules inside the β barrel than other palmitate-bound P2 variants. This is presumably the consequence 
of an increased flexibility of the α-helical lid and the β barrel structure of T51P, which at least to some extent 
arises from the lack of proper hydrogen bonds in the β sheet β1-4 (Fig. 1). The opening of the β barrel observed 
in the MD simulations and in solution SAXS is expected to be thermodynamically realistic, since no main-chain 
hydrogen bonds of the barrel need to be broken for the opening to occur. It is likely that we are, indeed, observ-
ing a functional mechanism for FABP opening, in a process that is complementary with ligand exchange. Such 
a mechanism was suggested earlier26, but to our knowledge, it has not been observed for FABPs. It is obvious 
that several factors may affect such conformational changes, including the bound ligand, contact to a membrane 
surface, and the presence of mutations. The opening of the β barrel could also be linked to misfolding and/or 
increased β aggregation, as observed for the T51P mutant.
A similar functional opening of a β barrel on the side has been observed for the bacterial outer membrane 
integral membrane protein BamA27,28. The barrel opens into the membrane, and the opening is believed to facil-
itate ligand exchange, similarly to the mechanism proposed here for myelin P2 and the FABP family. In the case 
of BamA, hydrogen bonds exist between the β strands in the closed state28, while in P2, no direct main-chain 
hydrogen bonds are observed even when the gap is closed. Lateral opening of the structure could present a gen-
eral means of ligand exchange in β-barrel proteins.
The altered biochemical and dynamic properties of the α-helical lid, the β barrel, and the internal binding 
pocket of the P2 mutants may also affect the binding of other possible ligands, including cholesterol, which is 
bulkier than fatty acids. Cholesterol is highly abundant in myelin, and it has a rate-limiting role in myelin com-
paction and protein trafficking in Schwann cells29. Schwann cells are sensitive towards changes in the stoichi-
ometry of their membrane components; for proper myelin assembly and especially myelin maintenance, precise 
amounts of different lipids are required30. Thus, altered fatty acid binding profiles and kinetics of membrane 
binding by the P2 mutants may lead to critical defects in Schwann cells and myelin stability.
P2 is localised in compact myelin, and it spontaneously stacks lipid membranes31. SPR showed that the mutant 
proteins bound to membrane surfaces, but had kinetics distinct from the wild-type protein, possibly indicating 
membrane-induced aggregation. Also all disease-associated forms of P2 induce the stacking of lipid membranes, 
as seen using TEM. A lower efficiency of the mutants to induce stable lipid membrane stacking could have severe 
effects on myelin compaction and stability.
Genetic knockout studies revealed changes in the lipid profile of PNS myelin in P2-deficient mice11, which 
emphasises the contribution and importance of P2 to lipid homeostasis of PNS myelin. In addition, all three 
CMT1-linked patient mutations disrupt the multilayered structure of myelin4–6. The altered stability, dynamics, 
and fatty acid/lipid membrane binding of the disease-associated P2 protein variants may be involved in CMT1 
etiology and give rise to myelin defects, including abnormal myelin compaction and irregular myelin sheaths, in 
P2-linked CMT1 patients.
To conclude, we have carried out a detailed characterisation of CMT1-linked P2 mutant proteins and observed 
differences in their respective structures, functional properties, and dynamics. While the crystal structures of all 
variants are very similar, the mutant variants show clear structural changes in solution and simulations, as well as 
functional and stability deficits. The pathogenic point mutations drastically lower the stability of the mutant pro-
tein variants, which also have altered ligand- and membrane-binding properties. The mutations may also affect 
the functional dynamics of the FABP β barrel, whereby the observed opening of the gap between strands β4 and 
β5 may represent a general ligand entry mechanism in the protein family.
Methods
ǡǡƤǤ Human P2 with an N-terminal His6 tag followed 
by a Tobacco Etch virus (TEV) protease cleavage site in the pTH27 vector9 was used as a template in mutagenesis 
to produce expression constructs with the c.T128A (p.I43N), c.C151A (p.T51P), and c.T155C (p.I52T) muta-
tions. Mutagenesis was carried out using the QuikChange Site-Directed Mutagenesis protocol, and all mutations 
were confirmed by DNA sequencing. Proteins were expressed in E. coli BL21 RIPL (DE3) cells in ZYM-5052 
autoinduction medium32 with 100 μg/ml carbenicillin and 34 μg/ml chloramphenicol at +18 °C for 66 h. Cells 
were harvested and suspended in lysis buffer (0.3 M NaCl, 10 mM imidazole, 50 mM HEPES pH 7.5). Cells were 
lysed by sonication, and insoluble material was pelleted by centrifugation (30000 g, 40 min, at +4 °C). The soluble 
fraction was then mixed with the HisPur Ni-NTA Resin (Thermo Fisher Scientific) at +4 °C for 1 h. The resin was 
washed twice with washing buffer (0.3 M NaCl, 40 mM imidazole, 50 mM HEPES pH 7.5) using centrifugation 
(500 g, 5 min, at +4 °C) and then transferred into a gravity-flow column and further washed with 50 ml of washing 
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buffer. P2 was eluted with elution buffer (500 mM imidazole, 0.3 M NaCl, 50 mM HEPES pH 7.5). To cleave 
the His6 tag, 33 nmol of recombinant TEV protease33 were added. Imidazole was removed by dialysis through 
6000–8000 MWCO dialysis tubing (SpectraPor) against 0.3 M NaCl, 1 mM DTT, 20 mM HEPES pH 7.5 at +4 °C 
for 16 h. Both TEV and the cleaved His6 tag were removed with reverse chromatography using HisPur Ni-NTA. 
Finally, P2 was purified with SEC using the dialysis buffer and a Superdex 75 pg 16/600 column (GE Healthcare) 
and concentrated with an Amicon Ultra 15, MWCO 10 kDa concentrator (Millipore). In T51P purification, all 
buffers, excluding the SEC buffer, also contained 10% glycerol to maintain the protein soluble during purification.
Protein crystallisation, data collection, and structure determination. P2 mutants were crystallised 
at +4 or +20 °C using the sitting drop vapour diffusion method, while the concentrations of the I43N, T51P, and 
I52T mutants were 8.5, 6.2, and 5.5 mg/ml, respectively. 0.3 M NaCl, 10% glycerol, 20 mM HEPES pH 7.5 was 
used as the protein buffer and 100 μl of 2.1 M DL-malic acid pH 7.25–7.5 as the reservoir solution, with 600-nl 
drops containing an equal volume of reservoir and protein. Diffraction data were collected at 100 K on beamline 
I03 and I04 at the Diamond Light Source, Didcot, UK, and processed using XDS34. The structures were solved 
by molecular replacement using the human P2 structure (PDB entry 4BVM10) as a search model in Phaser35. The 
structures were refined and built using phenix.refine36 and Coot37. The refined coordinates and structure factors 
were deposited at the PDB with the entry codes 5N4M (I43N), 5N4P (I52T), and 5N4Q (T51P).
Small-angle X-ray scattering. Synchrotron SAXS data were collected on beamline P12 at the PETRAIII 
storage ring, DESY, Hamburg, Germany. 0.6–4.1 mg/ml P2wt, I43N, and I52T were studied in a buffer containing 
0.3 M NaCl, 20 mM HEPES pH 7.5, and T51P in a buffer containing 0.3 M NaCl, 5% glycerol, 20 mM HEPES pH 
7.5. Data were processed and further analysed using the ATSAS program package38.
Protein aggregation analysis and dynamic light scattering. Samples from soluble and insoluble 
fractions were taken and run on SDS-PAGE. Intensities of the P2 protein bands were determined using ImageJ39. 
Soluble fractions were then calculated (%). DLS measurements were conducted as triplicates at +25 °C with 
protein concentrations of 0.6–0.9 mg/ml in a buffer containing 0.3 M NaCl, 20 mM HEPES pH 7.5, using the 
DynaPro Plate Reader II (Wyatt). After SEC, the proteins were stored on ice for 24 h before DLS measurements.
Circular dichroism spectroscopy. SRCD was carried out on the DISCO (SOLEIL synchrotron, Paris) and 
UV-CD12 (ANKA synchrotron, Karlsruhe) beamlines. Proteins were first dialysed into 10 mM sodium phosphate 
pH 7.5 or dH2O. SRCD spectra were measured at +30 °C using 0.2 mm pathlength quartz cuvettes with protein 
concentrations of 17–21 μM (~0.3 mg/ml). Spectra for the P2 variants were also recorded in the presence of unil-
amellar vesicles containing a 1:1 molar ratio of DMPC and DMPG, or DOPC and DOPG. The molar protein:lipid 
ratio was 1:100. Thermal stability measurements were carried out using a Chirascan Plus CD spectropolarimeter 
(Applied Photophysics). Proteins were first diluted into 10 mM sodium phosphate buffer (pH 7.5) to final con-
centrations of 3.4 μM (50 μg/ml). CD spectra were then recorded at 195–260 nm with a ramping rate of 1 °C/min 
between +22–90 °C. The melting temperatures (Tm) were calculated using Global 3 (Applied Photophysics).
Atomistic molecular dynamics simulations. The protein with bound palmitate was obtained from the 
PDB entry 4BVM10 and converted to the CHARMM36 force field40. The topology for P2wt was directly obtained 
from the conversion. The point mutations (I43N, T51P, and I52T) were constructed from P2wt. Water molecules 
were modeled using the TIP3P model41.
Eight different systems were studied: P2wt and its point-mutated forms I43N, T51P, and I52T, all with and 
without a bound palmitate molecule inside the binding pocket. The proteins were simulated in solvated cubic 
simulation boxes with sizes of approximately 8 × 8 × 8 nm3 and with 16000 water molecules, in accordance to 
our previous study42. Counter-ions (11 Cl− in palmitate-free proteins and 10 Cl− in proteins with palmitate) were 
included to neutralise the total charge of the system.
The MD simulations were carried out under NpT conditions. Temperatures were coupled using the 
velocity-rescale (v-rescale) method, with separate temperature coupling for protein and solvent. Reference tem-
peratures of 300 K were used with coupling time constants of 2.0 ps. Pressure coupling was done isotropically 
with the isothermal Parrinello-Rahman barostat43 at a reference pressure of 1 bar with a coupling time constant of 
2.0 ps and isothermal compressibility of 4.5 × 10−5 bar−1. All bonds were constrained with the LINCS algorithm44. 
Periodic boundary conditions were used. A cut-off radius of 1.0 nm was introduced for the neighbor list, the 
Lennard-Jones interactions, and the non-bonded interactions. The particle-mesh Ewald (PME) method45 with 
cubic interpolation was used for calculating long-range electrostatics, using a spacing of 0.16 nm for the Fourier 
grid.
All simulations were conducted using GROMACS 4.6.746. A time step of 2 fs was used in integrating the equa-
tions of motion. All systems were first energy-minimised with the steepest descent algorithm and then simulated 
for a total of 2.5 μs each. An equilibration period of 500 ns was removed from the beginning of each trajectory, 
using the final 2 μs for analysis. The trajectory coordinates were saved every 50 ps.
The RMSF was calculated for each residue using the GROMACS tool g_rmsf. The RMSF of a residue shows its 
stability; the larger the value, the more mobile it is. Therefore, by calculating the RMSF, we can determine, which 
parts of the protein are most affected by the mutation and/or the presence of the ligand. Water analysis was done 
with the GROMACS tool trjorder by calculating the number of water molecules within 0.9 nm of the center of 
mass of the protein backbone (the radius of the P2 barrel is about 1.0 nm) at every time step over the course of 
the simulation.
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	Ǥ Fatty acid binding to P2 was studied with a fluorescent fatty acid analog, 
DAUDA. 10 μM DAUDA and 10 μM P2 were incubated for 1 h in 150 mM NaCl, 10 mM HEPES pH 7.5 at +23 °C. 
Fluorescence emission spectra were recorded with excitation at 345 nm and emission between 400–700 nm, using 
a Tecan Infinite M1000Pro plate reader.
Liquid chromatography-mass spectrometry for fatty acids. 20-μl aliquots of protein solutions 
adjusted to the same concentration (30 μM; 0.45 mg/ml) were acidified with 1 μl formic acid and then precipitated 
with 20 μl of acetone. Samples came from 2–3 separate production batches for each variant, and each sample 
was analysed 1–2 times. After centrifugation, fatty acids were extracted into 20 μl of chloroform, the phases were 
separated by short centrifugation, and 5 μl of the chloroform phase was subjected to LC-MS using an Acquity 
UPLC system coupled to a SynaptG1 Q-TOF type mass spectrometer. The chromatography column was a BEH 
C18, 2.1 × 100, eluted with a gradient of acetonitrile (A: acetonitrile, B: 10 mM ammonium acetate 10% A to 
100% A in 8 min, flow 0.3 ml/min). The mass spectrometer was operated in negative mode, collecting 0.2-s scans 
in centroid mode from m/z 50 to 1000. LC-MS was performed at the Proteomics and protein analysis core facility 
of Biocenter Oulu.
Surface plasmon resonance. SPR assays were performed using BiacoreT200 (GE Healtcare) for P2wt as 
well as the I43N and I52T mutants. Due to its low stability and tendency to aggregate, T51P was not used in SPR. 
1 mM DOPC:DOPG (1:1) and DMPC:DMPG (1:1) vesicles in a buffer containing 150 mM NaCl and 10 mM 
HEPES pH 7.5 were immobilised on an L1 sensor chip (GE Healthcare) according to the manufacturer’s instruc-
tions. The surface was then saturated with an injection of 1 μM bovine serum albumin (BSA). Lipid immobilisa-
tion and BSA injection were done for each SPR cycle. Duplicate injections of P2wt and the mutants at 0.1–10 μM, 
using 150 mM NaCl, 10 mM HEPES pH 7.5 as the running buffer, were carried out at +30 °C. Results were ana-
lysed with BiaEvaluation (GE Heathcare) using a kinetic two-state binding model as well as steady-state affinity. 
Due to the shape of the binding curves, fitting was also done using a sigmoidal 4-parameter model
= +
+ − −
f y a
x x b(1 exp( ( )/ )) (1)0 0
in SigmaPlot.
Ǥ For a single-point assay, 0–10 μM P2 was mixed with 0.5 mM unilamellar vesicles 
containing a 1:1 molar ratio of DMPC:DMPG in 150 mM NaCl, 10 mM HEPES pH 7.5, and the samples were 
incubated for 35 min at +30 °C. The turbidity of the vesicle-protein solutions was measured with a Tecan Infinite 
M1000 Pro plate reader using absorbance at 450 nm at +30 °C. The assay was repeated 3–5 times with all concen-
trations and P2 forms.
In order to study the time course of vesicle aggregation, 0.5 mM DMPC:DMPG vesicles were mixed with 5 μM 
P2 in buffer containing 150 mM NaCl and 10 mM HEPES (pH 7.5). A VersaMax microplate reader (Molecular 
Devices) was used to measure the turbidity at 1-min intervals, shaking before each measurement. The tempera-
ture was set at +30 °C and the wavelength at 460 nm. The difference of 10 nm in the wavelength in the above two 
experiments was not considered to affect the outcome, as the measurement follows turbidity of the sample.
Transmission electron microscopy. 34 μM (0.5 mg/ml) P2 was mixed with 740 μM (0.5 mg/ml) 
DMPC:DMPG (1:1) unilamellar vesicles, and the samples were incubated at +22 °C for 1 h. 4-μl samples were 
then pipetted onto glow-discharged carbon-coated copper grids, and after incubating for 1 min, excess solution 
was removed with filter paper. After 4 washes in droplets of dH2O, samples were negatively stained with two 
drops of 2% uranyl acetate for 12 s in each drop and air-dried. TEM images were recorded using a Tecnai G2 Spirit 
120 kV instrument equipped with a Quamesa CCD camera (Olympus Soft Imaging Solutions) at the EM core 
facility of Biocenter Oulu.
Ǥ The crystal structure coordinates and structure factors are available at the PDB with the 
entry codes 5N4M (I43N), 5N4P (I52T), and 5N4Q (T51P). Other datasets analysed during the current study are 
available from the corresponding author upon reasonable request.
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Abstract
Background: Myelin is a multilayered proteolipid sheath wrapped around selected axons in the nervous system. Its
constituent proteins play major roles in forming of the highly regular membrane structure. P2 is a myelin-specific
protein of the fatty acid binding protein (FABP) superfamily, which is able to stack lipid bilayers together, and it is a
target for mutations in the human inherited neuropathy Charcot-Marie-Tooth disease. A conserved residue that has
been proposed to participate in membrane and fatty acid binding and conformational changes in FABPs is Phe57.
This residue is thought to be a gatekeeper for the opening of the portal region upon ligand entry and egress.
Results: We performed a structural characterization of the F57A mutant of human P2. The mutant protein was
crystallized in three crystal forms, all of which showed changes in the portal region and helix α2. In addition, the
behaviour of the mutant protein upon lipid bilayer binding suggested more unfolding than previously observed for
wild-type P2. On the other hand, membrane binding rendered F57A heat-stable, similarly to wild-type P2. Atomistic
molecular dynamics simulations showed opening of the side of the discontinuous β barrel, giving important
indications on the mechanism of portal region opening and ligand entry into FABPs. The results suggest a central
role for Phe57 in regulating the opening of the portal region in human P2 and other FABPs, and the F57A mutation
disturbs dynamic cross-correlation networks in the portal region of P2.
Conclusions: Overall, the F57A variant presents similar properties to the P2 patient mutations recently linked to
Charcot-Marie-Tooth disease. Our results identify Phe57 as a residue regulating conformational changes that may
accompany membrane surface binding and ligand exchange in P2 and other FABPs.
Keywords: Myelin, Crystal structure, Fatty acid-binding protein, Membrane binding, Molecular dynamics, Mutation,
Protein stability
Background
A multitude of proteins interact with lipid membrane
surfaces. These peripheral membrane proteins come
from various protein families, and have generally little in
common at the structural level. Both electrostatic and
hydrophobic interactions are important for protein bind-
ing onto membranes. Conformational changes in the
protein are often observed upon membrane binding and
embedding, and the dynamics of both the protein and
lipid components may be altered upon proteolipid com-
plex formation. The proteins of the myelin sheath are in
intimate contact with lipid membranes, being either per-
ipheral or integral membrane proteins [1]. Defects in
myelin protein structure and/or function are linked to
various chronic demyelinating conditions, such as mul-
tiple sclerosis and peripheral neuropathies.
Peripheral myelin protein P2 is one of the most abun-
dant proteins in human peripheral nervous system
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(PNS) myelin [2]. P2 is expressed inhomogeneously
along myelinated axons: it can reach 15% of total myelin
protein in selected areas in the PNS, and it is also
expressed in the central nervous system in small
amounts in the spinal cord and brain stem [2–4]. The
physiological role of P2 remains unclear, even though it
is expressed at such high levels in myelin. P2 is located
in compact myelin, and it is expressed more in large
axon myelin [3, 5]. P2 has the ability to stack membrane
leaflets together [6, 7], and a dysfunction of P2 may lead
to myelin degeneration. Recently, three point mutations
in human P2 were linked to Charcot-Marie-Tooth dis-
ease (CMT), an inherited neuropathy [8–10]. We
showed that these mutations all decrease the stability of
P2, although they did not lead to major differences in
the P2 fold in the crystal state [11]. The disease muta-
tions also slightly altered membrane binding properties
of P2 [11].
The structure of human P2 has been solved at 0.93-Å
resolution using X-ray crystallography [12]. P2 belongs
to the fatty acid binding protein (FABP) family, and the
structure of P2 is typical for FABPs [13, 14]: the body of
P2 is a barrel formed of 10 antiparallel β strands, and
the loops that connect the β strands cover the open ends
of the barrel. The loop between the first two strands is
extended with two antiparallel α helices that form a
lid-like cover for the open end of the barrel. Inside the
barrel, there is a large ligand binding pocket, typical for
FABPs [13, 14]. The β barrel is discontinuous, with no
main-chain hydrogen bonds present between β strands 4
and 5. This feature is common to the entire FABP fam-
ily, suggesting structural and/or functional importance.
During myelination, large-scale membrane synthesis
takes place, and both protein and lipid components need
to be transported to the correct location [15, 16]. P2
could, in addition to being a structural component of
the myelin sheath, be important for transporting lipidic
compounds into the myelin membrane. For example,
myelin is rich in cholesterol [17], and P2 might function
as a cholesterol transporter. Studies on P2-deficient mice
showed a mild effect on nerve conduction velocity and
an abnormal lipid composition during the period of
most active myelination, although the ultrastructure of
PNS myelin appeared visually normal [4]. A recent
follow-up study identified a role for P2 in remyelination
after nerve injury [18].
FABPs are small β barrel proteins that can function as
lipid transporters [19]. They can roughly be divided into
two groups based on their respective transport mecha-
nisms [20, 21]. P2 is a member of the group employing
collisional transfer upon interaction with a lipid mem-
brane. The other group includes e.g. liver FABP, having a
diffusive transfer mechanism, whereby the FABP spon-
taneously opens and closes to allow ligand exchange
[20]. P2 is unique in the FABP family, as it apparently
has a stable contact to membranes, and it can stack lipid
bilayers into highly ordered multilayers [6, 12]. Dynam-
ics of the so-called portal region, consisting of helix α2
and the loops β3-β4 and β5-β6, have been identified
as a key determinant of ligand binding-related con-
formational changes in the FABP family, although
differences in this behaviour are apparent between
family members [22, 23].
Here, we specifically focused on the conserved FABP
family residue Phe57 in human P2. Phe57 is in a central
position in the portal region, and it is believed to regu-
late ligand entry into the internal cavity in FABPs [24].
Mutagenesis of Phe57 into alanine (F57A) highlighted
specific roles for Phe57 in ligand binding and structural
integrity of the portal region. Stability and membrane
binding of P2 were affected by the F57A mutation simi-
larly to the CMT-linked point mutations. Furthermore,
molecular dynamics (MD) simulations of the F57A mu-
tant showed opening of the β barrel from the side, which
is likely to be a general mechanism for FABP portal re-
gion opening. The regulation of this conformational
change appears to be affected in mutant variants of P2.
Methods
Protein production and crystallisation
Wild-type P2 (wt-P2), as well as the F57A and P38G var-
iants, were produced as earlier described [14, 25, 26].
Briefly, the proteins were expressed as His-tagged fusion
proteins in E. coli using autoinduction [27], and they
were purified with immobilized metal ion affinity chro-
matography (IMAC) and size exclusion chromatography
(SEC). The His tag was cleaved with TEV protease, and
IMAC and SEC were further used to obtain highly pure
protein. Crystallization of the F57A mutant has been de-
scribed [26]. Two additional crystal forms were obtained
here; all crystallization conditions were similar, contain-
ing 40–42% PEG6000 at pH 6.0–7.0 (see results for de-
tails). Crystallization was done at + 4 °C.
Crystallographic data collection and structure refinement
Diffraction data were collected on the EMBL beamline
X12 at the DORIS synchrotron storage ring (DESY,
Hamburg). 20% PEG200 was used for cryoprotection,
prior to transferring the crystals to liquid nitrogen
temperature. Data were collected at 100 K. The data
were processed with XDS [28] and XDSi [29]. The
structures were solved with molecular replacement
using PHASER [30], using the wild-type P2 structure
[14] as template, and refinement was carried out in
phenix.refine [31]. Model building was done in coot
[32] and validation in MolProbity [33]. The structures
were deposited at the PDB with entry codes 6EW2,
6EW4, and 6EW5.
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Lipid preparation
For stock solutions, dimyristoylphosphatidylcholine (DMPC)
and dimyristoylphosphatidylglycerol (DMPG) (Larodan Fine
Chemicals AB, Malmö, Sweden) were dissolved in chloro-
form:methanol (9:1 v/v) at 10–40 mg/ml final concentra-
tions, and combined to reach an equimolar mixture
(DMPC:DMPG (1:1)). Stock solutions and equimolar mixes
of dioleoylphosphatidylcholine (DOPC) and dioleoylpho-
sphatidylserine (DOPS) (Avanti Polar Lipids, Alabaster, Ala-
bama) were prepared similarly, but without methanol. The
mixtures were divided into aliquots, which were dried
under a nitrogen stream at ambient temperature,
followed by lyophilization overnight at − 52 °C under
vacuum. The dried lipids were stored at − 20 °C until
further use. To prepare lipid vesicles, 20 mM HEPES,
150 mM NaCl, pH 7.5 was added directly onto the
dried lipids to obtain 5–7 mM concentration. Gentle
agitation was applied overnight at ambient temperature.
Large multilamellar vesicles (MLVs) were prepared
from the suspensions by freeze-thawing 7 times using
liquid nitrogen and a warm water bath, followed by vig-
orous vortexing. Large unilamellar vesicles (LUVs) were
prepared by passing the MLVs through a 100-nm mem-
brane 11 times, while heating to + 40 °C. All vesicle
preparations were used immediately in downstream
experiments.
Circular dichroism spectroscopy
A Chirascan Plus instrument (Applied Photophysics)
was used for circular dichroism (CD) spectroscopy. CD
spectra were measured at + 20 °C in a 0.5-mm quartz
cuvette. Protein concentration was 0.25 mg/ml (14 μM)
in 0.8 mM HEPES pH 7.5, 6 mM NaCl, 0.4% glycerol. In
mixtures with lipids, the lipids (DMPC/DMPG at 1:1
mixture) were in 100-fold molar excess (1.4 mM).
Temperature scans, at a heating rate of 1 °C/min, were
run for the same samples between + 20 − + 90 °C. Full
spectra were continuously measured as a function of
temperature. Temperature scan data were analyzed
using Global3™ (Applied Photophysics).
Atomistic molecular dynamics simulations
The crystal structure of P2-F57A was subjected to atom-
istic MD simulations exactly as previously described [11,
25] for wt-P2 and P2-P38G. Simulations were carried
out in the presence and absence of bound palmitate, in a
simulation box filled with TIP3P water molecules.
Briefly, the system was energy-minimized with the stee-
pest descent algorithm and then simulated for a total of
3 μs. MD simulations were run with GROMACS 4.6.7
[34]. The last 2.5 μs were used for analyses. Dynamic
cross-correlation map (DCCM) analysis was performed
using Bio3D [35].
Differential scanning calorimetry
Differential scanning calorimetry (DSC) was carried out
essentially as earlier described for myelin basic protein
(MBP) [36]. P2 and P2 F57A were mixed with MLVs of
350 μM DMPC:DMPG (1:1) in 20 mM HEPES, 150 mM
NaCl, pH 7.5, at 1:100 and 1:200 protein-to-lipid (P/L)
ratios. The samples were degassed for 10 min under vac-
uum with stirring at + 10 °C before measurements. A
control lipid sample without protein was also prepared.
DSC measurements were performed with a MicroCal
VP-DSC instrument. Cell volume was 527.4 μl. The ref-
erence cell was filled with 20 mM HEPES, 150 mM
NaCl, pH 7.5. Each sample was scanned from + 10 to +
40 °C and back to + 10 °C in 1 °C/min steps. Buffer base-
lines were subtracted from sample curves and zeroed be-
tween + 28–30 °C. All samples were prepared and
measured twice and deemed reproducible.
Membrane surface binding
Surface plasmon resonance (SPR) was performed as de-
scribed [11, 36]. Briefly, SPR measurements were per-
formed using a Biacore T200 system (GE Healthcare)
using 20 mM HEPES, 150 mM NaCl, pH 7.5 as running
buffer at + 30 °C. LUVs of 1 mM DOPC:DOPS were
immobilized on an L1 sensor chip (GE Healthcare),
followed by a blocking injection of 0.2 mg/ml BSA, and
a single injection of P2 or P2 F57A. Chip regeneration
was performed using a 2:3 (v:v) mixture of isopropanol
and 50 mM NaOH. The studied protein concentrations
were 0.1–15 μM. A single concentration was analyzed
per cycle, and all samples were measured in duplicate.
Equilibrium binding responses were plotted against pro-
tein concentration and fitted using a one-site binding
model (Y = Bmax*X / (Kd + X)).
Lipid vesicle aggregation
Turbidimetry was used to follow vesicle aggregation, a
sign of lipid membrane stacking by P2, as described be-
fore [11, 12, 37]. LUVs of 500 μM DMPC:DMPG (1:1)
were mixed with 0.5–10 μM P2 or P2 F57A in 100-μl
triplicate samples. Turbidity at 450 nm and 660 nm was
recorded immediately after sample preparation and mix-
ing at + 30 °C using a Tecan SPARK 20 M plate reader
for 15 min. The mixtures were stored overnight at + 4 °
C for further co-sedimentation analysis.
Protein-lipid co-sedimentation
To check for protein co-sedimentation with the lipid
vesicles, samples were picked from the 10 μM vesicle ag-
gregation samples, combined, and centrifuged at
16000 g, + 4 °C for 10 min to separate the lipid-bound
protein from soluble protein. The pellet was resus-
pended in 20 mM HEPES, 150 mM NaCl, pH 7.5. The
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protein content of the supernatant and the pellet sus-
pension was analyzed using SDS-PAGE.
In addition, co-sedimentation assays were separately
carried out using 20 μM wt-P2 mixed with 1 mM
DMPC:DMPG (1:1) or DOPC:DOPS in 20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 0.5 mM TCEP. After
a 30-min incubation at ambient temperature, the sam-
ples were subjected to ultracentrifugation for 75 min at
435000 g at + 20 °C. The supernatant and pellet were an-
alyzed by SDS-PAGE.
Bioinformatics
Using the crystal structure of wt-P2 [14] and all the six
independent F57A crystal structures described here, resi-
due interaction networks (RINs) were generated with
Chimera [38] through the structureViz [39] app for
CytoScape [40], using default parameters without hydro-
gen bonds, and with own contact detection software
(2.5–5 Å). RIN analyses were performed with the
RINspector [41] app for CytoScape. They included be-
tweenness and residue centrality analysis. Only Z scores
of ≥2 were considered relevant. The analyses were car-
ried out with and without the bound palmitate ligand;
the ligand dominated the networks when present.
Sequence-based predictions of protein flexibility were
done using DynaMine [42, 43]. Structure-based predic-
tion of point mutation effects on P2 thermal stability
was done with Cupsat [44] and MAESTRO [45].
Results
Myelin P2 folding and stability
The F57A and P38G mutants were compared to wt-P2
using CD spectroscopy (Fig. 1a). In solution, all three
variants had similar CD spectra, indicating no
large-scale structural effects by the mutations. This was
earlier confirmed for the P38G mutant [25]. A large ef-
fect on the CD spectra of membrane-bound P2 was in-
duced by both mutations (Fig. 1b), and difference
Fig. 1 Analysis of P2 folding by CD spectroscopy. a Comparison of CD spectra of wt-P2, P2-F57A, and P2-P38G. The spectra for wt-P2 and
P2-P38G were presented earlier [25]. b Spectra for the same P2 variants in the presence of lipids. The dashed lines indicate difference spectra
between wt-P2 and each mutant. c Stability analysis of P2-F57A by CD in solution. CD spectra are shown from + 20 (black) to + 90 °C (blue), at
intervals of 10 °C for clarity. The spectrum at + 50 °C is shown in red to aid in comparison between samples. d Stability of P2-F57A in the
presence of lipids. Inset: CD signal at 200 nm of wt-P2 (black), F57A (red), and P38G (green) bound to lipids as a function of T
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spectra indicate that the mutant variants contain less
overall secondary structure than wt-P2.
Thermal CD scans were further employed to follow ef-
fects of the two mutations on P2 heat stability. In our
previous study, we saw a decrease in stability for the
P38G mutant [25]. Here, a lowered melting point of the
P2-F57A protein was observed compared to wt-P2.
The secondary structure content of P2 changes once
mixed with DMPC:DMPG vesicles (Fig. 1b). The
temperature scans were repeated with proteins in a lipid
environment: wtP2 did not get fully denatured even at +
90 °C, only a conformational shift to a more helical struc-
ture was observed [12]. The same behaviour, but including
more unfolding, was observed for P2-F57A (Fig. 1c,d).
The different behaviour of wild-type and mutant P2 in
solution and in the presence of lipid vesicles shows a
strong effect on P2 stability and properties by lipid
membrane binding. In solution, both wt-P2 and the mu-
tants show very well-defined isosbestic points (Fig. 1c),
indicative of a simple two-state unfolding reaction; even
though the melting temperatures are different. However,
in the presence of membranes, the spectral changes are
gradual, and isosbestic points are not present at all (Fig.
1d). This is a sign of a complex stepwise conformational
adaptation to the membrane environment by P2 as a
function of temperature. A main change occurs in the
range of + 50 °C, and actually at a lower temperature for
wt-P2 (Fig. 1d, inset). After this transition, wt-P2 re-
mains stable, while the mutants gradually change their
structure even as temperatures approach + 90 °C; how-
ever, all the proteins remain in a folded state even at
these high temperatures in the presence of lipids. Inter-
estingly, the conformational changes start to be visible
around physiological temperature.
Membrane binding and stacking by P2-F57A
When P2 is mixed with lipid vesicles, visible aggregation
occurs, which can be quantified using turbidimetry [11,
12]. Turbidity can be used as a means to quantify the
function of myelin proteins - binding lipid membranes
together [36, 37]. At time point 0 of the vesicle aggrega-
tion experiments, there is only a marginal difference be-
tween P2 and the mutant, when the P/L ratio changes
(Fig. 2a). As a function of time, it seems that the proteo-
lipid aggregate stability is higher for wt-P2 (Fig. 2b).
F57A reaches its maximum level quicker, but also de-
creases over time. This suggests differences in vesicle ag-
gregation kinetics between wt-P2 and P2-F57A, which
may be linked to effects on the P2 membrane binding
mechanism by the mutation. The co-sedimentation of
wt-P2 and F57A with lipids is similar (Fig. 2c). Electro-
phoretic analysis of the proteolipid pellet also occasion-
ally reveals a ladder of different oligomeric forms of P2
in the protein-lipid pellet (Fig. 2d).
Using DSC, we followed the lipid tail phase transition
of DMPC:DMPG vesicles in the presence and absence of
P2 (Fig. 2e). The lipid phase transition behaviour is al-
tered by P2, and upon addition of wt-P2, the main tran-
sition population decreases and a wide, fairly
low-intensity population at + 25.5 °C is formed. The ef-
fect is dependent on P2 concentration. Earlier, we
showed similar effects by MBP on negatively charged
vesicles [36]. However, the F57A mutant does not show
this behaviour, and the phase transition is not much
affected.
We further studied the affinity of P2 towards DOPC:-
DOPS membranes using SPR (Fig. 2f,g). The mutant
seems to have a slightly lowered affinity for DOPC:-
DOPS (1:1) LUVs (Table 1), while the maximum amount
of protein bound to the surface is similar. In addition, as
seen before for the CMT disease mutant variants [11],
the binding kinetics for F57A are different from wt-P2;
apparently both binding and dissociation occur more
slowly with the mutant protein.
Structure of P2 F57A mutant in the crystal state
P2-F57A was crystallized in three different crystal forms
under similar conditions (Table 2), and the crystal struc-
ture was solved from all of them. Phe57 lies at the tip of
the β3-β4 loop, close to the bound fatty acid. The fatty
acid, originating from the E. coli expression host, was
modelled as palmitate. Phe57 forms C-H...π interactions
with the nearby residues Lys58 and Leu32 that lie on op-
posite sides of the Phe ring (Fig. 3a).
In line with CD spectroscopy, no large-scale changes
in P2 structure were induced by the mutation in the
crystal state. Once the C-H...π interaction gets elimi-
nated in P2-F57A, both helix α2 and the β3-β4 loop alter
their positions: helix α2 turns inwards towards the
palmitate bound in the cavity, and the β3-β4 loop bends
outwards, slightly opening the portal region (Fig. 3b). In
different crystal forms of P2-F57A, helix α2 and loop
β3-β4 are in slightly different conformations. The bound
fatty acid adopts a more elongated conformation in
F57A-P2 than in wild-type P2, correlating with the con-
formation of the β3-β4 loop (Fig. 3b). Strands β4 and β5
do not have any main-chain H bonds between them, and
a line of water molecules mediates contacts between
them (Fig. 3c).
Molecular dynamics simulations
In atomistic simulations of wt-P2 in solution, the Phe57
side chain alters its conformation occasionally, flipping
outwards and pointing towards bulk solvent (Fig. 4a,b).
Such conformations have been seen before in crystal
structures of FABPs, including P2 [46]. Phe57 side chain
flipping is apparently more frequent and lasts a longer
time in the presence of bound fatty acid (Fig. 4a).
Laulumaa et al. BMC Structural Biology  (2018) 18:8 Page 5 of 13
The F57A simulations presented here revealed a
large-scale opening of the β barrel between strands β4 and
β5 (Fig. 4c,d,e). Upon this opening, the ligand-binding
cavity becomes accessible, as the hairpin unit formed by
strands β5 and β6 flaps out. Based on the F57A simulation
results, we re-analyzed our earlier simulations of WT and
P38G P2 [25], and indeed, for both of them, an occasional
opening of the β barrel at the same site is observed, with
exposure of the bound ligand (Fig. 4d). This was especially
prominent for the palmitate-bound P38G mutant, which
we observed to have higher dynamics than the wild-type
protein.
An analysis of the root mean-square fluctuations in the
MD trajectories reveals that F57A shows higher dynamics
than wt-P2 in the absence of fatty acid (Fig. 4f), while dy-
namics are identical in the presence of bound ligand. Spe-
cifically, the site of the F57A mutation is not much affected,
but the β5-β6 and β7-β8 loops are more mobile, indicating
an increased flexibility of the portal region in the mutant.
For additional insight into concerted dynamics of
P2, DCCM analyses were performed on the MD tra-
jectories (Fig. 5). While wild-type P2 shows strong
anti-correlation between the β5-β6 loop and the rest
of the portal region (helices α1-α2 and the β3-β4
loop), no such correlation exists in the F57A mutant.
Similar results were obtained with and without bound
palmitate (Fig. 5). In addition, we analyzed our earlier
MD trajectories for the CMT disease mutations [11]
as well as P38G [25]. All the mutations had similar
effects to F57A, indicating loss of anti-correlations in
portal region dynamics (Additional file 1: Figure S1).
Table 1 SPR fitting parameters of P2 binding to DOPC:DOPS
(1:1) vesicles
Protein Bmax (R.U.) Kd (μM) R
2
P2 1466 ± 54 3.1 ± 0.3 0.9750
P2-F57A 1408 ± 56 6.2 ± 0.5 0.9884
Fig. 2 Lipid binding experiments. a wt-P2 (black) and P2-F57A (red) initial vesicle aggregation profiles as a function of protein concentration.
b Decrease in the turbidity signal over time in the mutant sample. c Co-sedimentation at 1:100 P/L (10 μM protein with 1 mM DMPC:DMPG)
suggests roughly 50% binding of protein to vesicles. 1, molecular weight marker; 2, wt-P2 in pellet; 3, P2-F57A in pellet; 4, wt-P2 supernatant; 5,
P2-F57A supernatant. d Co-sedimentation of wt-P2 with lipid vesicles. 1–2, supernatant and pellet of 20 μM P2 with 1 mM DMPC:DMPG; 3–4
supernatant and pellet of 20 μM P2 with 1 mM DOPC:DOPS. The asterisks indicate the positions of monomeric (*), dimeric (**), and trimeric (***)
P2 in the proteolipid pellet. e DSC measurements show the diminished effect of the F57A mutant (red) on the lipid phase transition behaviour,
while wt-P2 (black) has a clear effect. Dotted line: lipids alone, dashed line: P/L 1:200, solid line P/L 1:100. f Examples of SPR sensorgrams; shown
are duplicate injections of 10 μM wt-P2 (black) and P2-F57A (red) onto immobilized DOPC:DOPS (1:1). g The steady-state affinity of the F57A
mutants to DOPC:DOPS (1:1) vesicles is marginally weaker compared to wild type. All error bars are standard deviations
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Predictions and network analyses
Flexibility predictions were carried out based on the P2
sequence, to compare the predicted effects of F57A and
the CMT disease mutations. Each of the mutations is
predicted to cause a local increase in flexibility (Fig. 6a,b).
This is in line with the observed decrease in heat stabil-
ity and the increased dynamics in simulations for the
mutant variants. Based on the P2 crystal structure, we
further predicted the effects of the mutations on protein
stability (Table 3); overall, the predictions fit the mea-
sured decrease of Tm for the mutants. This result further
shows that the F57A mutation behaves similarly to the
disease mutations in structure-function assays.
For a deeper understanding of P2 folding and intramolecu-
lar interactions, residue interaction networks and centralities
in the crystal structures were characterized and compared
between wt-P2 and P2-F57A; all six independent F57A mole-
cules in the three crystal structures with different space
groups were included in the analysis. The analysis shows that
Phe57 is structurally not a very central residue in the P2
structure, and its mutation to alanine has subtle effects on
these networks (Additional file 2: Figure S2). This observation
is slightly unexpected, having experimentally seen a drastic
drop in thermal stability in the F57A mutant protein (see
above). Interestingly, a group of residues, including the dis-
ease mutation sites, as well as residues on strand β4 and in
Table 2 Data processing and structure refinement statistics for P2-F57A
Space group P43212 C2 [26] P212121
Unit cell dimensions a = b = 58.61 Å, c = 76.96 Å α = β = γ = 90° a = 112.76 Å, b = 36.08 Å, c = 31.17 Å,
α = γ = 90°, β = 96.87°
a = 52.12 Å, b = 76.11 Å,
c = 138.43 Å, α = β = γ = 90°
Wavelength (Å) 1.10 1.10 1.10
Resolution range (Å) 20–1.59 (1.63–1.59) 20–1.27 (1.30–1.27) 20–1.95 (2.00–1.95)
<I/σ(I)> 19.1 (1.0) 8.2 (1.2) 11.6 (2.3)
Rsym (%) 6.5 (111.4) 7.6 (60.7) 15.8 (75.0)
Rmeas (%) 7.2 (129.6) 9.2 (78.1) 17.3 (82.1)
Completeness (%) 98.7 (92.7) 96.8 (77.4) 99.1 (98.7)
Redundancy 5.7 (3.2) 2.9 (1.8) 6.0 (6.0)
CC1/2 (%) 99.9 (39.9) 99.6 (43.6) 99.4 (75.4)
Wilson B factor (Å2) 27.2 16.9 20.2
Rcryst (%) 18.6 17.1 18.8
Rfree (%) 21.6 22.4 23.6
rmsd bond lengths (Å) 0.012 0.009 0.005
rmsd bond angles (°) 1.3 1.2 0.9
Ramachandran favoured/allowed (%) 100/100 99.3/100 98.1/100
# molecules in asymmetric unit 1 1 4
MolProbity score (percentile) 1.25 (97th) 1.48 (79th) 1.32 (99th)
PDB entry 6EW2 6EW4 6EW5
Fig. 3 Phe57 in the P2 crystal structure. a The location and interactions of Phe57 in wt-P2. Note the C-H...π bonds on both faces of the Phe57
side chain. b Conformational effects of the F57A mutation (stereo view). Superposed are wt-P2 (magenta) and all individual P2-F57A monomers
from the three crystal forms (6 in total). Note the apparent flexibility of helix α2 and the β3-β4 loop. c Discontinuity of the β barrel of P2; a line of
water molecules mediates contact between strands β4 and β5
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the β5-β6 unit, become more central upon the F57A
mutation (Fig. 6c and Additional file 2: Figure S2).
Leu32 on helix α2 also belongs to this group. Also
the interactions between P2 and the palmitate ligand
are slightly altered through the mutation, in line with
the subtle conformational changes observed in the re-
spective crystal structures.
When the palmitate ligand is included in the analysis, it
dominates the network, highlighting its multiple interac-
tions and suggesting a stabilizing and therefore possible
structural role in P2 and the FABP superfamily protein
stability (data not shown). The two Arg residues coordin-
ating the palmitate anionic group are central in P2 intra-
molecular networks, when the palmitate is not taken into
account. Additional central P2 residues can be observed.
Some of them, especially Gln93 and Gln95, both pointing
inwards on strand β7 (Fig. 6c and Additional file 2: Figure
S2), have not been of obvious importance in earlier ana-
lyses of P2 crystal structures. Gln93 is sandwiched be-
tween the charged side chains of Arg106 and Glu72 (close
to the β5-β6 loop) - both carrying buried charges inside
the protein. Importantly, none of the central residues of
wt-P2 lie in the β5-β6 unit, which flips out during barrel
opening (Fig. 6c).
Discussion
While the FABP family contains proteins with distinct
functions, current evidence suggests that the FABPs
Fig. 4 MD simulations of P2-F57A. a Fluctuation of the distance between Phe57 and helix α2 shows flipping of the Phe57 side chain in wt-P2
during the simulation. The simulation was run with (magenta) and without (black) the fatty acid ligand. b The two conformations of Phe57
(cyan). Left: Phe57 points inwards and interacts with the fatty acid (magenta). Right: Phe57 points outwards. Bovine P2 crystal structure is shown
superposed in yellow, with the same conformation. c The structure shows the distance measured when studying barrel opening. d Distance
between the tips of the β3-β4 and β5-β6 loops during the simulation. Black: wt-P2; red: F57A; green: P38G. Left: simulations without ligand. Right:
simulations with bound palmitate. The red and green arrows indicate the positions of the snapshopt in the next panel. e Structural snapshots
from the simulations. Left: Closed starting structure for F57A; middle: open F57A structure at 1.5 μs; right: open P38G structure with ligand at
2.2 μs, identified from our earlier trajectories [25]. f RMSF of wt-P2 (black) and F57A (red) in the simulations. Thick lines indicate unliganded
simulations and thin lines those with bound fatty acid
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share not only structural, but also dynamical, properties.
Phe57 is a highly conserved residue in the FABP family,
thought to play an important role in the function of the
portal region and ligand binding [24, 47, 48]. Its con-
formation varies between FABP crystal structures, being
either swung in to interact with the hydrophobic ligand
and helix α2 or pointing towards the solvent. In struc-
tures of P2, Phe57 is normally pointing inwards, making
direct van der Waals contacts with the hydrocarbon tail
of the bound fatty acid, although the first structure of
bovine P2 had Phe57 pointing outwards [46]. We stud-
ied the importance of Phe57 in human myelin P2 pro-
tein through a variety of biophysical experiments.
P2 stability and folding
We showed before that binding of wt-P2 to lipid vesicles
induced an apparent unfolding of helical structures, i.e.
the lid of the β barrel [12]. Hence, we wanted to observe
any potential effects on this unfolding by two mutations
at the portal region, F57A and P38G. We showed that
the P38G mutation renders the P2 protein more dy-
namic on different time scales [25]. The folding of both
of the mutant proteins was affected by the presence of
lipid vesicles more than that of the wild-type protein.
Thermal stability of both mutant P2 variants was de-
creased. For P38G, a flexibility increase in loop areas
and helix α2 was also observed in computer simulations
Fig. 5 DCCM analysis of MD trajectories. a wt-P2 without fatty acid. Note the two regions of strong anti-correlation (arrows). b wt-P2 with
palmitate. c P2-F57A without ligand. d P2-F57A bound to palmitate
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[25], and for P2-F57A, the diversity in crystal structures
indicates increased protein flexibility in the portal region.
Previously, for wt-P2 it appeared that binding to phos-
pholipids would result in the unfolding of helices [12],
whereas the P2 N-terminal peptide was shown to be-
come helical when bound to lipids [14]. It is clear that
binding to phospholipids increases P2 thermal stability
drastically as a result of an interaction between the
phospholipids and P2. This interaction can partially
overcome the destabilizing effects of point mutations on
the protein in solution. All in all, F57A behaves similarly
to both P38G as well as the CMT-linked disease muta-
tions [11, 25].
Membrane binding and stacking
Many FABPs have been shown to interact with lipid
membranes [49–55]. For those FABPs employng a colli-
sional transfer mechanism, such interactions are func-
tionally crucial [49]. To our knowledge, however, P2 is
the only member of the FABP family that stacks lipid
membranes into multilayers; hence, one can expect its
structure-function relationships to differ somewhat from
other FABPs.
P2 bound to lipid membrane surfaces, and electro-
phoretic separation often resulted in a ladder of P2 in
the membrane pellet. This reflects a very tight inter-
action of P2 with stacked membranes, not being dis-
sociated by SDS and heating, and suggests the
formation of supramolecular complexes by P2 mole-
cules and two apposing lipid membranes. The struc-
tural details of this assembly are likely to be relevant
for myelin formation, and further research will be re-
quired to elucidate the molecular architecture, also
with respect to other myelin proteins present in the
same compartment, such as MBP and P0.
Our DSC experiment indicated effects by P2 on lipid
phase transition similar to those we observed with MBP
[36]. The effect was, however not observed for P2-F57A
here. This means that the insertion or hydrophobic ef-
fect of the protein – or the formation of lipid rafts or
structures that have altered phase transition behavior –
is not present with the mutant.
Crystal structures of P2-F57A
Phe57 is a conserved residue in most FABPs, and its sta-
bilizing interactions may be a common feature of FABPs
[12]. The conservation concerns especially FABPs thought
to transfer ligands to membranes through the collisional
mechanism. It is possible that upon membrane binding,
these interactions are altered, allowing for conformational
changes in the portal region of FABPs.
Fig. 6 Flexibility and contact network analysis. a. DynaMine prediction of F57A flexibility. b. DynaMine prediction of flexibility of the CMT disease
mutations in P2. Our residue numbering differs by − 1 from the mutation reports, to comply with the conventional numbering of residues in P2
and other FABP structures. c. Mapping of central residues onto the P2 structure. The structure shown is the liganded structure of the P38G
mutant during MD simulations, to highlight the opening. The centralities were calculated from the unliganded crystal structures. The bound fatty
acid is shown as a magenta surface and Phe57 in orange. Residues having high Z scores of centrality are indicated in blue, and the ones showing
higher centrality in F57A than the wild-type P2 in yellow. Note how the opening β flap has no residues of high centrality (red circle). See
Additional file 1: Figure S1 for more details
Table 3 Predicted and measured changes in heat stability for
various P2 variants. Tm values for P38G and the disease
mutations have been published [11, 25]
variant Cupsat ΔΔG
(kcal/mol)
MAESTRO ΔΔG
(kcal/mol)
Experimental
ΔTm (°C)
F57A −1.91 1.16 −6
P38G −5.38 1.64 −6
I43N −7.63 3.92 −17
T51P −1.51 1.43 −24
I52T −5.17 2.89 −13
Note that Cupsat defines a destabilizing mutation with a negative ΔΔG, while
in MAESTRO, a destabilizing mutation has a positive ΔΔG
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The possibility of crystallizing in different conformations
indicates an increasing flexibility of the portal region,
linked to the missing stabilizing C-H…π interactions of
Phe57. The absence of Phe57 seems to both destabilize P2
as well as bring about small but clear conformational
changes in the crystal state. These differences are likely to
correspond to molecular motions upon extrusion of the
ligand from the internal cavity. Phe57 lies close to the
anion-binding pocket we observed previously [12]. In the
structures of the F57A mutant, this pocket is usually occu-
pied by an anionic group in the crystal. We believe this
site can be relevant for membrane lipid headgroup bind-
ing and possible allosteric conformational changes in-
duced thereby.
While fatty acid binding to FABPs in general causes
only little changes in structure and dynamics [23], all ex-
perimental structures of P2 thus far have a bound fatty
acid molecule inside the protein. Thus, comparisons be-
tween liganded and empty P2 cannot be yet done based
on experimental data. MD simulations have shown, both
in the current study and our earlier work [25], that
bound palmitate decreases the overall dynamics of P2.
In all FABPs, the β barrel is in fact discontinuous, and
water molecules between two strands interrupt the
main-chain H-bonds one would expect for a perfect β
barrel. Already since early FABP structures, it has been
suggested that this could be a location of FABP flexibility
and related to the opening of the portal region [56].
P2 dynamics and networks
In earlier coarse-grained simulations, Phe57 was found
to be one of the residues possibly inserting into the
hydrophobic interior of the lipid bilayer [12]. The flexi-
bility of the large Phe57 residue observed in our simula-
tions could be important in the dynamics of the portal
region. Phe57 has been considered a gatekeeper of the
portal region in FABPs [24, 47, 48].
In the F57A simulation, a large opening of the barrel
between strands β4 and β5 was observed. Recently, we
observed the same phenomenon in simulations as well
as experimental SAXS solution studies for the
CMT-linked variants of human P2 [11]. The increased
dynamics of the F57A mutant correlate to the opening
of the β5-β6 unit. We believe to have observed a general
mechanism for opening of the FABP β barrel upon lig-
and exchange; the helical lid does not open in this
process. Earlier studies on different FABPs have identi-
fied slightly varying mechanisms for fatty acid entry and
egress [22, 57, 58]; while in general, opening of the por-
tal region is considered most important, alternative
routes for ligand entry and/or exit have been suggested at
the bottom of the β barrel structure [58]. The significant
opening of P2 at β5-β6 in our extended 3-μs simulations,
which are at least an order of magnitude longer than most
published FABP simulations, suggests this is the main lig-
and entry mechanism in the myelin P2 protein. How the
conformational change is affected by binding to lipid
membranes, remains currently unknown.
DCCM analyses indicated a clear loss of dynamic
anti-correlations between the opening β5-β6 flap and
the rest of the portal region in all analyzed mutants (Fig.
5, Additional file 1: Figure S1); similar results were ob-
tained in both the presence and absence of bound fatty
acid ligand. In wt-P2, this anti-correlation is likely to re-
flect coordinated open-close movements, and it appears
that such coordination is lost in both the disease vari-
ants and the F57A and P38G mutants. These results fur-
ther highlight the important role of Phe57 in regulating
portal region structure and dynamics. While Phe57 does
not directly interact with the β5-β6 loop, its close inter-
action with the α2 helix is likely to be important for this
indirect regulation; this mechanism may be applicable to
also other members of the FABP family.
Similarly to fatty acid binding, also membrane binding
mechanisms of various FABPs have been studied [49–
55]. The binding was suggested to be heavily affected by
macrodipoles present in the protein molecule [53]. The
orientation of the FABP with respect to the membrane
appears to not be conserved between different FABPs,
and docking may occur both through the portal region
or the opposite face [53, 59]. In this respect, it is import-
ant to remember that P2 is bound between two mem-
brane surfaces, and it is likely that both of these modes
are applicable to P2. Our earlier coarse-grained simula-
tions suggested membrane interactions through both the
portal region and the anti-portal bottom face of P2 [12].
Gln93 and Gln95, identified in our network analysis,
could be crucial for correct folding and function-related
conformational changes. Interestingly, alignment of all
human FABPs [12] shows that whenever Glu72 is
present, also Gln95 is conserved. Residue 93 is in these
cases either Gln, His, or Cys; when it is a Cys, residue
106 is Gln instead of Arg. Thus, a residue at position 93
interacts with a buried charge on the β5-β6 unit, and the
breaking of this interaction must take place upon β bar-
rel opening. Earlier, it was shown that mutation of
Glu72 to Ser caused destabilization of heart FABP [60].
Conclusions
Phe57 is a residue linking the β-turn loops β3-β4 and
β5-β6 and helix α2 in the portal region of P2, and in
other FABPs. It interacts directly with the bound fatty
acid, and it is likely to play a role in the regulation of
portal region opening upon membrane contact. The
opening of the β barrel observed in simulations of
P2-F57A reveals a mechanism for FABP ligand exchange
that has been long suggested [56], but was only recently
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shown for the CMT disease mutants of P2 [11]. The dis-
continuity of the FABP β barrel is likely to be instrumen-
tal for its opening upon ligand binding - also highlighted
by the fact that the hot spot for CMT mutations lies in
close vicinity to the opening site in P2, on strands β3
and β4. Comparing all human FABPs, we earlier showed
that only two Gly residues are fully conserved in all fam-
ily members [12]; of these, Gly67 lies in the β4-β5 loop
(Fig. 3c), which may act as a functional hinge in the
FABP superfamily during barrel opening.
Additional files
Additional file 1: Figure S1. DCCM analyses on earlier MD trajectories
from P2 mutants. A. P38G. B. I42N. C. T50P. D. I51T. The empty structures
are on the left and the palmitate-bound on the right. (PNG 3329 kb)
Additional file 2: Figure S2. Comparison of centrality analyses between
wt-P2 and P2-F57A mutants. A residue interaction network (top) was
generated from the crystal structures of P2 (bottom), and central residues
were mapped onto them. A. Central residues globally conserved between
wt-P2 and different P2-F57A mutant structures. Residues are considered
central if their Z score ≥ 2, and they are coloured in the network as a
function of this Z score with a gradient from yellow (Z score = 2) to red
(Z score ≥ 4). Z score values of the wt-P2 were chosen for these Figs. B.
Central residues only identified in one or several F57A mutant structures
and not in wt-P2. Yellow is indicative of Z score ≥ 2. (PDF 1416 kb)
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Abstract
Cell signaling controls essentially all cellular processes.While it is often as-
sumed that proteins are the key architects coordinating cell signaling, recent
studies have shownmore andmore clearly that lipids are also involved in sig-
naling processes in a number of ways. Lipids do, for instance, act as messen-
gers,modulate membrane receptor conformation and dynamics, and control
membrane receptor partitioning. Further, through structural modifications
such as oxidation, the functions of lipids as part of signaling processes can be
modified. In this context, in this article we discuss the understanding recently
revealed by atomistic and coarse-grained computer simulations of nanoscale
processes and underlying physicochemical principles related to lipids’ func-
tions in cellular signaling.
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INTRODUCTION
Life is based on communication. Even individual cells communicate as they receive messages from
the outside of the cell that guide their activity and functions.This information is received at the cell
membrane surface from which it is directed to the correct destination inside the cell. If anything
in this process goes wrong, the consequences are often unpleasant—in the most severe cases, a
disease. In essence, communication is crucial for survival.
The information arriving to the cell is primarily recognized by receptors embedded in cell
membranes. Given that cell membranes are mostly composed of lipids, a number of intriguing
questions emerge about the role of lipids in cellular signaling. How do lipids modulate receptor
activation and function? Is it possible that lipids could act as messages, or messengers, such that
their transport would also be a means of communication? Is it possible that the function of lipids
could be reprogrammed by chemical modification?
Quite surprisingly, there are major gaps in our understanding regarding the role of lipids in
cellular communication. This largely stems from the tiny scales in space and time that are typi-
cal for molecular-scale signaling processes. However, this is exactly the region where molecular
simulation techniques are often the method of choice.
Here in this review, we discuss how atomistic and coarse-grained molecular simulations can be
used to unravel how lipids contribute to cellular signaling. Given the conciseness of this article,
the aim of this review is not to be exhaustive—rather, we discuss selected examples of recent work
where computer simulations have shown the added value that they can provide to complement
experiments. Other review articles discussing related topics, largely from an experimental point
of view, are available in the literature (23, 98).
LIPID FLIP-FLOPS AS PROCESSES DELIVERING
INFORMATION ACROSS MEMBRANES
Lipid translocation across biological membranes (flip-flop) is of profound importance in cell
physiology. Phospholipids are mainly synthesized on the cytoplasmic face of the endoplasmic
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TMEM16
Rhodopsin
a
b
Figure 1
(a) Homodimeric transmembrane protein 16 (TMEM16) scramblase (containing bound Ca2+ indicated by
pink dots) capable of scrambling a lipid along a hydrophilic groove facing the membrane, similar to swiping a
credit card through a card reader. (b) Rhodopsin-mediated lipid scrambling taking place along the
rhodopsin–membrane interface (orange zone). Figure adapted from Reference 21.
reticulum (ER) and must be scrambled between the two leaflets for uniform expansion of
ER during cell growth (98). In plasma membranes, flip-flops are needed to establish and also
dissipate the characteristic transmembrane lipid asymmetry, where the asymmetry is crucial for
activating blood coagulation and apoptosis (38, 97). Specialized transporter enzymes such as
ATP-dependent flippases and floppases use metabolic energy to translocate specific lipids across
the membrane. Scramblases in turn promote rapid, nonspecific, and bidirectional movement
of lipids without consuming ATP. It is intriguing that despite decades of active research, the
molecular identities of scramblases and the understanding of their function are only beginning to
emerge.
The first X-ray crystal structure of a scramblase [transmembrane protein 16 (TMEM16)] was
reported in 2014 (12). The homodimeric structure of TMEM16 contains a membrane-faced,
transbilayer hydrophilic groove on each of the subunits, through which the polar headgroup of
a lipid can slide across the membrane, keeping the acyl chains in a favorable hydrophobic en-
vironment in a fashion that is analogous to swiping a credit card through a card reader (8, 12)
(Figure 1). Earlier, Menon et al. (61) had discovered unexpected and robust scrambling activity
for rhodopsin [a G protein–coupled receptor (GPCR)], which is structurally very different from
TMEM16. Upon reconstitution into vesicles, different conformational states of rhodopsin were
observed to facilitate rapid scrambling of phospholipids (>104 lipids per rhodopsin per second),
speeding translocation up by a factor of ∼1,000 and implying that conformational changes in
the scramblase protein are not required for scrambling (27). Similar scrambling ability for the apo
and the holo forms suggests that the lipid translocation path does not involve the water-containing
www.annualreviews.org • Lipids in Signaling 423
central core of the protein (27), which was also proposed earlier (61). These results suggest that
the transverse diffusion of lipids along the rhodopsin–membrane interface could be a possible
scrambling mechanism (21, 27) (Figure 1).
Computer simulations can provide precise atom-scale understanding of how the GPCR-
facilitated scramblase function takes place. This is highlighted in recent simulation studies. T.
Nieminen, M. Manna, T. Róg & I. Vattulainen (unpublished manuscript) used extensive atom-
istic molecular dynamics (MD) simulations to provide intriguing insight into the lipid scrambling
mechanism of opsin—the apoprotein of rhodopsin. The study assessed the feasibility of various
lipid transport routes and showed that opsin provides favorable conditions for the flip-flop of phos-
pholipids along the protein surface. By fostering the hydration of the lipid headgroup as it glided
next to helices II, III, and IV on the opsin surface, the free energy barrier of phospholipid flip-flop
was reduced by ∼50% compared to a protein-free membrane (Figure 2). This likely explains the
high scrambling rate found in experiments. The study also concluded that the free energy barrier
associated with the translocation of phospholipids through the central water core of opsin is very
high, thus supporting the prediction previously made based on experiments (61). The simulation
results (T. Nieminen, M. Manna, T. Róg & I. Vattulainen, unpublished manuscript) further sug-
gested that the scramblase activity of opsin is not lipid selective, since the study showed opsin
to lower the free energy barrier of cholesterol translocation by ∼60% compared to a protein-
free membrane with the same lipid composition (Figure 2). Similar conclusions were drawn for
another receptor in the class-A GPCR family [β2-adrenergic receptor (β2AR)], which was also
found to reduce the free energy barrier of cholesterol translocation, in agreement with experi-
ments. Overall, these simulations (T. Nieminen,M.Manna, T. Róg & I. Vattulainen, unpublished
manuscript) provide mechanistic insight into how selected proteins in the GPCR family function
as ATP-independent nonselective lipid scramblases.
The molecular mechanism by which opsin facilitates rapid phospholipid scrambling has also
been explored in another recent simulation study (63). The study reported that translocation took
place in a manner where the lipid headgroup migrates along a hydrophilic path between the trans-
membrane helices VI and VII of opsin, while the lipid chains remained in the hydrophobic mem-
brane region—similar to what is referred to as the credit card model proposed by experiment.
The Markov state model analysis discussed in this study suggests that the rate-limiting step of
the scrambling process is the opening of the hydrophilic path triggered by the conformational
changes in opsin structure, where the internal hydration of opsin plays a key role in the scram-
bling mechanism (63).
Recent studies have shown that lipid flip-flops can be facilitated by synthetic transmembrane
(TM) peptides characterized by low complexity (47). TM peptides can induce packing defects in
the bilayer due to movement of the helices, local bilayer thinning, and transient penetration of
water into the bilayer (39). Facilitated by defects at the lipid–helix interface, a lipid may “slip”
into the membrane hydrophobic core with its headgroup in a solvated state and then “pop out”
on the other side of the membrane (21). A recent study (67), which combined experiments and
MD simulations, showed that the lipid scrambling activity of a single TMmodel peptide depends
on the hydrophobic length of the peptide and the hydrophilicity of its central residues. Short
peptides were observed to cause membrane thinning under negative mismatch, and the presence
of a hydrophilic residue in the membrane core region fostered the penetration of water to the
membrane interior. Together, these factors promote peptide-induced phospholipid flip-flop. An
example highlighting this in practice is discussed in Reference 90, which demonstrated through
atomistic simulations that the transmembrane WALP23 peptide facilitates phospholipid flip-flop
by lowering the free energy barrier of lipid translocation.
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Figure 2
(a) Translocation path next to helices II, III, and IV of opsin. (b) Free energy profiles for POPC (1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine) (blue) and cholesterol (red) translocation along the opsin–membrane
interface. Statistical errors are depicted by the shaded area. The reaction coordinate (z) is the difference
between the lipid headgroup’s center of mass and the bilayer center along the bilayer normal. (c) Free energy
profiles for POPC (blue) and cholesterol (red) translocation in a protein-free membrane.
LIPID TRANSLOCATION MEDIATED BY MEMBRANE DEFECTS
In defect-free lipid membranes without proteins, passive lipid flip-flop is a very slow process—
typical rates per lipid being of the order of one per day (1). However, this does not mean that
flip-flops would not take place and the asymmetric lipid distributions in cell membrane structure
would last forever even without ATP-driven nonequilibrium transport. Simulations have revealed
that the slow rate is due to the energetically costly transport of the polar lipid headgroups through
the hydrophobic membrane interior. As demonstrated by simulations, this can be speeded up by
defects, such as membrane pores (29). Then the rate-limiting step in translocation is the forma-
tion of pores (defects) that can be induced by, for example, an applied external electric field, trans-
membrane ion imbalance, or the presence of surface-active molecules or antimicrobial peptides
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(6, 30, 49, 99). The kinetics and thermodynamics of passive lipid translocation thereby strongly
depend on membrane properties, such as lipid acyl chain length, headgroup chemistry, bilayer
phase behavior (lipid packing), and the concentration of cholesterol that quite strongly modulates
membrane packing (1, 7, 17, 52, 89).
PHOSPHATIDYLSERINE AS A MESSENGER OF DEATH—AND THE
ROLE OF OXIDATIVE STRESS
The most prominent loss of transmembrane lipid asymmetry occurs during programmed cell
death (apoptosis)—a coordinated process controlling the removal of damaged cells (4, 9, 22). In
healthy cells, phosphatidylserine (PS) is confined to the cytoplasmic leaflet of the plasma mem-
brane, while in cells undergoing apoptosis, PS is exposed to the exoplasmic leaflet. PS exposure
therefore serves as a so-called eat-me signal that ensures effective recognition and engulfment
of the dying cell by phagocytes. Given this, PS is a highly effective marker of apoptosis and has
clinical applications in, for example, cancer therapy and infections. Scramblases such as proteins
belonging to the TMEM16 family and Xk-related family are known to randomize the transmem-
brane PS distribution, while flippases such as P4-ATPase restore PS to the cytosolic leaflet (66).
Intriguingly, despite extensive research, the precise role of these specific enzymes in apoptosis and
their differential lipid translocation mechanisms remain obscure.
Another hallmark of apoptosis is oxidative stress. It takes place when the compensatory an-
tioxidant defense of a cell is overwhelmed by excessive production of reactive oxygen species
(ROS), which can oxidize membrane lipids and damage cell membranes. Recent studies (83, 100)
have demonstrated that the oxidative damage of the plasma membrane can effectively catalyze PS
scrambling in a nonenzymatic fashion.
Using MD simulations, Volinsky et al. (100) estimated the free energy of POPS (1-palmitoyl-
2-oleyl-sn-glycero-3-phospho-l-serine) translocation in the presence and absence of oxidized
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) (100). The oxidized POPC simu-
lated in this study had a truncated sn-2 hydrocarbon chain linked to an aldehyde group at the
chain end (PoxnoPC), which is one of the major oxidation products in polyunsaturated phos-
phatidylcholines (PCs). In a membrane with 20 mol% of PoxnoPC, Volinksy et al. observed a
20-kJ/mol reduction in the free energy barrier of PS translocation, which can enhance the flip-
flop rate by a factor of∼103–104.To validate the simulation predictions, the authors also measured
the transmembrane lipid diffusion using fluorescence techniques (100).They observed a profound
enhancement of PS flip-flop in liposomes containing oxidized PC; for example, the half-time was
found to be ∼2 h in membranes with 16 mol% of PoxnoPC, while in intact membranes, the half-
time was several weeks. These findings are supported by another simulation study, which showed
the free energy barrier of PS translocation to decrease linearly with increasing concentration of
peroxidized PC (83) (Figure 3). For 50 mol% peroxidized PC, the free energy barrier of POPS
translocation was found to drop ∼30% compared to an intact membrane. Interestingly, both of
the abovementioned computational studies indicate that the translocation of PS is accompanied
by the formation of a membrane defect, which facilitates the crossing of the polar lipid headgroup
through the hydrophobic core of the membrane. In membranes rich in oxidized lipids, the polar
oxidized group most obviously lowers the energy cost of formation of membrane defects/pores,
thus reducing the free energy barrier of PS translocation.
PS externalization in response to high-field nanosecond-long electric pulses was demonstrated
in Reference 99 using a combination of simulations and fluorescence microscopy imaging. In
simulations of asymmetric bilayers (with PS located in one of the leaflets) subjected to a high
transmembrane voltage (>450 mV/nm), Vernier et al. observed fast intrusion of water on the
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Free energy profiles for phosphatidylserine translocation through phospholipid bilayers with different levels
of peroxidation (see legend). Figure adapted from Reference 83.
cathode side of the membrane, leading to pore formation. The anionic PS headgroup was then
electrophoretically dragged along the pore wall. The authors showed that PS translocates only
after pore formation and always to the anode side of the membrane, in line with the experimental
observations made on live cells (99). Similar electroporation and PS externalization were reported
earlier based on coarse-grained simulations (35). The field-driven alignments of water and lipid
headgroup dipoles are critical for electropermeabilization and anode-directed PS translocation.
POLYUNSATURATED FATTY ACIDS INVOLVED IN STRESS
RESPONSE UNDER OXIDATIVE STRESS
As described above, an excessive amount of ROS causes cellular damage and contributes to aging
and age-related disorders. The significance of the problem is illustrated by the fact that nearly
5% of the total energy used by the body is spent for maintaining and repairing cell membranes
damaged by oxidation (11). In this context, the primary targets of ROS are polyunsaturated fatty
acids (PUFAs) because of the numerous double bonds in their hydrocarbon chains. In phospho-
lipids, two major oxidized lipid products of the PUFA chain in the sn-2 position typically include
either a hydroperoxide group or a truncated chain containing an aldehyde or a carboxylic group at
the terminus (102). When a hydrophilic group is attached to the sn-2 chain, the acyl chain is ex-
pected to change its orientation in order to contact water (acyl chain reversal), unlike intact PUFA
chains that adopt a typical orientation toward the hydrophobic core of a bilayer.The reorientation
of the acyl chain depends on the chemical structure of the oxidative modification. For example, an
oxidized chain with a terminal carboxyl group in the deprotonated state flips toward water along
the bilayer normal, whereas the protonated form of the chain adopts a parallel orientation along
the lipid–water interfacial plane (60). In the same context, it was found that while the hydroper-
oxide group of an oxidized lipid rises to the membrane surface, the peroxyl radical intermediate is
instead positioned in the innermost region of a membrane like a nonoxidized lipid (24). The acyl
chain reversal increases the area per lipid, leads to bilayer thinning, and decreases lipid chain con-
formational order, thus promoting water permeability and membrane deformation. The effects of
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Figure 4
Pore formation and micellation in a lipid bilayer for an increasing concentration of aldehyde lipids (green) mixed with nonoxidized
phospholipids (white). Green and white spheres represent the phosphorus atoms of the lipids. Red spheres depict the oxygen atom of
the aldehyde group of the oxidized lipid tails. Blue spheres represent oxygen of water. Figure adapted from Reference 10.
oxidized lipids on the structure and permeation properties of lipid bilayers have been studied by
simulations (10, 51, 69, 75, 93, 101) and experiments (37, 87) quite extensively.
A recent computational study demonstrated how the polar groups of oxidized lipids perturb the
bilayer, induce formation of pores and other membrane defects, and also induce micellation (10).
In a binary mixture of polyunsaturated PCs and their peroxide and aldehyde products, Boonnoy
et al. observed formation of membrane defects with both peroxide and aldehyde lipids, but full
pores were found only with aldehyde at medium concentrations (∼50 mol%). With aldehyde
lipids, the hydrophilic tips of the oxidized chains were highly mobile inside the bilayer and got
into contact with lipids of the opposing leaflet. Consequently, the aldehyde groups pulled water
into the bilayer interior, leading to the formation of a water pore stabilized by the flipping of lipid
headgroups along the pore wall (Figure 4) (10). At higher aldehyde concentrations (>75 mol%),
themembrane pores were unstable and the bilayer deformed into amicelle (Figure 4).Meanwhile,
no pores or micelles were formed with peroxidized lipids (10), suggesting that the highly polar
peroxidized groups prefer the membrane–water interface to the bilayer interior.
CHOLESTEROL AND OXIDATIVE STRESS
The role of cholesterol in oxidative stress and the related signaling phenomena is twofold. First,
results for intact (nonoxidized) cholesterol demonstrate that cholesterol has a protecting effect
against mechanical instability arising from lipid oxidation. Recent computational studies showed
that cholesterol forms hydrogen bonds with the oxidized lipids and thereby prevents pore forma-
tion and micellation (75). The condensing and ordering effects of the sterol backbone were found
to be significant even in amassively peroxidizedmembrane with all phospholipids and cholesterols
peroxidized (69).
Second, cholesterol itself can also be oxidized through the double bond in the ring of choles-
terol or H-atom transfer from the allylic position (102). ROS generate ring-oxidized sterols,
whereas tail-oxidized sterols are produced by enzymatic oxidation. Despite their relatively low
concentrations at physiological conditions, oxysterols are primary players in many biological pro-
cesses, including signaling, given that there are quite a few oxysterol-binding membrane receptors
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(40). As shown by MD simulations for a wide range of ring- and tail-oxidized sterols, the order-
ing and condensing effects of oxysterols correlate with their orientation in a lipid bilayer (42, 74).
While ring-oxidized sterols behave more or less similar to cholesterol, tail-oxidized sterols can
orient themselves either parallel or perpendicular to the bilayer normal because of an additional
polar group at the hydrocarbon chain. Oxysterols with rather weak headgroup polarity (e.g., the
3β-OH group replaced by the ketone group in 4-cholesten-3-one) undergo frequent interleaflet
movements or flip-flop motion (70, 86). Also, this oxidized derivative has a lower free energy bar-
rier for desorption from the membrane to the water phase than cholesterol, and it can be readily
transferred to its extracellular acceptors (70), which has a direct consequence for the cellular traf-
ficking of cholesterol.
As discussed above, lipid flip-flops in the absence of scramblases are usually very slow; how-
ever, sterols seem to be an exception to this rule. A variety of simulation studies have determined
free energy barriers associated with cholesterol translocation (7, 17, 70) and identified the flip-
flop mechanism, which is based on cholesterol turning around in the middle of the bilayer. For
oxysterols, the flip-flop mechanism can be distinctly different, as highlighted by a recent com-
putational study, which revealed a novel translocation mechanism for tail-oxidized sterols (41):
27-OH-cholesterol was shown to move back and forth along the membrane normal with either
its 3β-OH group (in the head) exposed to water with the 27-OH group (in the tail) buried in-
side the membrane, or vice-versa. This so-called bobbing mechanism does not require the en-
ergetically costly change in sterol orientation during the flip-flop process and thereby renders
the translocation process extremely fast (41). For a related oxysterol (25-OH-cholesterol), it has
been demonstrated that it transfers from the plasma membrane to the ER with a rate that is 100
times faster than that of cholesterol (45, 46). For 24S-OH-cholesterol and 27-OH-cholesterol, the
transport from erythrocytes to the plasma membrane is fast, while the transport of cholesterol is
almost negligible (59).While the reasons for the distinctly different transport rates are not known,
it is quite possible that the rapid translocation in terms of the bobbing mechanism plays a role in
the rapid signaling mediated by selected oxysterols.
MEMBRANE REGISTRATION AND INTERDIGITATION—MEANS
FOR CROSS TALK BETWEEN BILAYER LEAFLETS
Plasma membranes of eukaryotic cells are characterized by considerable transbilayer lipid asym-
metry. Sphingomyelin (SM) is more concentrated in the extracellular leaflet,whereas PS and phos-
phatidylethanolamine (PE) are more confined to the cytosolic leaflet (38, 98). The distribution of
cholesterol is a matter of debate, but it is inferred to be concentrated more in the extracellu-
lar leaflet by virtue of its predicted association with SM (38). If the two leaflets were uncoupled,
then only the extracellular leaflet would be expected to form raft-like domains. Such transbilayer
compositional asymmetry may lead to phase asymmetry or antiregistration, meaning that the two
opposing leaflets have different fluidity. Alternatively, a domain in one leaflet can induce the for-
mation of a similar domain in the opposite leaflet, leading to phase symmetry or registration (58,
71). This paradigm may explain why certain proteins that are exclusively associated with the cy-
tosolic leaflet of the plasma membrane are colocalized with raft components (103). But then, how
do the two leaflets of a biological membrane modulate each other’s physical properties? While
several plausible mechanisms have been proposed (18, 58), the idea of dynamic chain interdig-
itation is one of the most promising ways to understand the cross talk between the membrane
leaflets.
A recent study employed atomistic simulations to assess how the extracellular and cytosolic
leaflets of membranes interact through interdigitation (85). The study used realistic model
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Figure 5
(a) Transmembrane domain registration in a bilayer containing short-chain GM1. Lo stands for the liquid-
ordered phase (domain) and Ld for the liquid-disordered phase. (b) Mixing of saturated and unsaturated
lipids in the inner leaflet induced by interdigitation of GM1 with long acyl chains. Figure adapted from
Reference 53.
membrane systems, which closely mimicked the composition of eukaryotic plasma membranes.
The results revealed that SM with a long saturated acyl chain (SM 18:1–24:0) protruded deep
into the opposing bilayer leaflet, and the penetration was particularly strong when the bilayer
was asymmetric. The interdigitation affected the conformational order of the penetrating SM
acyl chain as well as the order of the opposing membrane leaflet, thereby strengthening the
interaction and the coupling across the membrane (85). A similar mechanism was reported in
another atom-scale simulation study, where a long-chain ganglioside (GM1) was observed to
promote transbilayer coupling through interdigitation (53). To unravel how the acyl chain length
of GM1 contributes to membrane registration, the study also used coarse-grained simulations
probing longer timescales in large membrane systems. The results showed that with short-chain
GM1 lipids (with ∼18 carbons) in the extracellular leaflet, both bilayer leaflets readily underwent
complete phase separation leading to a phase-symmetric bilayer with strong membrane regis-
tration (Figure 5). In contrast, GM1 with an extended acyl chain (∼30 carbons) was found to
perturb the phase of the GM1-free cytosolic leaflet. The significant interdigitation of the long
acyl chain of GM1 into the opposite leaflet was observed to induce the mixing of saturated and
unsaturated lipids, thus preventing or at least slowing down the phase separation in the cytosolic
leaflet and weakening the overall membrane registration process (Figure 5) (53).
An earlier study using extensive coarse-grained simulations showed a transition from the regis-
tered to antiregistered bilayer configurations when the length of the saturated lipids was increased
from ∼16 to ∼20 carbons, increasing the height mismatch between ordered and disordered do-
mains by ∼0.4 nm (80). The results showed that in compositionally symmetric phase-separated
bilayers composed of cholesterol, saturated lipids, and unsaturated lipids, the transbilayer phase
asymmetry results from the mismatched acyl chain lengths. Theoretical models have suggested
that domain registration is directed by the balance between two tensions (58): the interleaflet
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tension at the bilayer midplane, which is minimized by transbilayer registration, and the in-
traleaflet tension at domain boundaries due to height mismatch, which can be relieved by mixing
saturated and unsaturated lipids at domain boundaries (80).
In conclusion, the simulation studies suggest that the physical interactions between the two
leaflets in the form of interdigitation provide a means to mediate transmembrane communication
associated with signal transduction.
LIPID MESSENGERS BIND TO RECEPTORS AND TARGET
PROTEINS AS ORTHOSTERIC LIGANDS
Lipids are not just passive constituents of cell membranes or a source of stored energy; they
can also act as signaling molecules (23). Extracellular stimuli can elicit cellular responses
through generation of intracellular second messengers. Agonists of cellular receptors, such as
GPCRs and tyrosine kinases, activate enzymes such as phospholipases, sphingomyelinases, and
phosphatidylinositol-3-kinase, which catalyze the cleavage of lipids (73). Lipid metabolites such
as sphingosine-1-phosphate (S1P), diacylglycerol, or ceramide are important examples of lipid
messengers, which serve as intracellular signals and bind target proteins to mediate specific cellu-
lar responses.
The mechanisms of lipid signal transduction are poorly understood but often involve GPCRs.
As reviewed recently (96), over 50 GPCRs have been implicated in signaling lipids that in-
clude lysophospholipids, phospholipids, fatty acids, and eicosanoids. Dysregulation of these lipid
GPCRs contributes to diverse cancer-related processes and may be therapeutically exploited
(96). Most lipid GPCRs belong to class-A (rhodopsin-like) GPCRs. However, unlike prototypi-
cal GPCRs that recognize small hydrophilic ligands, lipid GPCRs are activated by lipid media-
tors, which possess a polar headgroup and long hydrophobic moieties, thus implying significantly
different activation mechanisms. Sphingosine-1-phosphate receptors (S1PR1–5) and lysophospha-
tidic acid receptors belong to this receptor superfamily. In the past few years, crystal structures of
several lipid GPCRs have been resolved, including the structure of antagonist-bound S1PR1 (33).
S1P activates five cell-surface GPCRs (S1PR1–5). By combining MD simulations and functional
assays using S1P analogs with different alkyl chain lengths, a recent study demonstrated that the
alkyl chain length of the lipidic agonist is the key structural feature in the activation of S1P recep-
tors (95). The data suggest that the headgroup of S1P is required for high-affinity binding, but the
alkyl chain is responsible for triggering the activation. S1P stabilizes the active state of S1PR1 by
inserting its lipid chain into the small hydrophobic cavity of the receptor between TM domains 3,
5, and 6. The ligand efficacy was observed to be directly related to the alkyl chain length and to
vary within receptor subtypes owing to different volumes of binding cavities (95). Another recent
work by the McCammon group (15) investigated the activation mechanism of ligand-free S1PR1.
The simulations captured four independent activation events and correlated helix movement dur-
ing activation.During the simulations, a lipid molecule was repeatedly found to enter the receptor
between the extracellular ends of TM1 and TM7.
Cholesterol is known for its modulatory role on GPCRs. Cholesterol and its derivatives are
even speculated to modulate functions of certain class-A GPCRs from the orthosteric binding
pocket, similar to conventional class-A ligands (5, 92). A recent crystal structure shows a choles-
terol molecule at the binding site of the extracellular domain of a class-F GPCR (14). The rather
surprising orthosteric mode of action of cholesterol is less explored. It has been postulated that
cholesterol can allosterically regulate GPCRs by directly interacting with them at specific sites
on the receptor surface or by indirectly changing the physical properties of the membrane (25,
76). In certain cases, however, the impact of cholesterol on GPCRs can go beyond pure allosteric
www.annualreviews.org • Lipids in Signaling 431
a b
1 2
3 4
Figure 6
(a,●1 –●4 ) Entrance of cholesterol (yellow) into the orthosteric ligand-binding site of the adenosine A2A
receptor (blue). (b) The average position of cholesterol in the binding site calculated from simulations (yellow
transparent region) and superimposed on the crystal structure of the agonist-bound receptor (red sticks). Also
shown is the final simulation snapshot of cholesterol at the binding site (yellow sticks). Figure adapted from
Reference 28.
modulation. By combining experimental and computational approaches, a recent study showed
that membrane cholesterol can spontaneously invade into the orthosteric ligand-binding pocket
of the adenosine A2A receptor (Figure 6) and compete with specific ligand binding (28). In ad-
dition to several interaction sites on the receptor surface, simulations demonstrated high choles-
terol densities to populate a significant area of the orthosteric ligand-binding site of the receptor,
overlapping with the position of the ligand found in the crystal structure (Figure 6). Cholesterol
entered the binding pocket through the extracellular side of TM5–6 using the same portal gate
that was previously suggested for the entry of a ligand into opsin. Confirming the simulations, ex-
periments showed specific ligand binding to increase for decreasing cholesterol content. Further,
the authors confirmed the presence of cholesterol inside the receptor by chemical modification
of the receptor interior in a biotinylation assay. The study (28) strongly suggests a new regulatory
mechanism of cholesterol and also provides an example of how simulations can bring added value
to experiments.
LIPIDS IN ALLOSTERIC MODULATION OF RECEPTOR ACTIVATION
Lipids are progressively emerging as essential modulators of membrane protein functions, includ-
ing major families of cellular receptors such as GPCRs (19, 25, 82), receptor tyrosine kinases (36,
62), T-cell receptors (94), and ligand-/voltage-gated ion channels (3, 31, 43, 78). These recep-
tors are signaling machines embedded in cell membranes, which convert extracellular stimuli into
cellular responses. Biological membranes host dynamic lipid–protein assemblies, where a protein
with selected lipids may create its own functional lipid microenvironment (44, 78). Several studies
have identified and characterized lipid interaction sites in a variety of membrane proteins (34, 44,
78). A lipid specifically bound to a protein at a site that is not an orthosteric site may also regulate
protein structure and function, a process referred to as allosteric modulation. Despite substantial
instances of lipid modulation, the mechanisms of allosteric modulation remain unclear.MD simu-
lations could offer detailed insight into specific lipid–protein interactions and their effects (2, 91),
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but so far, only limited computational studies have been able to link these physical interactions
to functional consequences of receptor activation/function. These studies have mostly focused on
GPCRs owing to their involvement in a multitude of physical processes, the acknowledged lipid
dependency of GPCRs, and also the availability of several crystal structures, which make GPCRs
viable for computational investigations.
Biologically relevant phospholipids can act as allosteric regulators of GPCR function. A recent
experimental study showed that lipids with the phosphatidylglycerol (PG) headgroup strongly fa-
vor agonist binding and receptor activation of the β2AR, whereas the PE headgroup favors antag-
onist binding and stabilizes the inactive state of the receptor (19). A recent computational study
(13) provided mechanistic insight into positive and negative allosteric modulation and showed
that the effect is attributed to the chemical differences between and charges of these lipid head-
groups, which modify the lipid–receptor interactions and alter membrane properties. Simulations
also showed that the negatively charged 1,2-dioleoyl-sn-glycero-3-phosphoglycerol (DOPG) lipid
preferentially interacts with the positively charged residues of the intercellular loop 3 and the in-
tercellular end of TM6, which give rise to an outward pull on TM6 and stabilize receptor con-
formation with an open G protein–binding interface that is characteristic of the active state of
the receptor. Further, this study, and also an earlier computational investigation, showed that PG
from the cytosolic leaflet intrudes into the empty G protein–binding site between TM6 and TM7
of β2AR that is in the active state (13, 68). The negatively charged PG headgroup specifically in-
teracts with R1313.50 on TM3 and inhibits the formation of a conserved R1313.50–E2686.30 ionic
lock, which characterizes the inactive state of the receptor. These studies suggest that the bind-
ing of anionic PG stabilizes the active state of the receptor via conformational selection. Mean-
while, the neutral 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) lipids (with a posi-
tively charged ethanol amine moiety in the headgroup) create unfavorable interactions with the
positively charged residues of TM6, thereby destabilizing the active state and strongly favoring
complete deactivation of β2AR (13).
Another recent computational study (88) showed that the PE headgroup and the polyunsatu-
rated docosahexaenoic acid chains preferentially bind to the inactive conformation of rhodopsin,
suggesting that the lipid modulation arises from both solvent-like (membrane mediated) and
ligand-like (direct lipid–protein) interactions that depend on the state/conformation of the
receptor. Reference 13 further showed that another neutral lipid [1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC)] can induce partial deactivation of β2AR, in agreement with compu-
tational results by Dror and colleagues (20, 48) that showed gradual inactivation of β2AR in a
POPC membrane. Unlike PE, the PC headgroup is more hydrophobic and unable to form inter-
lipid hydrogen bonds, resulting in a lower membrane density. In a less dense DOPC membrane,
β2AR exhibits greater conformational freedom and inactivates slower than in a DOPE bilayer, in
agreement with experimental results (19).
Cholesterol is frequently invoked as a modulator of protein structure (16, 55, 65), stability (32,
104), oligomerization (reviewed in Reference 79), and ligand binding of several GPCRs (25, 26,
72, 76, 77, 81, 82). The literature reporting the functional role of cholesterol as a positive or neg-
ative modulator of GPCR activity is extensive. It has been a matter of intense debate whether
the modulation is due to cholesterol-induced changes in membrane properties, specific and direct
cholesterol–GPCR interactions, or both. Crystal structures have revealed the binding of choles-
terol to the surface of several GPCRs (25, 32, 34), suggesting specific allosteric sites for cholesterol.
However, the functional relevance of these physical interactions and the atomic-scale mechanism
of cholesterol modulation have remained unknown. A recent computational study clarified this
issue to a large degree, however. It provided atomistic insight into the mechanism of allosteric
regulation of β2AR by cholesterol (56). The study showed that under cholesterol-rich conditions,
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cholesterol has a large impact on the conformational dynamics of β2AR, as cholesterol limits the
receptor conformation predominantly to one state. Under cholesterol-poor conditions, the con-
formational distribution was found to be very broad (54, 56). The mechanism of action was re-
vealed to be based on binding of cholesterol at two specific interaction sites located near the TM5,
TM6, and TM7 domains, which are evolutionally conserved among β2AR orthologs. Choles-
terols bound at these sites significantly impeded the mobility of the respective helices, thereby
reducing the overall conformational flexibility of the receptor. The effect was found to depend
on the strength of cholesterol binding and not on the physical state of the surrounding bilayer
(56). The study also showed that cholesterol bound between TM5 and TM6 on the intracellular
side exerts the strongest effect by preventing the outward movement of TM6 required for activa-
tion of β2AR. However, cholesterol also stabilizes the active state of the receptor by preventing
the inward movement of TM6. Altogether, the study shows that cholesterol reduces the con-
formational flexibility of β2AR, weakening chances to switch between different functional states
(56).
LIPIDS MODULATING LIPID RECEPTORS
Not all receptors are proteins. There are also quite a few lipids acting as receptors, with glyco-
sphingolipids being perhaps the primary example of this class. Glycolipids are challenging to con-
sider through computer simulations, since in these lipids, the carbohydrate headgroup carries out
the recognition that is highly dependent on the chemical details of the headgroup. Instead of
coarse-grained models, the most appropriate approach is to use atomistic simulations (57). Ling-
wood et al. (50) used this strategy to reveal the mechanism used by cholesterol to modulate the
receptor function of GM1. By inducing a tilt in the GM1 headgroup, cholesterol was able to in-
duce a loss of access for ligand binding. Recent simulations by Rissanen et al. (84) support this
picture. Exploring this issue more broadly would be exceptionally justified.
CONCLUDING REMARKS
Cell signaling coordinates cell actions and controls a variety of cellular processes. Errors in signal-
ing often lead to diseases such as cancer and diabetes. By understanding the underlying physical
and chemical bases of signaling, the chances of clarifying why and how these diseases emerge
would be significantly improved.
Even though membrane proteins are the main contributor to cellular communication taking
place in or through cell membranes, there is reason to keep in mind that membrane proteins
are modulated by a number of factors, particularly lipids. Further, since it is quite possible that
membrane lipid compositions are altered in certain diseases (64), the modulation of membrane
proteins by lipids is also dependent on whether the subject is healthy or exposed to a disease.
In this article, we have discussed how lipids contribute to and take part in cell signaling. Among
many other ways, lipids modulate protein conformations and act as messengers, and they are sub-
ject to structural modifications that can change the lipids’ functions in the context of signaling.
Further, even though there is not enough space to discuss this topic more broadly, it is worth men-
tioning that lipids can also control protein activation by, for example, modulating the partitioning
of membrane proteins by varying membrane physical properties and altering the intramembrane
pressure profile exerted on transmembrane proteins. There are many ways in which lipids can
take part in signaling, but the very essence of the matter remains the same: The role of lipids in
cellular signaling is significant. And the added value given by simulations to reveal how lipids are
involved in cellular signaling is impressive.
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